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ABSTRACT  
Uronates are charged sugars that constitute a major component of glycosaminoglycans 
(heparin, heparin sulfate, hyaluronan etc.,) and cell wall polysaccharides of plants (pectate/ pectin) and 
marine algae (alginate, ulvan). Glycosaminoglycans (GAGs) participate in a variety of cellular 
functions including stabilization of the extracellular matrix, control of hydration and organism 
development, whereas pectate, alginate and ulvan represent a huge biomass with wide industrial 
applications. Bacteria that encounter GAGs and plant algal biomass express enzymes to degrade 
uronate polysaccharides as a source of nutrients. These enzymes are called polysaccharide lyases (PL) 
and degrade the uronate polysaccharide by a β-elimination mechanism. Polysaccharide lyase enzymes 
are known to be involved in microbial pathogenicity and gut microbiome interactions. In addition, PL 
enzymes serve as biotechnology tools for industrial biomass conversion. 
The overall objective of this PhD project is to expand the existing structural and mechanistic 
knowledge of enzymes belonging to the PL families, with the emphasis on newly identified families 
for which no three-dimensional structures or catalytic mechanisms have been established. The first part 
of the thesis describes the structure and catalytic mechanism of Heparinase III from Bacteroides 
thetaiotaomicron. This enzyme specifically degrades the heparan sulfate GAG. The second part of the 
thesis concerns with the structure and catalytic mechanism of three newly identified lyases that degrade 
ulvan, the cell wall polysaccharide present in marine green algae. These ulvan lyases are; LOR107 
from Alteromonas, PLSV3936 from Pseudoalteromonas, NLR48 form Nonlabens ulvanivorans.  
The methodologies used in this research included: (1) X-Ray crystallography to determine the 
atomic structure of the aforementioned enzymes and the enzyme/substrate complex, (2) site-directed 
mutagenesis of key residues involved in substrate binding or catalysis, (3) enzymatic characterization 
of designed mutants to obtain insight into the roles of the selected residues in the catalytic process. 
 These studies resulted in: (1) the structure of HepIII and the identification of conformational 
flexibility prevalent in this class of enzymes, (2) the first structures of three ulvan lyases, called 
LOR107, PLSV3936 and NLR48. The ulvan lyases LOR107 and PLSV3936 share the 7-bladed β- 
propeller fold and NLR48 has a β-jelly roll fold. Despite different structural scaffold, the β-elimination 
catalytic machinery is conserved among the families. However, the complex structure with the bound 
tetrasaccharide substrate reveals the difference in the active site and mode of substrate cleavage. 
Overall, the structures determined as part of this research provide structural templates for a large 
number of lyases classified into the four different PL families. 
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1. Introduction 
 
 Living systems are made up of four types of macromolecules: nucleic acids, proteins, lipids 
and carbohydrates. Carbohydrates are the most complex of these macromolecules and are 
synthesized and metabolized by all living organisms. They are often present as polymers (either 
oligo or polysaccharides) linked to proteins or lipids and possess multiple chiral centers. The 
monosaccharides are connected by α or β glycosidic linkages and exist as linear (e.g. alginate, 
hyaluronan) or branched polymers (e.g. glycogen). They undergo a wide range of modifications, 
including acetylation, methylation, oxidation, and sulfation (Bertozzi and Kiessling, 2001; 
Cummings and Stephen, 2007). The stereochemical variability, linkages, diversity, branching and 
modifications present in polysaccharides gives rise to their structural complexity (Rodrigues et al., 
2011). 
 The structural complexity of polysaccharides lead to their functional diversity in living 
organisms. Polysaccharides are known to participate in a wide variety of cellular functions. They 
function as energy storage molecules (e.g. starch, glycogen) and aid in structural rigidity (chitin, 
cellulose). Polysaccharide capsules on the bacterial cell surface mediate an interaction between the 
bacterium and host. This capsule also promotes survival of the bacterium and protects it from 
immune system assaults after infection (Corbett and Roberts, 2009). In eukaryotes, 
glycosaminoglycans (GAGs), either free (hyaluronan) or attached to core proteins (proteoglycans) 
are abundant in the extracellular matrix (ECM) and on the cell surface where they maintain ECM 
integrity and are involved in a variety of biological processes. Other polysaccharides (e.g. alginate, 
ulvan, cellulose, pectin and agarose) are predominant in plants, marine bacteria, algae, fungi and 
are significant components of biomass (Hehemann et al., 2014; Grondin et al., 2017). They have 
enormous industrial and medical applications. For example, hydrogels derived from cross-linked 
polysaccharides are employed as drug delivery systems and in tissue engineering (Laurienzo, 
2010; Senni et al., 2011). 
 Two predominant reaction mechanisms are found in enzymes that degrade 
polysaccharides: hydrolysis and lytic cleavage. Hydrolysis is catalyzed by glycoside hydrolases 
(GH) that utilizes water to break the glycosidic bond, while polysaccharide lyases (PL) break the 
glycosidic linkage by abstracting a proton from the C5 position of the sugar. This leads to the 
 2 
 
formation of an unsaturated product at the nonreducing end. Extensive information on 
polysaccharide processing enzymes are available in the CAZy database (http://www.cazy.org) 
(Lombard et al., 2014). The research described in this thesis is focussed on the determination of 
the structure of PL family enzymes and on characterizing their catalytic mechanism. Using X-ray 
crystallography, mutagenesis and enzyme activity assays, the structure and catalytic mechanism 
of four polysaccharide lyases were studied. These are (1) Heparinase III (HepIII) from gut 
bacterium Bacteroides thetaiotaomicron, (2) Ulvan lyase LOR107 from Alteromonas species, (3) 
Ulvan lyase PLSV3936 from Pseudoalteromonas species and (4) Ulvan lyase NLR48 from 
Nonlabens ulvanivorans. In the following sections, a general background on the mechanisms of 
polysaccharide degradation is given. This is followed by a detailed overview, specifically on 
uronate polysaccharides, classification of polysaccharide lyases, their structural diversity and 
catalytic mechanisms. 
 
Literature review 
 
3 
 
2. Literature review 
 
 Polysaccharide degrading enzymes 
2.1.1 Glycoside Hydrolases (GHs) 
 Polysaccharide breakdown catalyzed by GHs is the most common and well understood 
reaction mechanism. Currently, GHs are classified into ~150 families based on their aminoacid 
sequences in the CAZy database. These enzymes employ a water molecule to facilitate the 
cleavage of a glycosidic bond between the anomeric carbon and the bridging oxygen. Hydrolysis 
of the glycosidic bond can occur with an inversion or retention of configuration of the product’s 
anomeric carbon after cleavage. Both mechanisms have a pair of amino acids with carboxylic 
groups at the active site and involve oxacarbenium ion-like transition states. (Rye and Withers, 
2000).  
 In the inverting hydrolase mechanism, one carboxylate acts as a general base and promotes 
the nucleophilic addition of a water molecule onto the anomeric carbon while the other carboxylate 
acts as an acid and donates its proton to the leaving group. This reaction proceeds through a single-
displacement mechanism (Rye and Withers, 2000; Vuong and Wilson, 2010) (Figure 2.1A).  
 In the retaining hydrolase mechanism, the reaction occurs through double displacement. 
In step 1, one of the carboxylates in the active site acts as a nucleophile and attacks the C1 anomeric 
carbon to form the covalent enzyme-substrate intermediate. Another carboxylate known to 
function as an acid/base donates a proton to the leaving group. In step 2, the carboxylate that 
donates a proton to the leaving group acts as a base and coordinates the water for nucleophilic 
attack on C1, resulting in a cleavage of the enzyme-substrate intermediate (Rye and Withers, 2000; 
Vuong and Wilson, 2010) (Figure 2.1B). 
2.1.2 Polysaccharide Lyases (PLs) 
Uronic acid-containing polysaccharides can be degraded by a lytic mechanism. The uronic 
acid sugar contains a carboxylic group at the C6 position. This depolymerization reaction is 
dependent on the presence of this carboxylic group and is catalysed by polysaccharide lyases (PL 
enzymes). Examples of uronate-containing polysaccharides are GAGs, pectin, alginate, ulvan and  
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(A) Schematic of inverting hydrolase mechanism. (B) Schematic of retaining hydrolase 
mechanism (Vuong and Wilson, 2010). All the reaction mechanisms and schematics of 
polysaccharides in this thesis were drawn using chemdraw. 
 
xanthan. So far, there are 27 sequence related PL families classified in the CAZy database. Many 
enzymes of bacterial, viral, algae, fungal and plant origin employ lytic mechanisms to 
depolymerize the uronate-containing polysaccharides. The lytic elimination mechanism occurs in 
three steps. First, the C6 carboxylate group of the uronate substrate is neutralized to reduce the 
pKa of the C-5 proton. Second, the C-5 proton is abstracted by a base to form an enolate anion 
intermediate. Finally, the electrons rearrange to form a double bond between C-4 and C-5 with 
concomitant cleavage of the C4–O1 glycosidic bond. This degradation mechanism leads to the 
formation of an unsaturated sugar at the newly formed non-reducing end while the sugar on the 
newly formed reducing end remains saturated (Figure 2.2) (Feingold and Bentley, 1987). Relative 
to the GH family of enzymes, PLs are somewhat understudied. Thus PL enzymes and their  
Figure 2:1 Catalytic reaction mechanism of GH. 
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associated lytic mechanisms are the focus of this thesis. The lytic elimination mechanism is 
described in detail in a later section (section 2.5). 
2.1.3 Subsite nomenclature 
  A common naming pattern of the subsite has been proposed for polysaccharide processing 
enzymes. The sugars of the substrate are numbered in both directions from the cleaved bond, with 
a ‘-’ sign on the nonreducing side and a ‘+’ sign on the reducing side of the bond. Thus, the bond 
to be cleaved is between -1 and +1 sugars (Davies et al., 1997). The residues of the enzyme that 
interact with individual sugars of the substrate are called the subsites and are given the number of 
the sugar they interact with (Figure 2.3).  
 Uronate-containing polysaccharides 
 Polysaccharides containing uronic acid are abundant in nature. They are present in algae, 
bacteria and higher eukaryotes such as plants and vertebrates. These polysaccharides are composed 
of repeating disaccharide units, containing a six membered sugar linked to a uronate sugar. Based 
on the nature of the uronic acid sugar at the +1 position,  the uronate polysaccharides are classified 
into three groups: (1) galacturonic acid (GalA) - this group contains pectate and pectin, (2) 
glucuronic acid (GlcA), iduronic acid (IdoA) - this group includes GAGs, namely hyaluronan, 
chondroitin, chondroitin sulfate, dermatan sulfate, heparin, heparan sulfate, heparosan, 
glucuronan, and non-GAGs namely xanthan, ulvan and (3) mannuronic acid (ManA)/guluronic 
acid (GulA) - this group contains alginates (Garron and Cygler, 2010). All the aforementioned 
uronates are stereoisomers of one another: GlcA and IdoA are C5 epimers, IdoA and GalA are C4 
epimers, IdoA and GulA are C2 epimers, GlcA and ManA are C2 epimers, GulA and ManA are 
C5 epimers (Figure 2.4). 
 
Figure 2:2 Schematic of β-elimination mechanism of PL. 
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Figure 2:3 Nomenclature of subsites in polysaccharide processing enzymes. 
The non-reducing end (NR) of the substrate is on the left and reducing end (R) is on the right. The 
scissile bond to be cleaved is between +1 and -1 subsite is shown by the arrow.   
 
 
Figure 2:4 Stereochemistry of uronate monomers. 
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2.2.1 Pectin/Pectate (Galacturonic acid (GalA) containing PL substrate) 
 Pectin is a complex structural cell wall polysaccharide present in plants. The 
monosaccharide components of pectin are D-GalA and L-Rhamnose (Rha). Pectins are classified 
into three types based on the sugar component, degree of modification and branching.  
The first type is called homogalacturonan (HGA) or polygalacturonan (PGA) and is composed of 
repeating α-1, 4-linked D-GalA residues. In PGA, the carboxylate groups are methyl esterified 
and, to a lesser extent, the C-2 and/or C-3 positions are acetylated. This region of pectin is often 
called the “smooth” region. The other two types are called Rhamnogalacturonans (RG I, RG II) 
and have branched pectin with a backbone composed of alternating units of L-Rha and D-GalA. 
RG1 and RG2 are often called the “hairy” region. In RG1 and RG2, L-Rha undergoes many 
modifications and the C-2 and C-3 positions of D-GalA are partially acetylated (Hugouvieux-
Cotte-Pattat et al., 2014; Abbott and Boraston, 2008; Ridley et al., 2001). Pectin plays an important 
role in plant growth, morphology, and plant defense mechanism. In addition, pectin has many 
industrial applications. For example, pectin is used as a gelling and stabilizing polymer in the 
cosmetic industry. Pectin is also employed in the production of a variety of specialty products 
including edible, biodegradable films, paper substitutes, and adhesives (Mohnen, 2008).  
2.2.2 Glucuronic (GluA) /Iduronic (IduA) containing polysaccharides 
 The glycosaminoglycans (GAGs), xanthan and ulvan are the uronate polysaccharides in 
this category. GAGs are a family of linear, sulfated, heterogeneous polysaccharides present in the 
extracellular matrix (ECM) and on the surface of animal cells. GAGs are composed of repeating 
disaccharide units. These disaccharides are predominantly made of GlcA or IdoA linked to a 
hexosamine, either N-acetylglucosamine (GlcNAc) or N-acetylgalactosamine (GalNAc) 
(Mizumoto and Sugahara, 2012). GAGs are classified into four groups based on differences in the 
repeating disaccharide units: (1) heparin (HP) / heparan sulfate (HS), (2) chondroitin sulfate (CS) 
/ dermatan sulfate (DS or CS-B), (3) hyaluronan (HA) and (4) keratan sulfate (KS). With the 
exception of HA, all GAGs undergo post-polymerization modifications on the sugars including 
sulfation, epimerization and desulfation (De Angelis, 2012). Some bacteria produce 
polysaccharides with a backbone structure resembling that of GAGs. 
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  Heparin (HP)/Heparan sulfate (HS) 
 Heparin sulfate (HS) consists of repeating disaccharide units of GlcA and GlcNAc. The 
disaccharide units are linked in this fashion [→4) β-D-GluA (1→4)-α-D-GlcNAc (1→] and are 
primarily non-sulfated or mono-sulfated (N-sulfated at C2). Heparin (HP) is a form of HS, with a 
high degree of sulfation and contains IdoA. The major repeating disaccharide sequence of HP is 
[→4)-α-L-IdoA (1→4)- α-D-GlcNAc) (1→] with sulfation occurring at C2, C6 of GlcNAc and O- 
sulfonation at C2-IdoA. The difference between HS and HP is in their GlcA/IdoA composition 
and degree of sulfation. HS has a high GlcA composition and contains ≥1 sulfate group per 
disaccharide, whereas HP contains high IdoA and ~2.7 sulfate groups per disaccharide, on average 
(Shriver et al., 2012; Cummings and Pierce, 2010).  
 Both HS and HP are linked to a serine residue of a number of core proteins and function 
as proteoglycans (HSPG) (e.g. serglycin, glypican and syndecan). HSPG participates in various 
cellular functions including blood coagulation, wound healing, embryonic development, and viral 
infections (Sarrazin et al., 2011). Defects in HSPG biosynthesis are linked to human multiple 
exotoses syndrome and skeletal developmental abnormalities (Huegel et al., 2013).  
 Chondroitin sulfate (CS)/Dermatan sulfate (DS) 
 Chondroitin sulfate (CS) is made of repeating units of GlcA and GalNAc with the linkage 
[→4) β-D-GlcA (1→3) β-D-GalNAc (1→]. Variations in the sulfation pattern of CS give rise to 
many CS subtypes: (1) chondroitin 4-sulfate or chondroitin sulfate A (CS-A) has GlcA (1→3) 
GalNAc (4S), (2) chondroitin 6-sulfate or chondroitin sulfate C (CS-C) has GlcA (1→3) GalNAc 
(6S), (3) chondroitin sulfate D has GlcA (2S) (1→3) GalNAc (6S), (4) chondroitin sulfate E has 
GlcA (1→3) GalNAc (4S and 6S) (Mikami and Kitagawa, 2013; Sugahara et al., 2003).  
 Dermatan sulfate (DS) has a similar backbone to CS but GlcA is replaced by IdoA and 
sulfated at the C2 position. DS has the linkage pattern of [→4) β-IdoA (1→3) β-GalNAc (1→] 
(Trowbridge and Gallo, 2002). DS has a subtype called chondroitin sulfate iE, which has (IdoA) 
(1→3) GalNAc (4S and 6S) (Sugahara et al., 2003). In addition to their structural roles, CS/DS 
has an important role in central nervous system (CNS) development, wound repair, infection, 
growth factor signaling, morphogenesis and cell division (Schwartz and Domowicz, 2002; Mikami 
and Kitagawa, 2013; Thelin et al., 2013). 
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  Hyaluronan (HA) 
 Hyaluronan (HA) is the only glycosaminoglycan lacking post-polymerization 
modifications. It functions as a free polysaccharide without being attached to a core protein and is 
built of repeating disaccharide units comprised of GlcA and GlcNAc with linkage [4→) β-GlcA 
(1→3) β-GlcNAc (1→] (Gandhi and Mancera, 2008).  
  Keratan sulfate (KS) 
 Keratan sulfate (KS) consists of repeating disaccharides of Gal and GlcNAc with the 
linkage [3→) β-Gal(1→4) β-GlcNAc(1→].The post-polymerization modification in keratan 
sulfate is sulfation at the C6 position of both hexose moieties (Funderburgh, 2002; Garron and 
Cygler, 2010).  
  Biological role of GAGs 
 GAGs are abundant in the ECM and connective tissues. They contribute to the native 
folding and function of proteoglycans, as well as to tissue and organ behavior. In fact, GAGs are 
involved in stabilization of the fibrillar ECM, control of hydration, regulation of tissue, and 
organism development by controlling the cell cycle, cell behavior, and differentiation (Lin. 2004, 
Mizuguchi, et al., 2003, Perrimon et al., 2000). The negative charges on glycosaminoglycans can 
bind large quantity of water molecules onto the cartilage and thereby ensures tissue visco-
elasticity, which is essential for the proper functioning of the locomotive system. 
  Ulvan (GlcA/IdoA containing polysaccharide from marine algae) 
 Ulvan is a complex sulfated polysaccharide biosynthesized by the seaweed marine green 
algae genera Ulva and Enteromorpha. Ulvan constitutes one of the major cell wall polysaccharides 
and contributes 8-29% of the dry weight of ulva species (Colle et al., 2011). This water-soluble 
polysaccharide is composed predominantly of 3-sulfated rhamnose (Rha3S), GlcA, IdoA and 
xylose. The most common repetitive units within the ulvan polysaccharide are disaccharide units 
[→4)- β-D-GlcA-(1→4)-α-L-Rha3S-(1→] called type A ulvanobiourinic-3-sulfate (A3S) and 
[→4)-α-L-IdoA-(1→4)-α-L-Rha3S(1→], called type B ulvanobiouronic-3-sulfate (B3S) (Lahaye 
and Robic, 2007). The presence of IdoA and sulfated rhamnose differentiates ulvan from other 
polysaccharides of marine origin and displays similarity with mammalian GAGs such as CS and  
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Schematic representation of the steps involved in the beneficial degradation of ulvan. Figure 
adapted and modified from (Bikker et al., 2016). 
 
HA. This distinctive chemical feature makes ulvan an attractive candidate for various biomedical, 
nanobiotechnological and drug delivery applications. Also, the physicochemical and biological 
properties of ulvan make it of interest for a variety of industrial applications in the food, 
agriculture, chemical and biomaterials industries (Cunha and Grenha, 2016; Manivasagan and Oh, 
2016; Morelli et al., 2016; Alves et al., 2013). Sulfated ulvan oligosaccharide has been reported as 
a synthetic elicitor for disease control in plants (Dumas et al., 2010). In addition to medicine and 
agriculture, the ulvan polysaccharide has captured attention in environmental and bioenergy fields 
(Singh and Olsen, 2011; Ulaganathan et al., 2018; Ulaganathan et al., 2017).  
Figure 2:5 Ulvan biomass conversion processes. 
Literature review 
 
11 
 
 The green algae called sea lettuce (Ulva lactuca) is a common dietary component in Asian 
and Mediterranean countries. Some green algae are notorious for eutrophication and causing green 
tides. The expanding environmental impact of these green algae has prompted efforts to mitigate 
this biomass or to make better use of it. Characterization of Ulva spp. shows high crude protein 
content of up to 44 % dry weight. Biorefining protein and non-protein constituents of seaweed will 
meet the protein demand to feed increasing animal populations. The sugar waste Rha, GlcA, IdoA 
will serve as starting material for various synthetics (e.g. Biofuel) (Bikker et al., 2016) (Figure 
2.5). 
  Xanthan 
 Xanthan is an extracellular hetero-polysaccharide synthesized by the pathogenic 
bacterium, Xanthomonas campestris. The main chain polymer is composed of the repeating 
Glucose (Glu) disaccharide unit with linkage [→4)-β-D-Glu-(1→4)-β-D-Glu-(1→]. The second 
Glu at C3 has a branch trisaccharide [β-D-Man-(1→4)-β-D-GlcA-(1→2)-β-D-Man-(1→3]. Both 
mannose units in the branch can be acetylated at the C-6 position and a pyruvate can be added on 
the C-4 or C-6 position. Xanthan is used as a common food additive and also in food packaging 
material (Garron and Cygler, 2010; Ahmad et al., 2015). Xanthan is also useful in pharmaceutical 
and biomedical applications that involve ingestion (Morris and Harding, 2009) .  
 Glucuronan  
 Glucuronan is a simple homouronic polysaccharide synthesized by bacteria, fungi and 
algae.  Glucuronan has repeating units of GlcA with linkage [→4)-β-D-GlcA-(1→4)-β-D-GlcA-
(1→] and undergoes partial acetylation at the C2 or C3 position. This polysaccharide has many 
applications in food and pharmacological industries (Garron and Cygler, 2010).  
2.2.3  Alginates (Mannuronic (ManA) /Guluronic (GulA) polysaccharides) 
 Alginate is a linear polysaccharide with repeating disaccharide units composed of β-D-
ManA and its C-5 epimer α-L-GulA with the linkage [→4) β-D-ManA (1→4) α-L-GulA (1→].  
Alginate is classified into three types depending on the distribution pattern of monomers; 
homopolymeric M block (PolyM) containing only ManA, homopolymeric G block (PolyG) 
containing only GulA or alternating M and G monomers (PolyMG). The main sources of alginate 
are brown seaweed. Alginate is present on the cell well and contributes to nearly 40% of the dry 
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weight of brown algal biomass (Xu et al., 2017). Bacteria belonging to the Pseudomonas and 
Azotobacter genera also produce alginates. In Pseudomonas species, alginate-mediated biofilm 
formation helps to avoid phagocytosis (Leid et al., 2005; Pritt et al., 2007). The gelling properties 
and the ion chelating properties make alginate an attractive candidate with a wide array of 
applications in industry (e.g. viscosifier, stabilizer, and a gelling agent in the food, printing and 
biomaterial industries) (Nalamothu et al., 2014).  
 Polysaccharide lyases (PLs) 
 Uronic acid-containing polysaccharides are depolymerized through a lytic mechanism by 
PL family enzymes. PL enzymes are mostly of bacterial, fungal, algal or plant origin and are highly 
substrate specific.  
2.3.1  PLs in bacterial infection 
 Pathogenic bacteria interact with host components and modulate their activities to promote 
pathogenesis. The key components involved are host GAGs and the PL produced by pathogens. 
The process begins with adhesion of microbes to the host cell through interactions with GAGs. 
Heparan sulfate proteoglycans (HSPG) act as host receptors for adhesion of the antibiotic resistant 
bacteria Enterococci onto host colonic epithelial cells (Sava et al., 2009). Adhesion to GAGs has 
also been demonstrated in a variety of Gram-positive organisms as follows: Streptococcus 
pneumoniae attaches to HP, HS, and CS; Staphylococci adhere to CS-A and HS; Streptococcus 
pyogenes recognizes DS, HS, and HP; and Streptococcus mutans binds mainly HP (García et al., 
2016).   
 The next step is invasion - One invasion strategy employed by microbes is to degrade the 
ECM.  PLs are the key players in this mechanism. During bacterial infection, PLs have been 
demonstrated to depolymerize GAGs. Hyaluronate lyase (Hyl) produced by S. pneumoniae during 
infection, degrades HA to facilitate bacterial invasion (Li et al., 2000). HepP from Pseudomonas 
aeruginosa, a homolog of the heparinase enzyme, showed a significant contribution to the 
virulence of this pathogenic bacteria. HepP represents a new potential target for antimicrobial 
agents (Dzvova et al., 2017; Dzvova et al., 2018). Moreover, it has been demonstrated that many 
bacterial pathogens use the PL degradation products (i.e. anionic polysaccharides) to neutralize 
cationic antimicrobial factors (Jinno and Park, 2015).  
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 Nutrient source - Pathogenic bacteria utilize GAGs as their carbon source. Streptococcus 
pneumoniae, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes, 
Streptococcus intermedius, and Mycobacterium tuberculosis expressing hyaluronan lyase (Hyl), 
have all been shown to use HA as their sole carbon source (Marion et al., 2012).  
 Pathogenic bacteria produce GAG degrading enzymes as virulence factors to overcome the 
mobility barrier caused by GAG in the extracellular matrix. Also, GAGs are a rich nutrient source. 
Thus, bacteria have a dual advantage in degrading the GAG polysaccharide. For this reason, 
inhibitors of the GAG enzyme may be potential bacteriostatic agents. The bacterial enzymes (PL 
enzymes) involved in GAG degradation has no mammalian homologs, and thus presents an 
attractive target for drug development (Jongkees and Withers, 2011). 
 Recent research interest for the use of PL as antimicrobial adjuvants arises from studies 
on AlgL, an alginate lyase from Pseudomonas aeruginosa. In vitro studies have demonstrated that 
addition of AlgL affects biofilm formation and causes lysis of P. aeruginosa. (Thallinger et al., 
2013; Alkawash et al., 2006).  
2.3.2 PL in Gut Microbiome  
 Other than pathogenic bacteria, commensal gut-residing symbiotic (friendly) bacteria 
encode a repertoire of PL enzymes. The gut microbiome community influences a variety of cellular 
functions. Abnormalities in their composition are associated with inflammatory bowel disease, 
colon cancer, antibiotic-associated colitis and obesity (Koropatkin et al., 2012). Availability, 
distribution and composition of the gut microbiome depends on its access to nutrients. Some 
members (e.g. Bacteroidetes species) depend on the host GAGs as a high priority carbon source 
(Flint et al., 2012; Cartmell et al., 2017). Other symbiotic bacteria feed on the complex dietary 
polysaccharides from plants and animals and aid in their saccharification as an energy source for 
the host (Ndeh and Gilbert, 2018; Ndeh et al., 2017). The glycoside hydrolases and polysaccharide 
lyases required to cleave the complex glycans are not present in the human genome and the 
microbiome supplements the host with these useful enzymes (Kau et al., 2011).  
2.3.3 Plant lyases  
 Several PL enzymes have been reported as virulence factors in plant pathogens. Targeting 
the plant cell wall is a simple and efficient pathogenic attack mechanism.  Plant pathogenic bacteria 
and fungi produce an arsenal of enzymes to degrade plant cell wall polysaccharides. Soft rot 
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infection in plants, caused by pectinolytic microorganisms such as Erwinia carotovora and 
Erwinia chrysanthemi, leads to plant tissue maceration and cell death (Hugouvieux-Cotte-Pattat et 
al., 2014; Abbott and Boraston, 2008).  
 Uronate-containing polysaccharides represent a substantial biomass (e.g. alginate present 
in the cell wall of brown algae and pectin polysaccharide of the plant cell wall). Employing 
polysaccharide lyases with broad substrate specificity is one approach to efficiently degrade this 
biomass. 
 Scarcity of fossil fuel resources, steady increase in energy demand, and concern over 
climate change by greenhouse gas emissions has increased the need to find alternative sources for 
biofuel production. Microbial fermentation of available biomass is a feasible alternative. In this 
aspect, cell wall polysaccharides of plants (pectin) and algae (alginate, ulvan) represent a usable 
biomass ( Singh and Olsen, 2011; Medipally et al., 2015). The major drawbacks to use plant 
polysaccharides for producing fuel are: (1) that they represent a potential food source and (2) the 
presence of lignin, which is recalcitrant to microbial fermentation. Meanwhile, macroalgae 
(alginate, ulvan) is an abundant alternative and the absence of lignin in algae makes the extraction 
simple and inexpensive. The ultimate goal is to breakdown this complex material, which can then 
be converted into ethanol or other useful compounds. Polysaccharide degrading enzymes and 
complementary enzymes encoded in the polysaccharide utilization loci (PULs) form a powerful 
toolkit to aid in this process (Hemsworth et al., 2016). Recent research on an engineered microbial 
platform showed a simultaneous assimilation and degradation of alginate from brown algae into 
ethanol. Catabolism of alginate by the engineered microbe produces the common metabolic 
intermediate pyruvate, from which a plethora of fuels and chemical compounds can be synthesized 
(Figure 2.6). (Wargacki et al., 2012) 
 Polysaccharide lyases are also useful in synthetic biology to produce polysaccharides of 
specific length.  
 Thus, identifying new PL enzymes has potential applications in a wide array of fields. 
Studying the structure, catalytic mechanism and substrate specificity of the PL enzymes has been 
a long standing interest in glycobiology.  
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(A) The middle figure shows the schematic representation of E. coli engineered for alginate uptake 
and degradation. pALG3 contains the genes for alginate uptake and metabolism. The different 
genes in the pALG3 are shown in the left figure. The right figure is the enlarge view describing 
the steps in alginate metabolism. In the first step, alginate polymers are degraded into oligomers 
by an alginate lyase followed by transport through the outer membrane porins (KdgMN) into the 
periplasmic space. In the periplasm, the oligomers are further degraded into di-, tri-, and tetramers 
by periplasmic alginate lyases (AlyABCD). This is followed by transport into the cytosol through 
oligoalginate transporters (ToaABC). In the cytoplasm, oligoalginate lyases (OalABC) further 
degrades the oligomers into monomer units of 4-deoxy-L-erythro-5-hexoseulose uronic acid 
(DEH). DEH reductase (DehR) catalyze the conversion of DEH to 2-keto-3-deoxy-D-gluconate 
(KDG). The KDG enters the Entner–Doudoroff (ED) pathway. This platform can be employed to 
produce fuels and chemicals such as ethanol. Figure adapted and modified from (Wargacki et al., 
2012) 
 
 
 
 
 
Figure 2:6 Engineered microbial platform to produce biofuel, ethanol other starting 
material from alginate. 
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 Classification of PLs 
With the continued efforts in genome sequencing, the number of PL families are increasing 
over time. There are currently 27 PL families grouped by sequence similarities in the CAZy 
database. At least one representative structure from each family is now available and representative 
structures for three such families are described in this thesis. The following section summarizes 
the known details of fold, substrate specificity and catalytic mechanism of the PL family enzymes, 
which are grouped by their substrates. 
2.4.1 GAG lyases 
 Families classified as GAG lyases depolymerize GlcA/IdoA-containing GAGs. Based on 
their sequences, they are classified into PL 6, 8, 12, 13, 16, 21 and 23 families in the CAZy 
database. PL6 contains chondroitinase B (ChonB, EC 4.2.2.19), PL8 contains GAG lyase with 
broad substrate specificity, hyaluronate lyase (HyL, E.C. 4.2.2.1), chondroitin AC lyase 
(ChonAC, E.C. 4.2.2.5) and chondroitinase ABC lyase (ChonABC, E.C. 4.2.2.20), PL12 
contains heparin sulfate lyase/heparinase III (HepIII, E.C. 4.2.2.8), PL13 contains Heparinase I 
(HepI, E.C. 4.2.2.7), PL16 contains hyaluronan lyase (HyL, E.C. 4.2.2.1), PL21 contains 
Heparinase II (HepII, E.C. 4.2.2.8), acharan-sulfate lyase (EC 4.2.2.-) and PL23 contains 
chondroitin lyase (CsL, EC 4.2.2.-). Xanthan lyase and ulvan lyase are exceptions in this category; 
they degrade GlcA/IdoA containing substrates other than GAGs.  
Structure diversity in GAG lyase – Figure 2.7 displays the various structural folds observed in 
GAG lyase. 
2.4.1.1 Multidomain (α/α)n toroid fold 
  In general, the (α/α)n toroid fold contains predominantly two domains; one domain with α- 
helices and another domain with β strands. The α- helices form helical hairpins and fold into a 
horseshoe-like toroid shape, where n represents the number of helical hairpins. The number of 
helical hairpins vary among different families. The β strands fold into antiparallel β sheets. 
 This is the fold seen in many GAG lyase families (PL8, PL12, PL21, and PL23). HyL, 
Chon AC and Chon ABC are classified in the PL8 family and share significant sequence, structure 
and mechanistic homology (Garron and Cygler, 2010). This lyase subfamily has broad substrate 
specificity.  
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Cartoon diagram of representative structures of GAG lyase with different folds. Their PDB code 
and the names are shown below each structure. The structures are rainbow colored from blue at 
the N-terminus to red at the C-terminus. The structure of the enzyme substrate complex is shown 
for families where complex structures are available. The substrates are shown in stick 
representation. The top panel shows multi domain folds seen in the PL6 subfamily (ChonAC, 
ChonABC, Hyl).The bottom panel shows the multi domain fold seen in PL23 (CS lyase), PL21 
(HepI) family, the β-jelly roll fold seen in PL21(HepI) and the right handed β-helix fold seen in 
PL6 ChonB. This figure and the other protein structure figures were made using PyMol 
(pymol.org). 
 
 Chondroitin AC lyase (ChonAC) - Crystal structures of ChonAC from Flavobacterium 
heparinum (PDB code: 1HMW) and Arthrobacter aurescens (PDB code: 1RWH) are available in 
the Protein Data Bank (PDB). Both ChonAC structures have two domains with an (α/α)5 toroid 
fold at the N-terminus and 4 antiparallel β-sheets at the C-terminus. ChonAC has depolymerization 
activity on CS-A, CS-B and hyaluronan (Rye and Withers, 2002). The two enzymes differ in their 
Figure 2:7 Structural Diversity in GAG lyases. 
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mode of action. Flavobacterium ChonAC is an endo-lytic enzyme, whereas Arthrobacter ChonAC 
acts in exo-lytic fashion on the GAG substrate. The difference in the mode of cleavage is attributed 
to the insertion (~35 residues forming secondary structure of α helices and a loop) present at the 
N-terminal domain of Arthrobacter ChonAC. This minimizes the size of the substrate binding 
cavity and prevents the binding of large oligosaccharides. The catalytic residues in Flavobacterium 
ChonAC (His225, Tyr234, Arg288, and Glu371) and Arthrobacter ChonAC (Asn183, Tyr242, 
His233) are structurally conserved. (Lunin et al., 2004; Huang et al., 2001; Rani et al., 2017) 
 Chondroitinase ABC lyase (ChonABC) - Crystal structures of ChonABC from Proteus 
vulgaris (PDB code: 1HN0) and Bacteroides thetaiotaomicron (PDB code: 2Q1F) have been 
determined. Despite little sequence identity, the two structures adopt the same fold. Unlike 
ChonAC, ChonABC has an extra domain at the N-terminus. This domain has a two-layered β-
sheet fold resembling the carbohydrate binding domain in cellulase (Huang et al., 2003). The 
middle domain has a (α/α)5 toroid fold and shows structural homology to ChonAC. The C-terminal 
domain has four antiparallel β-sheets. Chondroitinase ABC is an endo-lytic enzyme and has 
demonstrated depolymerization activity on CS-A, DS and HA (Shaya et al., 2008; Huang et al., 
2003). Interestingly, the structural determinants for specificity toward DS (the GAG with IduA-
C5 epimer of GlcA) have been gleaned from the crystal structure of Bacteroides thetaiotaomicron 
ChonABC (PDB code: 2Q1F). A second cluster of conserved residues were identified 12Å away 
from the catalytic tetrad. Site directed mutagenesis and enzyme activity assays on the second 
cluster revealed that His345 is necessary for the breakdown of DS but not for CS (Shaya et al., 
2008; Rani et al., 2017). 
 Hyaluronan lyase (HyL) - Crystal structures of HyL from Streptococcus pneumoniae and 
Streptococcus agalactiae have been determined in apo and complex form with different GAG 
substrates. HyL is an endo-lytic, processive enzyme reported to have four domains: an N-terminal 
domain for GAG binding, a linker domain (which separates the binding and catalytic domain and 
assists in processivity of the enzyme), a catalytic domain and a C-terminal domain (Rigden et al., 
2006). The catalytic domain has an (α/α)5 toroid fold and the C terminal domain has three stacks 
of antiparallel β sheets (Rigden and Jedrzejas, 2003). The overall structure resembles other PL8 
family members ChonAC and ChonABC. One interesting feature learnt from several crystal 
structures of HyL is its flexibility and domain movement. The observed domain movements open 
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or close the substrate binding site. Indeed twisting and bending of the domains has been related to 
the processivity and catalytic mechanism of the enzyme (Rigden et al., 2006). 
 PL23 family contains chondroitin lyase (CsL) (EC 4.2.2.) (ODV-E66) from Baculovirus. 
Even though they share <12% sequence identity, the structural features are similar to the PL8 
family of lyases. The overall fold is α/α toroid with antiparallel β sheets. The CsL is reported to 
have specificity for non-sulfated or the CS-C substrate (6S sulfated) (Kawaguchi et al., 2013).  
 PL21 – Heparinase II (HepII) is classified in the PL21 family and acts endolytically, 
cleaving both heparin sulfate and heparin GAGs. The crystal structure of hepII from the soil 
bacterium Pedobacter heparinus showed that the enzyme forms a homodimer with two 
independent active sites in each monomer. The overall fold is (α/α)n toroid with antiparallel β sheet 
and composed of three domains: An N-terminal domain forms an (α/α)6 helical hairpin toroid, a 
central domain contains two layered β sheets and the C-terminal domain containing β-strands is 
folded like a β- barrel. HepII shows overall structural similarities to the PL8 HyL, ChonAC and 
PL15 alginate lyase. A Zn2+ ion is reported at the interface of the N-terminal and the central domain 
and plays a structural role. The catalytically important residues deduced from the complex 
structures are His406 and Tyr257 for both GlcA and IdoA containing HS and HP. Meanwhile, 
similar to ChonABC, a distant Histidine residue His202, is necessary for the degradation of IdoA 
(C5 epimer of GlcA) containing HP (Shaya et al., 2006; Shaya et al., 2010).  
 PL12 - Heparinase III (HepIII) from Bacteroides thetaiotaomicron is classified in the 
PL12 family. Heparinase enzymes (HepI/II/III) of bacterial origin were first isolated from the soil 
bacteria Pedobacter heparinus and have been used to study the structure and sulfation patterns in 
HP and HS (Desai et al., 1993). Structural studies of heparinase enzymes HepI (PDB code: 3ILR) 
(Han et al., 2009) and HepII (PDB code: 2FUQ, 3E7J) from P. heparinus (Shaya et al., 2010) have 
been previously carried out in our laboratory and their catalytic mechanisms were proposed. 
Heparinase enzymes show no recognizable sequence similarities. Also, HepIII has a different 
substrate specificity than HepI/II and prefers low sulfated, GlcA rich regions of HS. Efforts to 
determine the structure of HepIII from P. heparinus were unsuccessful. To overcome this obstacle, 
an orthologous protein BT4657 from Bacteroides thetaiotaomicron was cloned in our laboratory. 
The first part of this thesis research will describe the structure and catalytic mechanism of the 
BT4657 gene product.  
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2.4.1.2 β-jelly roll fold 
 The common feature of the β-jelly roll fold has two antiparallel β-sheets (SA, SB) stacking 
against each other. They are bent nearly 90° in the middle, forming a substrate binding groove that 
extends the length of the enzyme. The inner sheets (SA) of the groove have the conserved residues 
which perform the depolymerization reaction. The number of strands in the inner and outer sheet 
varies among the different PL families. The loops lining the β-sheets are of variable lengths. A 
disulfide bridge is seen in a few PL enzymes with this fold (Garron and Cygler, 2010).  
 PL13- Heparinase I (HepI) (PDB code: 3INA) from Bacteroides thetaiotaomicron is well 
characterized and structures of the enzyme in complex with varying substrate lengths have been 
reported. HepI acts in endo-lytic fashion and cleaves the HP substrate. HepI has the classical β-
jelly roll fold, two antiparallel β-sheets stacking together with a thumb-like insertion domain. The 
structural integrity of HepI is maintained by a Ca2+ ion at the hinge region between the β-jelly roll 
fold and the thumb domain. This thumb domain facilitates binding of the heparin substrate, 
because deleting the thumb domain impairs the substrate binding of HepI (Han et al., 2009). 
2.4.1.3 Right-handed β-helix fold 
 This is the fold predominantly seen in extracellular pectate lyase from plant pathogenic 
bacteria or fungi. The ChonB lyase is classified within the PL6 family and adopts an unusual 
right-handed β-helical fold. The architecture of the β-helix fold comprises three β-sheets PB1, 
PB2, and PB3. The sheets are connected by turns or loops, designated T1 (connecting PB1 and 
PB2), T2 (connecting PB2 and PB3) and T3 (connecting PB3 and PB1) (Huang et al., 1999). This 
fold is well adapted for the recognition of highly polyanionic polysaccharides. ChonB from 
Pedobacter heparinus specifically degrades DS (IdoA) in an endo-lytic manner. The β-helical fold 
in ChonB has 13 coils and possesses all of the common stacking interactions (aromatic stack, 
aliphatic stack and asparagine ladder) observed in the β-helical fold. The interactions are extensive 
and involve more residues than other proteins having this fold (Michel et al., 2004). PL6 also 
contains 3 alginate lyases and ChonB shows significant sequence homology to polyM specific 
alginate lyase AlyP (398 amino acid residues) from Pseudomonas sp. OS-ALG-9 (Xu et al., 2017). 
ChonB differs from ChonAC and ChonABC lyases not only in its fold but also in the mode of 
substrate recognition and the catalytic mechanism. The former interacts with substrates mostly 
through ionic interactions whereas the latter utilizes aromatic stacking (CH/π bonds interactions) 
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for substrates binding. This could explain the broad substrate specificity of ChonAC facilitating 
the binding of GAGs with varying sulfation patterns. In ChonB, the Ca2+ ion in the active site plays 
a catalytic role; Lys250 and Arg 257 are also reported to be essential for catalysis (Michel et al., 
2004; Garron and Cygler, 2010; Rani et al., 2017).   
2.4.1.4 Triple Strand β-helix 
 PL16 - Several crystal structures of HyLs from Streptococcus pyogenes have been 
determined. They are composed of three intertwined polypeptides, which fold independently into 
three β-helices (Garron and Cygler, 2010). PL16 HyLs are different from PL8 HyLs in both fold 
and substrate specificity. PL16 HyLs degrades only HA and not CS. The overall architecture is 
elongated with an α/β capping at the N-terminal domain, which is connected to the central right-
handed β-helix domain by two helical coils. The central domain resembles an irregular triangular 
tube and the β-strands of the domain are bent, with their concave surface facing outside the helix. 
This creates a depression along each side of β-helix, which serves as the substrate binding site for 
HA polysaccharide chains (Smith et al., 2005; Mishra et al., 2009). 
2.4.2  Alginate lyases 
 Alginate polysaccharides are degraded through a β-elimination mechanism by PL 
enzymes. Based on sequence similarity, these enzymes are classified into seven different families 
(PL5, 6, 7, 14, 15, 17 and 18) in the CAZy database. Alginate lyases are identified in both 
prokaryotes and eukaryotes as well as in viruses. So far, the structure of at least one alginate lyase 
is available for each of these 7 families. The common structural folds seen in alginate lyase are; β-
jelly roll, (α/α)n toroid and β-helix fold. Both endo-lytic and exo-lytic alginate lyases with broad 
and narrow substrate specificities have been observed. 
 The following section describes the structural diversity in alginate lyases and Figure 2.8 
displays the various folds seen in alginate lyase. 
2.4.2.1 β-jelly roll fold  
 This fold is seen in PL7, PL13, PL14, PL18 and PL20. The well-studied alginate lyase 
from the PL7 family is A1-II’ from Sphingomonas (PDB code: 2CWS). The complex structure 
with trisaccharide and tetrasaccharide substrates have been reported for this alginate lyase. A1-II’ 
is an endo-lytic alginate lyase with broad substrate specificity acting on PolyG, PolyM and  
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Cartoon diagram of representative structures of alginate lyase with different folds. Their PDB code 
and the names are shown at the top of each structure. The structures are rainbow colored from blue 
at the N-terminus to red at the C-terminus. The structure of the enzyme substrate complex is shown 
for families where complex structures are available. The substrates are shown in stick 
representation. The top panel shows the single and multi-domain (α/α) toroid fold seen in PL5, 15 
and 17. The middle panel and the bottom left panel shows the β-jelly roll fold seen in PL7, 14 and 
18. The bottom right panel shows the right handed β-helix fold seen in PL6.  
 
Figure 2:8 Structural diversity of alginate lyases. 
Literature review 
 
23 
 
PolyMG (Ogura et al., 2008). The other enzymes classified in PL7, namely PA1167 (PDB code: 
1VAV) from Pseudomonas aeruginosa (Yamasaki et al., 2004), AlyA (PDB code: 4OZX) from 
Klebsiella pneumoniae, AlyPG (PDB code: 1UAI) from Corynebacterium (Osawa et al., 2005) 
and AlyA1 (PDB code: 3ZPY) from Zobellia galactanivorans are also endo-lytic, with the 
canonical elongated active site feature, whereas AlyA5 (PDB code: 4BE3) from Zobellia 
galactanivorans is an exo-acting lyase. The active site of AlyA5 has a pocket-like architecture, 
with one end of the active site groove closed by a long loop (Thomas et al., 2013). PL14 is the 
only alginate lyase family with representatives from bacteria, eukaryotes and viruses. The alginate 
lyase vAL-1 from Paramecium bursaria Chlorella shows two pH dependent modes of action; 
either endo- or exo- acting. The catalytic domain of vAL-1 acts as endo-lytic lyase at neutral pH 
(releases hexasaccharide) and an exo-lytic lyase under basic conditions (releases disaccharides at 
pH 10).  The ionic charge at the active site is reported to regulate the exo-/endo- action in vAL-1 
(Ogura et al., 2009). Alginate lyases classified under PL18 are bifunctional and endo-lytic. The 
overall fold and catalytic site architecture are similar to the PL7 family but the presence of a unique 
N-terminal region in the PL18 family acts as an intramolecular chaperone and facilitates protein 
folding (Dong et al., 2014). Also, PL18 family enzymes have calcium ions, which play a central 
role in orienting the catalytic residues. Such Ca2+ ions have not been reported in PL7 enzymes. 
The PL20 family has enzymes from both bacteria and eukaryotes. Structural details of 1,4-
glucuronan lyase from Trichoderma reesei are available (PDB code: 2ZZJ). Like PL18 alginate 
lyase and PL13 HepI, the 1,4-glucuronan lyase has a Ca2+ ion contributing to the stability of the 
enzyme (Konno et al., 2009). 
2.4.2.2 (α/α)n toroid fold in alginate lyase 
 This fold is present in alginate lyase families PL 5, 15 and 17. PL5 enzymes have a single 
domain whereas PL15 and PL17 contain multiple domains. A well-studied PL5 family member is 
A1-III, a mannuronate specific alginate lyase, from Sphingomonas species A1. A1-III has six inner 
and five outer helices forming a toroid fold with four helical hairpins (α/α)4 (Yoon et al., 1999). 
Most characterized PL5 alginate lyases are endo-lytic and polyM-specific enzymes from bacteria. 
But Smlt1473 from Stenotrophomonas maltophiliacan shows broad substrate specificity. It utilizes 
pH as a mechanism to achieve substrate selectivity. At pH 5 it degrades HA substrates, at pH 7 it 
degrades poly GlcA substrates and at pH 9 it degrades alginate (MacDonald and Berger, 2014). 
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The enzymes reported in PL15 and PL17 are exo-lytic with a multi domain architecture. PL15 
family Atu3025 (PDB code: 3A0O) from Agrobacterium tumefaciens is a multi-domain alginate 
lyase with a small N-terminal beta sheet domain, a central toroid fold and a C-terminal β-sheet 
domain. The active site is between the central toroid fold and the C-terminal domain. The exo-
lytic mode of action in PL15 family is related to the conformational changes caused by lid loop 
motion upon substrate binding (Ochiai et al., 2010). PL17 family Alg17c from Saccharophagus 
degradans is a two-domain protein with an N-terminal toroid fold (α/α)6 and a C-terminal anti-
parallel β-sheet domain. As in PL15, the active site is located between the barrel and the C-terminal 
domain. But PL17 exist as a homodimer and the dimerization results from the insertion of a β-turn 
from the β-sheet domain to the N-terminal domain of another monomer (Park et al., 2014).  
2.4.2.3 β-helix class 
 Among alginate lyases this fold is only seen in enzymes classified under the PL6 family. 
The structure of AlyGC from the marine bacteria Glaciecola chathamensis was recently solved 
and the structural features and catalytic mechanism was revealed. The enzymes are exo-lytic and 
showed preference for a PolyG block. The architecture of the β-helix fold comprises three β-sheets 
PB1, PB2, and PB3. The sheets are connected by turns or loops T1 (connecting PB1 & PB2), T2 
(connecting PB2 & PB3) and T3 (connecting PB3 & PB1). This alginate lyase has two domains; 
both the N- and C-terminal domains adopt a right-handed β-helix fold. The enzyme exists as a 
homodimer in solution. Most of the conserved residues are identified in the T3-PB1-T1.  The active 
site is present at the N-terminal domain but the C-terminal domain is also necessary for catalysis 
and dimerization. This is evident from the loss of enzyme activity and dimerization in a mutant 
lacking the C-terminus. (Xu et al., 2017). 
2.4.3  Pectate lyases 
 Pectate lyases (E.C. 4.2.2.2) were identified in the genomes of pathogenic bacteria, fungi 
associated with plants, the gut residing bacterial community, human pathogenic bacteria, fungi, 
archaea and eukaryotes. These organisms employ a series of enzymes to degrade the plant cell 
wall in order to obtain their carbon source (Yadav et al., 2009; Herron et al., 2000). Humans do 
not produce enzymes to degrade pectin, so we depend on the gut microbiome to degrade pectin 
from plant dietary sources (Flint et al., 2012). In all these organisms, pectin degradation is carried 
out by a series of pectinases (Hugouvieux-Cotte-Pattat et al., 2014; Ndeh et al., 2017). To 
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accomplish pectin degradation, some of the pectate lyases are secreted into the extracellular 
environment. Pectate lyases have also been reported as both exo- and endo-acting enzymes. Most 
of the characterized endo- pectate lyases act in the extracellular environment and in the periplasmic 
space and break long pectin polysaccharides into small oligosaccharides of differing sizes. These 
oligogalacturonans are transported into the cytoplasm where the exo-pectate lyase carry out the 
degradation process (Abbott and Boraston, 2008; Gilbert, 2010).  
 Of the 27 families in the CAZy database, members of PL1, PL2, PL3, PL9 and PL10 have 
demonstrated activities on pectic polysaccharides (Seyedarabi et al., 2010). Members of the PL22 
family act on oligogalacturonans, whereas PL4 and PL11 family members degrade 
rhamnogalacturonans (RG). Structural characterization of these PL families revealed a number of 
different folds including a right handed β-helix, (α/α)n toroid fold, β-propeller fold, β-sandwich 
fold and different requirements for metal co-factors. A brief outline of the structural features, and 
catalytic mechanism of pectin/pectate lyase follows. 
 The following section describes the structural features of pectate lyase and Figure 2.9 
displays the various structural folds observed in pectate lyase. 
2.4.3.1 Right handed β-helix 
 The right-handed β-helix is the most common fold observed in pectate lyase families. 
Pectate lyase, belonging to families PL1, PL3, and PL9 share this fold. The right handed β- helix 
fold was first discovered in PL1 family PelC from Dickeya dadantii (M D Yoder et al., 1993). As 
mentioned in the GAG lyase and alginate lyase section, the core of this fold contains three parallel 
β sheets forming a helical architecture. Each coil of this helical architecture is composed of three 
consecutive β strands (PB1, PB2 and PB3) connected by turns (T1, T2 and T3). The stability of 
the cylindrical core is strengthened by the characteristic “asparagine ladder” and interaction of 
aliphatic, aromatic side chains in the interior of the core (Yoder et al., 1993; Jenkins et al., 2004). 
This structural rigidity helps with the secretion of pectinases into harsh and competitive 
environments, such as the gastrointestinal tract of animals, soil, and plant cell walls (Abbott and 
Boraston, 2008). Sequence variability in the PB1 strands and T3 turns reflect adaptations in the 
substrate binding site and catalytic region to accommodate specific substrates (Garron and Cygler, 
2010). The PL1 family has enzymes from all classes of living organisms. Most notably, PL1  
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Cartoon diagram of representative structures of pectate lyase with different folds. Their PDB code 
and the names are shown at the top of each structure. The structures are rainbow colored from blue 
at the N-terminus to red at the C-terminus. The structure of the enzyme substrate complex is shown 
for families where complex structures are available. The substrates are shown in stick 
representation. The top panel shows the right handed β-helix fold seen in PL1, 3 and 9 family. The 
middle panel shows the (α/α) toroid fold seen in PL2 and PL10 family. The right middle panel 
shows the multidomain β-sandwich fold seen in PL4. The bottom panel shows the β-propeller fold 
seen in PL11 and PL22 family. 
Figure 2:9 Structural Diversity in pectate lyases. 
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pectate lyases are virulence factors of plant pathogens. PelA, PelB, PelC, PelD, PelE and PelZ are  
PL1 virulence factors from Erwinia chrysanthemi (Hassan et al., 2013). PL3 members are endo-
lyases with substrate preference for methylated pectin and are the shortest β-helix folds with only 
eight turns (Akita et al., 2001). Unlike PL1 and PL9 families, the structural  rigidity of PL3 
members (PelI from Erwinia chrysanthemi) is maintained by disulfide bridges and an inner stack 
of aliphatic interactions (Creze et al., 2008). PL9 has both exo- and endo-pectate lyases of bacterial 
and eukaryotic origin. The endo-lyases are mostly extracellular and degrade pectate into large 
oligogalacturonates and the exo-lyases are in the periplasmic space and degrade 
oligogalacturonates into unsaturated digalacturonates. An endo-pectate lyase, PelN from Erwinia 
chrysanthemi shows an unusual pH optimum at neutral pH (in contrast to the pH optimum of ~8-
10 seen in extracellular pectate lyases) and uses Fe2+ as a cofactor (Jenkins et al., 2004; Hassan et 
al., 2013).  
2.4.3.2 (α/α)n toroid fold in pectate lyase 
 Another fold observed in the pectate lyase family is the (α/α)n toroid fold. PL2 and PL10 
belong to this fold. The PL2 pectate lyases with the (α/α)7 toroid are divided into two subfamilies 
based on cellular localizations, mode of activity and metal selectivity. Subfamily 1 includes 
periplasmic, endo-acting lyases with high specificity for homogalacturonans (HGA) (e.g. YePL2A 
from Yersinia enterocolitica). Plasticity in the metal cofactor selection in subfamily 1 reflects the 
periplasmic localization (multi metal environment) with a pH optimum of 9.6. Subfamily 2 
includes cytoplasmic exo-acting lyases with specificity for trigalacturorans and a pH optimum of 
8.5. Subfamily 2 have selective metal affinity for Mn2+ ion (e.g.YePL2B from Yersinia 
enterocolitica) (Hugouvieux-Cotte-Pattat et al., 2014; Abbott and Boraston, 2008). YePL2A and 
YePL2B show significant sequence conservation (37% identity) and revealed the presence of an 
extra loop in the cytoplasmic exo-acting lyase subfamily 2-YePL2B. Mapping of the loop in the 
structure of YePL2A subfamily 1 places the loop at one subsite of the active site (Abbott and 
Boraston, 2007). Domain swapping experiments, of the loop region between YePL2A (subfamily 
1) and YePL2B (subfamily 2) reduced the rate of HGM degradation by periplasmic subfamily 1 
enzyme. This is evidence that the loop contains residues which form the subsite for longer 
substrates. VvPL2 from Vibrio vulnificus YJ016, is an endo-exo transition lyase classified in 
subfamily 2 (McLean et al., 2015). VvPL2 can degrade both HGM and trigalacturonans with more 
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specificity for the latter. The presence of a tryptophan residue at the entrance to the active site is 
responsible for the exo- mode of action. In YePL2A (subfamily 1), endo-acting lyases, the 
tryptophan at the active site gate is replaced by a lysine. Mutation of the Trp to Lys and Ala in 
subfamily 2-YePL2B changes its mode of action from exo- to endo-. This is evidence that the 
gating mechanism responsible for exo-/endo-activity is a single amino acid (McLean et al., 2015).  
 The pectate lyases of the family PL10 are found in soil, plant and gut bacteria. PL10 
enzymes from Cellvibrio japonicus adopt a (α/α)3 barrel topology. The PL10 family enzymes are 
endo-lytic with substrate specificity for HGA. They show the usual properties of pectate lyases 
that is an alkaline pH optimum and a Ca2+ dependence for enzyme activity (De Armas et al., 2004; 
Charnock et al., 2002; Hugouvieux-Cotte-Pattat et al., 2014). This is the first family showing 
convergent evolution of the catalytic site in PL family enzymes (Charnock et al., 2002). 
2.4.3.3 β-propeller fold 
 PL22 family (Oligogalacturonate lyases (OGLs)). OGL adopts the seven bladed β-
propeller fold and a tunnel like active site.  Each blade has four antiparallel β sheets. OGL shows 
different preferences for localization, substrate specificity and metal cofactor compared to PL1, 3, 
9 pectate lyase. OGL are cytoplasmic lyases with substrate specificity for oligogalacturonates. 
OGL has a pH optimum of 7.3–7.7, which is consistent with their cytoplasmic localization. They 
use Mn2+ or some other transition metal (Co2+, Ni2+ or Fe2+) as a cofactor instead of Ca2+. In OGL, 
a histidine residue acts as the proton abstractor (Abbott et al., 2010). 
 PL11 (Rhamnogalacturonan lyase-RGL) – PL11 family members are mostly of bacterial 
origin and break the glycosidic bond between Rha and GalA in the hairy region of pectate. 
Structural data are available for endo-acting (YesW) and exo-acting (YesX) lyases from Bacillus 
species. Both YesW and YesX fold into an 8 bladed β-propeller with an N terminal extension 
which folds into two stacks of three-stranded antiparallel β-sheets. Each blade in the propeller has 
four antiparallel β-strands and except one blade, all other blades possess Ca2+ ion which plays 
mainly a structural role. The active site is present within the deep cleft in the center of the propeller. 
Structural studies suggest that an extra loop over the active site in the YesX is responsible for its 
exo-mode of action (Ochiai et al., 2007; Ochiai et al., 2009). 
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2.4.3.4 Multidomain β-sandwich fold 
 PL4 (Rhamnogalacturonan lyases-RGL) – PL4 has members of bacterial, fungal and plant 
origin. RGL from Aspergillus aculeatus is a multidomain protein with a new modular architecture 
and is composed predominantly of β-strands. The N-terminal domain is the largest domain with 
two antiparallel β-sheets and possesses the catalytic residues. The central and C-terminal domain 
are involved in substrate binding. RGL is an endo-lyase and degrades RG-I having a minimum 
length of 12 saccharides. Conserved arginine residues on the multi-domain surface are evidence 
of an elongated substrate binding site, which can accommodate 12 residues. Ca2+ is observed in 
the structure and mainly plays a structural role. RGL has a pH optimum of 6 and cleaves the 
glycosidic bond between Rha and GalA (McDonough et al., 2004; Jensen et al., 2010). 
2.5 Catalytic Mechanism 
 As elaborated in the previous section, six structural folds (β-helix, β-jelly roll, (α/α)n toroid, 
multidomain β-sandwich, β-propeller and triple-stranded β-helix) have been observed among the 
27 PL families. In spite of the diverse substrate specificity and tertiary folds, the degradation of 
uronate substrate through β- elimination (Figure 2.2 and section 2.1.2) is conserved across the 27 
PL families. The observed β- elimination mechanism is either His/Tyr mediated catalysis or a 
metal assisted elimination mechanism.  
 Briefly, in the β-elimination mechanism, the negative charge of the C6 carboxylic group 
(of the uronate substrate) is neutralized either by a metal ion (mostly Ca2+) or by an amino acid 
(mostly Asn, Asp, Gln or Glu side chains). This neutralization reduces the pKa of the C5 proton 
and makes it easy for abstraction by a base. Finally, an acid donates a proton to the leaving group. 
This results in cleavage of the scissile bond between O1-C4 and the generation of an unsaturated 
product in the newly formed non-reducing end of the sugar substrate.  
 The lytic mechanism can be classified into two types: (1) the syn elimination mechanism, 
where the abstracted proton and the C4 bridging oxygen are on the same side of the uronate ring 
and (2) the anti elimination mechanism, where the abstracted proton and C4 bridging oxygen are 
on opposite sides of the uronate ring (M. L. Garron and Cygler, 2014).The following section will 
describe the β-elimination catalytic mechanism seen in the PL family enzymes. 
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2.5.1 Metal mediated elimination mechanism 
 In the metal assisted elimination mechanism, the negative charge of the C6 carboxylic 
group is neutralized mostly by Ca2+ ion. This mechanism is commonly seen enzymes with a right 
handed β-helix fold. Pectate lyase from family PL1, 3, 9, 10 were shown to utilize this type of 
elimination mechanism. These are pectate lyases secreted into the extracellular matrix or 
periplasm. Depending on their intracellular localization, PL2 members were reported to use either 
Mg2+ or Mn2+ to degrade the highly anionic pectate polysaccharide (Abbott and Boraston, 2007; 
McLean et al., 2015). Arginine has been observed to act as a catalytic base in PL1, 2, and 10 
(Herron et al., 2000; Abbott and Boraston, 2007; Charnock et al., 2002).  Here, the enzyme pH 
optimum is ~10.5 and the Arg interacts with carboxylate group residues in the active site, which 
causes a shift in the pKa of Arg (~2 units) and makes it a potential base (Charnock et al., 2002). 
In PL3 and PL9, a Lys residue plays the catalytic base role (Creze et al., 2008;Jenkins et al., 2004). 
In all these families, a water molecule plays the role of catalytic acid (Garron and Cygler, 2010). 
 Interestingly, this reaction mechanism has been reported in the PL6 enzymes ChonB, a 
GAG lyase and AlyGC an alginate lyase. The amino acids playing the catalytic base and acid roles 
are Arg and Lys, respectively (Huang et al., 1999; Michel et al., 2004; Xu et al., 2017). PL22 
OGL, an exo-lyase in the cytoplasmic compartment utilizes a Mn2+ ion as neutralizer and a His 
residue as the putative base (Abbott et al., 2010).  
2.5.2 His/Tyr mediated elimination mechanism 
 The His/Tyr mediated elimination mechanism is seen in GAG lyase and alginate lyase 
(PL5, 7, 14, 15, 17 & 18) family enzymes. These lyases degrade C-5 epimeric substrates, 
(GlcA/IdoA in GAG and GulA/ManA in alginate) which arises from their adoption of a His/Tyr 
catalytic apparatus, allowing them to carry out either syn or anti mediated elimination reactions 
(Garron and Cygler, 2010). Based on the structural studies on PL family enzymes, this mechanism 
can be sub-classified into two types: 1) Tyr/Tyr mechanism where one Tyr residue plays both 
catalytic base and acid role. 2) His (Tyr’)/ Tyr where a His or different Tyr plays the catalytic 
base role. In both subtypes the neutralization of negative charge on the C-6 carboxylate group is 
performed by Arg/Asn/Asp/Gln/Glu (M.-L. Garron and Cygler, 2014). 
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 GAG lyase - PL8 family ChonAC and HyL enzymes degrade GlcA containing GAG 
through syn elimination. In ChonAC, Tyr248 is identified to play both the catalytic base and acid 
role. This dual role of the tyrosine was confirmed by kinetic studies (Rye et al., 2006). ChonABC 
in PL8 can depolymerize both CS (GlcA) and DS (IdoA). Through a structural comparison with 
ChonAC and mutational studies, the putative catalytic residues were identified in ChonABC. 
Tyr461 plays the dual role of proton abstractor and donor for CS-4 or CS-6 (GlcA) substrates 
through syn elimination. To degrade DS (IdoA), however, His345 and Tyr461 perform the base 
and acid function, respectively. The degradation reaction proceeds in an anti-manner (Shaya et al., 
2008). HepII from the PL21 family is similar to ChonABC and degrades both GlcA/IdoA 
containing HS. Like ChonABC, HepII utilizes Tyr257 as catalytic base and acid to degrade the 
GlcA substrate. For degrading IdoA-containing substrates, His202 and Tyr252 play the role of 
catalytic base and acid, respectively (Shaya et al., 2010). HepI from PL13 family degrades IdoA 
containing HS. HepI degrades the substrate by anti elimination using His151 and Tyr357 as base 
and acid (Han et al., 2009). In general, GAG lyase adopts the Subtype 1 (Tyr/Tyr) to degrade 
GlcA containing substrates and the subtype 2 His (Tyr’/Tyr) to degrade IdoA containing 
substrates. 
 In the alginate lyase, Subtype 1 (Tyr/Tyr) is seen in PL5 (A1-III) and PL18 family (aly-
SJ02) enzymes. In AI-III, Tyr246 plays both catalytic base and acid role in a syn fashion (Yoon et 
al., 2001), whereas aly-SJ02 uses Tyr353 as catalytic base and acid (Dong et al., 2014). The 
subtype 2 His (Tyr’/Tyr) mechanism is reported in PL7 (A1-II’) and PL15 (Atu3025) families. 
In A1-II’, His191 and Tyr284 play the catalytic base and acid role, respectively (Ogura et al., 
2008). Atu3025 from PL15 utilizes His311 and Tyr365 as the catalytic base and acid, respectively 
(Ochiai et al., 2010). Alginate lyase Alg17c from PL17 displays the (Tyr’/Tyr) mechanism, where 
Tyr450 plays the general base abstracting the C-5 proton and Tyr258 plays the role of an acid 
(Park et al., 2014). 
2.5.3 Conformational changes favouring catalysis  
 Three types of conformational changes have been identified from different crystal 
structures of PL enzymes. These conformational changes assemble the catalytic residues and 
facilitates the open and closed states of the active site for catalysis.  
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1) Lid loop open/close movement – This feature is mostly noticed in the β-jelly roll fold and the 
single domain (α/α)n toroid fold. This movement is reported in alginate lyase PL5, PL7, PL18 and 
GAG lyase PL13 (HepI) ( as reviewed in Xu et al., 2018; Han et al., 2009).  
2) Domain rotation movement - Upon substrate binding, the multidomain protein undergoes rigid 
body movement resulting in a rearrangement of residues around the active centre to interact with 
the ligand. This movement is seen in PL8 family GAG lyases (HyL) (Rigden et al., 2006). This is 
also seen in alginate lyase PL15 and PL17 families. In particular, the C-terminal β-sheet domain 
of substrate-bound PL15 alginate lyase undergoes a 10o rigid body rotation relative to the apo 
enzyme. Similarly, the β-sheet domain in PL17 alginate lyase undergoes a rigid body rotation of 
12o relative to the apo structure ( as reviewed in Xu et al., 2018). 
3) Subunit rotation movement - This is seen in PL6 family AlyGC alginate lyase. This enzyme 
exists as a homodimer and contains an identical active site in each subunit. The complex structure 
of mutant AlyGC with the ManA tetrasaccharide revealed that the substrate binds the active centre 
of molecule A, but not that of molecule B. Intriguingly, the initial enzyme-substrate interaction 
causes a small rotation of molecule B, which enlarges the active site in molecule A with 
concomitant narrowing of the active site in molecule B. This widening of the (molecule A) active 
site facilitates substrate binding (Xu et al., 2017).    
2.6 New Polysaccharide lyase family - Ulvan Lyase 
 Ulvan, the cell wall polysaccharide of green algae represents a huge potential biomass. 
Unlike other marine polysaccharides, alginate (from brown algae), agar and carrageenans (from 
red algae), ulvan polysaccharides have been less explored (Colle et al., 2011). The development 
of applications for ulvan polysaccharide will require specialized enzymes to process this polymer. 
Gram-negative bacteria isolated from mud were the first to show the presence of ulvan degrading 
activity. Based on the reaction product being an unsaturated uronic acid (4-deoxy-L-threo-hex-4-
enopyranosiduronic acid, ΔUA), the corresponding enzyme was identified as a lyase (Lahaye et 
al., 1997). The lyase enzyme from a filamentous fungus Trichoderma sp. GL2 was also reported 
to utilize ulvan as a substrate, but its main substrate was identified to be oligoglucuronan (Delattre 
et al., 2006). Only recently, two ulvan degrading enzymes were identified in the Gram-negative 
bacterium Nonlabens (Persicivirga) ulvanivorans strain PLR (NLR42, NLR48) (Colle et al., 
2011). The identified genes were cloned, purified and biochemically characterized. They both 
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degrade ulvan in an endo-lytic fashion. The protein sequence of this novel lyase was unrelated to 
any other lyases and became the first representative of a new lyase family called PL28 (Colle et 
al., 2011). Subsequent genome sequencing of marine bacteria identified many novel ulvan lytic 
enzymes.  The genome of N. ulvanivorans was recently sequenced (Kopel et al., 2014a), followed 
by sequencing the genomes of Pseudoalteromonas sp. Strain PLSV (Kopel et al., 2014b) and 
Alteromonas sp. strains LTR and LOR (Kopel et al., 2014c). This led to the identification of several 
putative ulvan lyase genes. The identified putative ulvan lyase gene clustered with genes predicted 
for β-glucuronyl hydrolase, sulfatase, rhamnosidase and xylosidase activities. It was proposed that 
this gene cluster coordinates the complete saccharification of ulvan polysaccharide (such gene 
clusters are called Polysaccharide utilization Loci (PULs)) (Foran et al., 2017). Ulvan PULs in 
Alteromonas strain LOR, Pseudoalteromonas strain PLSV and Nonlabens are shown in Figure 
2.10 and the putative ulvan lyases are highlighted in a purple box. These newly identified ulvan 
lyases are classified under PL24, PL25 and PL28 family in the CAZy database (Lombard et al., 
2014). In addition to ulvan lyases, the first ulvan hydrolase from N. ulvanivorans was 
characterized. The enzyme showed unsaturated β-glucuronyl activity and works together with 
ulvan lyases to fully depolymerize the ulvan polymer (Collén et al., 2014). 
 Many of these putative ulvan lyase genes were recombinantly expressed and partially 
characterized. LOR107 from Alteromonas classified in the PL24 family was reported to act 
endolytically on ulvan polysaccharide. The end product of the degradation reaction is 
predominantly a tetrasaccharide with IdoA (Rha3S-IdoA-Rha3S-ΔUA) (Kopel et al., 2016). This 
shows the preference of LOR107 for cleavage next to GlcA in the ulvan. Currently, there are 30 
and 27 sequences of bacterial origin classified in the PL24 and PL25 families respectively.  
 Biochemical characterization of the first identified ulvan lyase NLR42 (NCBI accession 
number: AEN28574, 46 KDa with two domains) and NLR48 (NCBI accession number: 
KEZ94336) from Nonlabens ulvanivorans strain PLR (PULs is not identified) showed that these 
enzymes endolytically degrade ulvan. The end product is a mixture of tetrasaccharides comprised 
of IdoA and GlcA (Rha3S-GlcA-Rha3S-ΔUA and Rha3S-IdoA-Rha3S-ΔUA). This shows that 
NLR42 and the homolog of its catalytic module, can cleave ulvan next to both GlcA and IdoA. 
The PL28 family has presently 18 sequences of bacterial origin. 
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PULs identified in Alteromonas strain LOR, Pseudoalteromonas strain PLSV and Nonlaben 
ulvanivorans. Hydrolases (colored blue), lyases (colored yellow), sulfatases (colored green) and 
their color code is shown in the insert. The enzymes highlighted in purple boxes are the lyases, we 
have received from collaborators. Figure adopted and modified from (Foran et al., 2017) 
 
 Ulvan lyases have not been structurally characterized and their catalytic mechanism is 
unknown. It is therefore of interest to determine if the ulvan-degrading enzymes display a novel 
architecture and what catalytic mechanism and apparatus they utilize. 
 
 
 
 
 
 
  
Figure 2:10 Ulvan PULs identified in marine bacteria. 
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3. Thesis rationale and objective 
 
 Studying the structure and catalytic mechanism of bacterial GAG lyases has been a long 
standing interest in our laboratory. The structure of several chondroitin lyases, chondroitinase B, 
heparinase I (HepI) and heparinase II (HepII) have been previously solved in our laboratory. These 
structural studies revealed several interesting features of the fold and allowed us to propose the 
catalytic mechanism.  
 HepI degrades the highly sulfated heparin (HP), whereas HepII degrades both HP and less 
sulfated heparan sulfate (HS). As mentioned in the previous section, HepIII, a member of the PL12 
family, degrades the heparan sulfate (HS) substrate. All three heparinase enzymes share limited 
sequence similarity. When the candidate joined the laboratory, the structures of HepI and HepII 
had already been determined and published but the structural studies of HepIII were in progress. 
Although the structure of the apo HepIII had already been determined in our lab, additional 
investigations of HepIII were required to detail its catalytic mechanism. The objective of this 
project is to obtain the HepIII/substrate complex structure to understand the catalytic mechanism. 
We hypothesized that HepIII might utilizes the His/Tyr catalytic mechanism as seen in other 
GAG lyases. The major efforts in this research were directed towards: 1) identification of catalytic 
residues, 2) generation of putative active site mutants and measuring their enzyme activity, 3) 
crystallization of wild type and active site mutants of HepIII with the tetrasaccharide substrate.  
 At about that time, a new family of PL enzymes with the ability to degrade a marine 
polysaccharide called ulvan was discovered. Several potential ulvan lyases were identified in 
marine bacteria through large-scale genome sequencing efforts of marine organisms. These lyases 
were classified into three new sequence families in the CAZy database and there was no structural 
information on any of them. In collaboration with the groups that identified and characterized the 
first ulvan lyases we engaged in their structural studies. The objective of this project is to expand 
the structural and functional information on polysaccharide lyases by providing structural 
information on three new PL lyase families: PL24, PL25 and PL28. We hypothesized that the 
ulvan lyases might evolved to have a different scaffold (fold) but preserves the β-elimination 
catalytic machinery. The efforts of the candidate were focused on: 1) determination of the atomic 
structure of ulvan lyases: LOR107, PLSV3936 and NLR48, 2) identification of putative active site 
residues by the generation and testing of mutants, 3) obtaining the structures of enzyme/substrate 
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complexes to determine the substrate binding mode, recognition of the specific oligosaccharide 
sequence and the catalytic mechanism.  
Table 3-1 Knowledge gap in the structural studies of PL family enzymes 
PL Family Organism Substrate Fold Mechanism 
12 
Heparin 
lyase III 
Bacteroides 
thetaiotaomicron 
Heparan 
sulfate 
(α/α)6 toroid + 
anti-parallel β-
sheet 
* 
24 LOR107 Alteromonas sp. LOR Ulvan * * 
25 PLSV3936 
Pseudoalteromonas sp. 
PLSV 
Ulvan * * 
28 NLR48 
Nonlabens 
ulvanivorans 
Ulvan * * 
* - Uncharacterized 
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4. Methods and materials 
 
 This chapter is divided into three sections. The first section will describe the steps in 
crystallography and briefly explain the methods in each step. The second section of this chapter 
will describe the experimental procedures followed in specific projects. The third section will 
outline the materials (list of primers, plasmids, expression cell lines and list of all chemicals) used 
in this research. 
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4.1 Steps in protein crystallography 
4.1.1 Cloning 
 The first step in determining the three-dimensional structure of a protein by crystallography 
is to produce a sufficient quantity of highly purified target protein. For protein crystallization one 
needs a few milligrams of protein sample at >95% purity. Typical problems at this step are low 
expression of the target protein, poor solubility and difficulty in removing contaminating proteins. 
In addition, the protein may form soluble aggregates, precipitate or degrade during or after 
purification. Additional difficulties may occur for eukaryotic proteins as they may require post-
translational modifications for proper folding. The advancement in recombinant DNA technology, 
coupled with the design of more efficient and diverse expression systems, have made these 
problems tractable. An adjustment of a growth parameter such as time, growth temperature and 
inducer concentration is frequently sufficient to decrease the fraction of insoluble protein and to 
increase the yield. Other strategies to produce soluble, well-behaving protein are: 1) to fuse the 
protein with tags like MBP (Maltose Binding Protein) or GST (Glutathione S-transferase), which 
have been demonstrated to help in protein folding (Bell et al., 2013), 2) to make truncations of the 
protein based on secondary structure predictions by removing the unstructured regions, 3) to 
change the expression system, e.g. for expression in E. coli there are several specialized E. coli 
strains that might improve the yield and quality of expressed protein  such as E.coli strains carrying 
chaperones to assist in protein folding (Makhoba and Mthembu, 2015) or strains with additional 
tRNAs for rare codons (Rosano and Ceccarelli, 2014).  
4.1.2 Quality assessment of protein sample for crystallization 
 Quality of the protein in terms of both purity and homogeneity determines its 
crystallization propensity. The protein sample should be homogeneous (meaning a single 
oligomeric state) to increase the chances of crystallization. Sometimes the purified protein tends 
to form soluble aggregates or precipitates and degrades. Many parameters like temperature, ionic 
strength and the pH of the buffer influence homogeneity of the sample. Upon obtaining soluble 
protein, the purity and homogeneity of the sample is evaluated by SDS-PAGE, size exclusion 
chromatography (SEC) and dynamic light scattering (DLS). Troubleshooting a heterogeneous 
sample is often carried out by changing the buffer, pH, ionic strength or by adding chemical 
additives. The effects of these changes are monitored by DLS. In this case, the DLS experiment is 
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very helpful because it consumes a limited amount of protein and allows the simultaneous 
screening of multiple conditions (96 well format) in a short time (Proteau et al., 2010). Protein 
degradation can be eliminated by the addition of protease inhibitors in all the steps during 
purification or by engineering the site susceptible to proteolysis. (Lebendiker and Danieli, 2014; 
Wingfield, 2015) 
4.1.3 Crystallization  
 The crystallization phenomenon involves changing the solubility of protein to attain the 
supersaturated state.  Under favorable conditions, protein molecules form small, ordered nuclei 
that assemble into crystals.  Many parameters such as precipitant, buffer, pH, ionic strength, 
protein concentration and temperature affect protein solubility. Thus, these parameters are varied 
in the crystallization experiment to guarantee that the solubility limit is reached. 
 The crystallization phase diagram helps to predict the change in solubility as a function 
of different experimental parameters. The phase diagram consists of four zones: the high 
supersaturation zone where protein precipitates; the moderate supersaturation zone, which 
favors nucleation events; the metastable zone where the protein crystals may grow big and the 
undersaturation zone where the protein concentration is below saturation and there is no chance 
for its crystallization (Rupp, 2015; Chayen, 2004) (Figure 4.1).  
 Challenges in protein crystallization are offset to some extent by tremendous improvements 
in recombinant DNA technology, protein production, purification and quality assessment. The 
process and parameters influencing protein crystallization are also well understood. But the 
condition under which a specific protein will crystallize is not yet predictable. It still remains a 
trial-and-error screening approach, using a wide array of chemical conditions (Garman, 2014).  
 Some proteins are recalcitrant to crystallization and this may be an inherent property of the 
protein. In such cases, rescue strategies like surface entropy reduction, lysine methylation, limited 
proteolysis or cloning different constructs by removing the predicted unstructured flexible regions 
are potentially useful. Chemical modification of surface lysine residues reduce the protein 
solubility and modify its surface properties, which may promote crystallization. (Walter et al., 
2006; Sledz et al., 2010). 
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Figure 4.1:1 Phase diagram for protein crystallization. 
The supersaturation zone where protein precipitates; the nucleation zone where the nucleation 
event occurs; the metastable zone where crystals are grown due to lower supersaturation; the 
under-saturation zone where protein crystals does not grow (Figure adapted from (Chayen, 
2004)).  
4.1.3.1  Crystal growth optimization 
 The initial crystallization conditions obtained from broad screening must often be 
optimized to produce bigger and better diffracting crystals. In this step, conditions are varied in a 
finer grid by varying protein concentration, buffer, pH, ionic strength and precipitant concentration 
around the initial conditions. Additives (divalent metal ions and other chemicals) are often used in 
this step to improve the crystal quality. Seeding is a powerful manipulation technique in the 
optimization step that disconnects nucleation from crystal growth. In microseeding, the crystals 
are crushed and added to a fresh crystallization drop. These invisible crystals act as nucleation 
sites for crystal growth. In macroseeding, a single crystal is transferred to the pre-equilibrated drop 
(in the metastable zone). This crystal serves as a single point of nucleation, whereupon protein 
molecules from the drop can arrange themselves on the existing crystal and make it grow bigger. 
(Till et al., 2013; Shaw Stewart et al., 2011). 
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4.1.3.2 Crystallization of protein-ligand complex 
 The structure of a protein-ligand gives more information (e.g. active site, residues crucial 
for catalysis, residues facilitating substrate binding) than the apo protein structure alone. The 
protein-ligand complex can be captured by using a non-hydrolysable substrate analog or by using 
an inactive catalytic site mutant (here the reaction cannot proceed and the substrate will stay in the 
active site). The ligands can be introduced either by co-crystallization or soaking. In co-
crystallization, the protein and ligand are mixed prior to crystallization. This method usually 
requires searching for new crystallization conditions. The other option is to introduce the ligand 
into a preformed protein crystal by immersing the crystal in a ligand-containing solution and 
relying on diffusion of the ligand into the crystal. Protein crystals are composed of ~50% to 70% 
water and the ligand can diffuse into the protein molecules in the crystal through solvent channels. 
A disadvantage of soaking is that the introduction of ligand can disintegrate the protein crystal 
because of the change in chemical environment. Soaking might also disturb the crystal lattice and 
packing, ultimately affecting the diffraction negatively. The concentration of ligand to use in the 
co-crystallization and soaking experiment and the time of ligand soaking (diffusion time) are the 
major parameters to work through (Hassell et al., 2006; Müller, 2017). 
4.1.4 Cryo-crystallography and data collection 
 Preparation of the crystal for exposure to a very intense X-Ray beam is a crucial step in the 
experiment; the protein crystals are very delicate and are easily damaged by radiation. The quality 
of diffraction data determines the level of structural details we obtain from the structure. Before 
irradiating with X-rays, the cryo-protected crystals can be flash cooled in liquid nitrogen and the 
experiment performed at low temperature, usually ~100K, to minimize radiation damage 
(Rodgers, 1994; Pflugrath, 2015). The critical step here is choosing the appropriate cryogenic 
conditions to prevent ice formation within the crystal. Also, other experimental parameters like X-
ray exposure time, crystal to detector distance and oscillation degree need to be taken into account. 
Frozen crystals are mounted on the goniostat and placed in the X-ray beam. The crystal is kept at 
low temperature during the experiment by being immersed in a N2 gas stream cooled to 100K. The 
crystal is rotated during data acquisition and the diffraction intensities in various spots of the flat 
detector surface are integrated over a small rotation angle and stored in separate files (frames). The 
quantities to be followed during the data collection experiment are the number of measured 
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reflections out of all possible reflections (completeness) and how many times each reflection was 
recorded (redundancy) (Wlodawer et al., 2013; Krojer et al., 2013). 
4.1.5 Data processing 
 The computational part of the crystallography experiment starts with data processing. The 
result of diffraction experiment is a large dataset containing information about the intensities and 
positions of the scattered X-rays (reciprocal space). In data processing, the measured intensities 
are converted into structure factor amplitudes. This involves many intermediate steps. Indexing - 
involves identification of spots in the diffraction frame and assigning Miller indices (hkl) to each 
reflection, followed by refinement of the crystal and instrument parameters to best fit the observed 
positions of the spots to predicted ones. This step provides the unit cell parameters and the Bravais 
lattice of the crystal. Integration - The intensity of each reflection is obtained by summation of 
intensities over all pixels considered to be part of the diffraction spot and the background noise is 
subtracted. These raw intensities are corrected for distortions due to the experimental setup. The 
next step is scaling and merging of redundant, symmetry related reflections into a unique dataset. 
Several algorithms and software packages are available for data processing. (Wlodawer et al., 
2008; Powell, 2017) 
 The quality of the diffraction data is assessed through the following parameters: data 
redundancy, merging R-values, data completeness, <I/σ(I)> (signal-to-noise ratio) and CC1/2 
(Wlodawer et al., 2013; Wlodawer et al., 2008). In the diffraction experiment, each reflection is 
measured multiple times because of the symmetry in the crystal and the oscillation method of data 
collection. Redundancy is the number of times one unique reflection is measured. Each reflection 
intensity is measured with some error and the data accuracy can therefore be improved by 
increasing redundancy. R-merge reflects the difference between symmetry related reflections and 
is calculated using equation 4.1. For a good dataset, a low discrepancy between symmetry related 
reflections coincides with a small value of Rmerge. For a suboptimal dataset the Rmerge would be 
>10% and this value tends to rise slightly with higher redundancy. Rmerge can be artificially 
manipulated by omitting weak or partial reflections and less redundant data, but this will eliminate 
the useful high resolution reflections. Hence the modified R parameters Rmeas (redundancy 
independent merging R factor) and Rpim (precision indicating merging R factor) are taken into 
consideration while assessing data quality (Wlodawer et al., 2008). Data completeness above 95 
4. Methods and Materials 
 
43 
 
% and 75 % should be measured in the overall and highest resolution shell respectively (Dauter, 
2017). The resolution cutoff for the dataset is primarily decided by the signal to noise ratio 
<I/σ(I)> and a value in the range of 1-2 is generally accepted (Evans and Murshudov, 2013). 
Another statistical parameter to determine resolution cutoff is CC1/2 and a value above 60% is 
generally accepted (Karplus and Diederichs, 2012).  
𝑅𝑚𝑒𝑟𝑔𝑒 = ∑∑|𝐼(ℎ)𝑖 − 𝐼(̅ℎ)|
𝑁
𝑖=1ℎ
/∑∑𝐼(ℎ)𝑖
𝑁
𝑖=1ℎ
 
(4.1) 
Where 𝐼(ℎ)𝑖 is the i
th intensity measurement of a reflection h and 𝐼(̅ℎ) is its average intensity. 
4.1.6 Phasing 
 The electron density map (ρ(xyz)) of a protein molecule in real space is calculated from the 
reciprocal space amplitudes by a Fourier transform. This calculation requires two components for 
each reflection: the structure factor amplitude (|Fhkl|) and its phase (αhkl) (shown in equation 4.2). 
In the diffraction experiment, only the intensities of X-rays scattered from the crystal are measured 
and the structure factor amplitude can be calculated from the measured intensity using [|Fhkl| ∝ 
√(Intensityhkl)]. Unfortunately, the phase information is lost in the diffraction experiment, the so-
called phase problem in crystallography (Taylor, 2003). 
𝜌(𝑥𝑦𝑧) =
1
𝑉
∑|𝐹ℎ𝑘𝑙 | exp(𝑖𝛼ℎ𝑘𝑙) exp⁡[−2𝜋𝑖(ℎ𝑥 + 𝑘𝑦 + 𝑙𝑧)] (4.2) 
 One of the major breakthroughs in protein crystallography is the development of methods 
and techniques to solve the phase problem. The available methods for protein crystallography are: 
Multiple Isomorphous Replacement (MIR) where phasing is done by a heavy atom soak into the 
native protein crystal, Molecular Replacement (MR) where the phase information is extracted 
from homologs, Multiple-wavelength and Single-wavelength Anomalous Dispersion (MAD & 
SAD) method where phases are obtained by the use of anomalous scatterers. Advancement in the 
methods and algorithms such as density modification (solvent flattening, non-crystallographic 
symmetry (NCS) averaging) makes SAD a routine method to determine new structures of proteins 
and MR to determine structure of proteins where the structure of a homolog (sequence identity ≥ 
25%) is known (Taylor, 2010).  
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4.1.6.1 Isomorphous replacement 
  The first protein structure, myoglobin was solved in the 1950’s by the MIR method using 
heavy atom soaks (Kendrew et al., 1958). For this method, it is critical that the soaking process 
does not significantly affect the unit cell parameters or the orientation of molecules, such that 
isomorphism between the native and derivatized dataset is maintained. The heavy atom causes 
measurable change in intensities during the diffraction experiment. These intensity changes are 
used to find the heavy atom positions. Then the initial phase estimation of the native protein is 
calculated by comparing the intensities of (non-derivative) native and (derivatized) heavy atom 
datasets. This method gives two solutions. To overcome this apparent phase ambiguity, usually 
more than one derivatized dataset is needed. With the help of solvent flattening and density 
averaging methods, however, it is possible to obtain initial phase estimates from a single derivative 
dataset (Taylor, 2010; Taylor, 2003).  
4.1.6.2 Molecular replacement (MR)  
 Initial phase estimates are obtained using the structure of a homologous protein, which has 
≥25% sequence identity with the unknown structure, as a model. The proper orientation of this 
within the unit cell of the unknown protein is determined through a search for best correlation of 
the Patterson functions of the model and unknown protein as a function of the orientation of the 
model. In the second step the properly oriented model is translated across the unit cell of the 
unknown protein to find the position of the model that gives the highest correlation between the 
calculated and observed structure factors. Combining the phases from the model with the observed 
structure amplitudes allows us to calculate an electron density map that has somewhat distorted 
features of the unknown molecule and provides a good starting point for refinement (Evans and 
McCoy, 2008). 
4.1.6.3 Single anomalous dispersion (SAD)  
 When an atom is irradiated at a wavelength far from its absorption edge, the scattering is 
predominantly elastic. However, when the X-ray wavelength is at the absorption edge of an atom, 
the inelastic scattering becomes measureable. This is related to the excitation of an electron from 
a low energy orbital to a higher energy shell followed by its return to the ground state. This 
phenomena results in anomalous scattering and causes a 90o phase change of the emitted photon. 
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This difference in the diffraction pattern is used to estimate the location of the anomalous scatterers 
and, in a manner similar to SIR (Single Isomorphous Replacement), to derive estimates of the 
phases of protein structure amplitudes. The most commonly used anomalous scatterer is selenium. 
The popularity of this relatively light atom is due to an easy incorporation of selenium into the 
protein as a selenomethionine (SeMet) in place of methionine during recombinant protein 
expression. In the SAD experiment, the SeMet incorporated crystals are irradiated at a wavelength 
corresponding to the selenium absorption edge (Taylor, 2010).  
4.1.6.4 Selenomethionine (SeMet) labelling of recombinant proteins 
 Two alternative methods are frequently used to incorporate SeMet into the protein of 
interest: 1) using an E. coli methionine auxotroph mutant as an expression strain (Hendrickson et 
al., 1990) or 2) by inhibiting the methionine biosynthesis pathway during protein expression 
(Walden, 2010). In the first method, the auxotroph cells only grow in the medium supplemented 
with methionine or SeMet. In the second method, the methionine biosynthetic pathway is inhibited 
by adding hydrophobic amino acids which inhibit aspartokinase, the first enzyme involved in 
methionine biosynthesis. By supplementing with SeMet, these cells, which lack the ability to 
produce their own methionine, are forced to incorporate this alternative amino acid into their newly 
synthesized proteins.  
4.1.7 Model Building and Refinement 
 The final result from a protein crystallography experiment is the electron density map. By 
applying the inverse Fourier transform to structure factors (amplitude and phase) and through 
density modification (solvent flattening and symmetry related density averaging) the initial 
electron density map is obtained. An initial protein model can be built into the density map using 
specialized crystallographic software. The initial electron density map and model are not accurate 
and need to be improved by several rounds of refinement. The aim of refinement is to minimize 
the difference between structure factor amplitudes calculated from experimental data and those 
calculated from the model. It is an iterative process that cycles between automated correction of 
refinement parameters (e.g. x, y, z positional coordinates and B factors or atomic displacement 
parameters) by a specialized software and manual improvement of the model. The progress of 
refinement is monitored by statistical parameters called R-factors (R-work and R-free) given by 
the equation 4.3. 
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𝑅𝑤𝑜𝑟𝑘 = ∑[|𝐹𝑜𝑏𝑠(ℎ𝑘𝑙)| − |𝐹𝑐𝑎𝑙𝑐
ℎ𝑘𝑙
(ℎ𝑘𝑙)|]/∑|𝐹𝑜𝑏𝑠
ℎ𝑘𝑙
(ℎ𝑘𝑙)| 
(4.3) 
Where |𝐹𝑜𝑏𝑠(ℎ𝑘𝑙)| is the observed structure factor amplitude from the diffraction experiment and 
|𝐹𝑐𝑎𝑙𝑐(ℎ𝑘𝑙)| is the calculated structure factor amplitude from the model. 
 To cross validate the refinement process and to avoid overfitting the model, a small 
percentage of reflections (~5%) are not included in the refinement. The parameter called R-free is 
calculated for these reflections using the above equation (Brünger, 1992). In an ideal refinement 
process, the R-work and R-free values should attain a minimum value and their difference should 
be less than ~5% (Wlodawer et al., 2013; Wlodawer et al., 2008).  
4.1.8 Electron density map and its interpretation 
 There are two types of electron density maps commonly used to evaluate the model: the 
2Fo-Fc and Fo-Fc maps. The 2Fo-Fc map is usually contoured at 1 σ. The Fo-Fc map gives the 
positive and negative peaks which indicate insufficient or excessive regions of electron density 
predicted by the model (Wlodawer et al., 2013; Wlodawer et al., 2008). After each round of 
refinement, both density maps are inspected. Water molecules are added to the structure 
automatically during the refinement step or manually during rebuilding.  
4.1.9 Model validation and submission  
 The chemical environment of the protein structure is carefully examined during the 
refinement step. In addition, the refined model is investigated for deviations from the expected 
chemical, stereochemical and biochemical parameters (e.g. bond length, bond angle, torsion 
angles, Ramachandran outliers). Validation servers (e.g. procheck, molprobity) are available for 
this task (Chen et al., 2010). The completed, validated model is then deposited to the Protein Data 
Bank (PDB) where it is made available to other researchers. 
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4.2 Experimental procedure 
4.2.1 Molecular biology and microbiology techniques 
4.2.1.1 Ligation independent cloning (LIC) 
 The protein constructs used in this research were made by following the ligation 
independent cloning protocol. Briefly, LIC cloning uses the 3’→5’ exonuclease activity of T4 
DNA polymerase to make sticky complementary ends (of ~15 nucleotides in length) in the vector 
and insert. T4 DNA polymerase has 3’→5’ exonuclease activity and 5’→3’ polymerase activity. 
In the absence of nucleotides in the reaction mixture, the exonuclease activity takes over and clears 
the strand. Interestingly, if we supply more of a single nucleotide (e.g. dGTP), upon encountering 
nucleotide “C” in the opposite strand, the polymerase and exonuclease activity competes and the 
enzyme is stalled at this site (Eschenfeldt et al., 2009).  
4.2.1.2 PCR components 
 The vector and insert were amplified by PCR with specific sets of primers using KOD 
polymerase. The 50 µl PCR reaction mixture consists of ~50 ng template DNA, 1X reaction buffer, 
1.5mM MgSO4, 200 µM dNTP mix, 0.3 µM primer pair, 1 unit of KOD hot start polymerase and 
nuclease free water. The thermocycle protocol of PCR is shown below. This is the standard 
protocol followed in this thesis. Annealing and extension temperatures were varied based on the 
primer and the length of DNA to be amplified. 
Thermocycle protocol for the PCR reaction 
1) Polymerase activation 95°C for 2 minutes 
2) Initial Denaturation 95°C for 20 seconds 
3) Annealing Average TmoC-5oC of primer pair for 20 seconds 
4) Extension 70°C for 20 seconds/KB 
5) Final extension  70°C for 5 minutes 
Steps 2 to 4 were repeated in ~25 to 30 cycles. In site directed mutagenesis PCR, steps 2 to 4 were 
repeated for 20 cycles. The amplified vector and insert were analysed and separated in a 1% 
agarose gel. The DNA of correct molecular weight was excised from the agarose gel and extracted 
using QIAquick Gel Extraction Kit by following the manufacturer’s protocol.   
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4.2.1.3 T4 Polymerase treatment and ligation 
 The purified vector and insert DNA were subjected separately to T4 DNA polymerase 
treatment. The 40 µl reaction mixture consists of ~200 ng DNA, 1X NEBuffer2, 1×NEB BSA, 5 
mM DTT,  0.3 µl T4 DNA polymerase and 2.5 mM of a single nucleotide. The nucleotide used in 
the treatment of vector and insert were dGTP and dCTP, respectively. The reaction was carried 
out for an hour at 22oC followed by deactivation of the enzyme at 75℃ for 20 minutes. T4 DNA 
polymerase treated vector and insert were mixed in the ratio of ~ 1:5 to 1:10 and incubated on ice 
for 30 minutes to allow ligation.  
4.2.1.4 Transformation 
 The ligated mixture was transformed into chemically competent E.coli DH5α cells. For 
transformation, 5 µl of ligated product was incubated with 50 µl of chemically competent E.coli 
DH5α cells on ice for 30 minutes. This was followed by heat shock at 42° C for 30 seconds and 
rapid cooling on ice for 2 minutes. Five hundred µl of Luria-Bertani broth (LB, 1% (w/v) tryptone, 
0.5% (w/v) yeast extract and 1% (w/v) NaCl) was added and the recovery was carried out for an 
hour at 37oC. After recovery, the cells were pelleted at 3000 rpm for ~3 minutes and the pellet 
was plated on an LB agar (supplemented with appropriate antibiotic) and incubated overnight at 
37° C.  The next day, a single colony was inoculated in LB media and grown at 37° C for ~16 
hours. After 16 hours of growth, the cells were spun down and the plasmid was isolated using 
QIAprep Spin Miniprep Kit following the manufacturer’s protocol.  The inserts were further 
confirmed by sequencing at the National Research Council (Saskatoon, Canada) and at the 
Eurofins (Huntsville, USA) sequencing facility. This transformation protocol was used for all 
constructs listed in this thesis.  
4.2.1.5 Site directed mutagenesis 
Several putative active site mutants were made using the Quickchange site-directed 
mutagenesis protocol and using KOD polymerase. The primer pairs carrying the desired 
mutations used in the projects are shown in section 4.3. Briefly, the plasmid containing the gene 
of interest was amplified with the primer pairs carrying the mutation using KOD polymerase as 
described in section 4.2.1.2. After PCR, the template plasmid was digested with 1 µl of DpnI 
enzyme for an hour at 37° C. Five µl of PCR product was then transformed into 50µl of chemically 
competent E.coli DH5α cells, as described in section 4.2.1.4. The clones carrying the desired 
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mutation were confirmed by sequencing at the National Research Council (Saskatoon, Canada) 
and Eurofins (Huntsville, USA) facility.    
4.2.2 Recombinant protein production  
 Expression plasmids carrying the gene of interest were transformed into chemically 
competent E.coli expression cells lines as described in section 4.2.1.4. For large scale protein 
production, a single positive colony was inoculated into 25 mL LB media supplemented with 
appropriate antibiotics and grown overnight at 37° C. This overnight inoculum was subcultured 
into 1 litre of Terrific Broth media (TB media, 1.2% (w/v) tryptone, 2.4% (w/v) yeast extract, 72 
mM K2HPO4, 17 mM KH2PO4, and 0.4% (v/v) glycerol) supplemented with the appropriate 
antibiotic. Cells were allowed to grow at 37° C until the absorbance at 600 nm reached 1.2-1.5, 
then the temperature was reduced to 18° C or 20° C and protein expression was induced using 0.5 
mM isopropyl 1-thio-β-D-galactopyranoside (IPTG). The IPTG induced cells were allowed to 
grow at low temperature for ~16 hours. After that, the cells were centrifuged at 6200 x g in a 
JLA8.1 beckman rotor for 20 minutes. The cell pellets were resuspended in a lysis buffer and the 
protein was purified from them. Sometimes, the cell pellets were stored at -80 oC until further 
processing could be carried out. The various expression vectors and cell lines used in the different 
projects are listed in tables 4.2.1 and 4.2.2, respectively.    
Table 4.2-1. List of vectors and their description. 
Plasmid Description  Source  
pMSCG7  Ampicillinresistant (Ampr), expression vector with an 
N-terminal 6xHis tag and a TEV cleavage site  
Cygler’s Lab 
pRL652  Ampr, expression vector with an N-terminal GST 
tag and a TEV cleavage site (modified version of 
pGEX vector adopted for LIC cloning) 
Made by Dr. Andrey 
Grishin at Cygler’s 
Lab  
pET28a  Kanamycinresistant (Kanr), expression vector with a 
C-terminal 6xHis tag and a thrombin cleavage site 
Novagen 
pMCSG9 Ampr, expression vector with an N-terminal MBP 
tag and a TEV cleavage site.  
Cygler’s Lab 
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Table 4.2-2. List of bacterial strains used in the various projects. 
Cell Lines Project 
E. coli DH5α  All 
E. coli BL21  HepIII 
E. coli BL21(DE3)  NLR48 
E. coli BL21(DE3)-RIPL  LOR107, PLSV3936 
4.2.2.1 Purification of recombinant protein 
The resuspended cells were lysed using either a cell disruptor at 35 psi (Constant Systems 
Ltd, UK) or sonicator (4 minutes, 7 sec on, 15 sec off). The soluble fraction was obtained by 
centrifuging at 39,000 x g for 40 min using a JA25.50 beckman rotor. Proteins were purified from 
the soluble fraction by affinity chromatography.  
For His tagged protein, Ni-NTA or Cobalt talon resin was used in the purification. The 
resin was first equilibrated with lysis buffer and the soluble fraction was incubated with resin for 
an hour.  This was followed by a wash step with buffer containing a low concentration of Imidazole 
to remove contaminants. The target protein was then eluted with a buffer containing higher 
imidazole concentration. 
For GST fusion proteins, glutathione resin was used in the purification. The glutathione 
resin was pre-equilibrated in lysis buffer and the soluble fraction was incubated with resin for two 
hours. The unbound contaminants were washed with high salt buffer, followed by on-column GST 
tag cleavage using His-TEV (Tobacco Etch Virus) protease. The TEV protease was added at a 
mass ratio of 1:50 and the reaction was carried out for ~8 to 12 hours, either at room temperature 
or at 4oC. After GST cleavage, the elution fraction containing untagged target protein and His-
TEV protease was passed through the Ni-NTA column. This step removed the TEV protease and 
resulted in pure target protein.  
This purification protocol is followed in all the projects described in the thesis with slight 
modifications based on the protein behavior. The composition of lysis buffer, wash buffer and 
elution buffer used in the purification of various proteins is mentioned in the following section.  
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4.2.2.2 Quality assessment of protein sample  
All the fractions obtained in the purification steps were analyzed by (SDS-PAGE), which 
separates the proteins by molecular weight. Protein fractions containing pure samples of correct 
molecular weight were pooled and examined for oligomeric state by size exclusion 
chromatography (SEC) using GE S200 or Biorad SEC650 size exclusion columns. In SEC, the 
samples are separated based on their molecular weight. The sample coming off in the void volume 
represents large aggregates and is not useful. The target proteins are separated based on oligomer 
size. 
4.2.3 Crystallization trials and crystal growth optimization 
After obtaining an adequate amount of homogeneous sample from SEC, the samples were 
concentrated using an appropriate molecular weight cut-off centrifugal filter at 4000 rpm in 10-20 
min intervals. Crystallization experiments were attempted for the concentrated sample. A wide 
range of commercial screens were used in the search for hit conditions. These screens were of the 
96-well, sitting drop format and our screening protocol involved mixing 0.3 µl protein with 0.3 µl 
reservoir using a Gryphon crystallization robot. The initial crystal hits were optimized by hanging 
drop vapor diffusion method with seeding. This step is carried out in all projects. 
4.2.3.1 Diffraction experiment and structure determination  
 All the diffraction data described in this research were collected at the CMCF (Canadian 
macromolecular crystallography facility) beamline (ID or BM), Canadian Light Source (CLS). 
Details of the data collection and processing are described in the following sections for individual 
projects. The structures determined in this thesis work were solved by MR and SAD. Detailed 
information about individual projects are given in the following sections. 
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4.2.4 Heparinase III 
 The HepIII gene (Bt4657) from Bacteroidetes thetaitomicron without the signal peptide 
(HepIII21-666) was previously cloned in Dr.Cygler’s lab. HepIII21-666 was cloned in pRL652 
expression vector as a GST fusion protein with a TEV cleavage site. For protein expression, the 
PRL652/HepIII plasmid was transformed into chemically competent E.coli BL21 cells as 
described in section 4.2.1.4.   
4.2.4.1 Protein Expression and Purification 
 HepIII was expressed as described in section 4.2.2. Briefly, an overnight inoculum of the 
E. coli expression strain harboring HepIII plasmid was subcultured in one liter of TB medium 
supplemented with ampicillin. These cells were allowed to grow at 37° C until the absorbance of 
the culture at 600 nm reached 1.2. The temperature was reduced to 20° C and protein expression 
was induced by the addition of IPTG to a final concentration of 1 mM. After overnight growth, 
the cells were harvested as described in section 4.2.2 and resuspended in 30 mL of lysis buffer 
containing 15 mM HEPES pH 7.5, 150 mM NaCl and 5 mM dithiothreitol (DTT). The cells were 
lysed using a cell disruptor and the protein was purified using glutathione resin as described in 
section 4.2.2.1. The GST tag was cleaved at room temperature by adding TEV protease at a mass 
ratio of 1:50 and incubated for 8 hours. Removal of TEV protease was then carried out as described 
in section 4.2.2.1. 
Table 4.2-3. Buffers used in HepIII project. 
HepIII 
Lysis buffer 15 mM HEPES pH 7.5, 150 mM NaCl, 5 mM DTT 
Wash buffer Phosphate-buffered saline (PBS) + 200 mM NaCl,  
PBS + 350 mM NaCl 
TEV cleavage buffer and condition  15 mM HEPES pH 7.5, 150 mM NaCl, 5 mM DTT, room 
temperature for 8 hours 
SEC column and  buffer GE S200 column, 20 mM HEPES pH 7.5, 150 mM NaCl 
and 3 mM DTT 
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4.2.4.2 Methylation of HepIII 
The pure fractions of HepIII were concentrated to 9 mg/mL for the methylation experiment. 
Twenty µl of dimethylamine borane complex (methylating agent) and 40 µl of 10% formaldehyde 
were added to 1 mL of HepIII solution, mixed well, and incubated at 4οC for 2 hours. This step 
was repeated one more time. After the incubation, 10 µl of the methylating reagent was added and 
incubated overnight at 4οC. The next day, the reaction was stopped by adding 125 µl of 1 M glycine 
and the methylating chemicals were removed by SEC. Methylated HepIII was passed through the 
GE S200 column and the protein eluted as a single peak corresponding to a monomeric molecular 
weight (72.5 kDa for a monomer). Those fractions representing the monomer were then analyzed 
by SDS-PAGE. The clean fractions were pooled and concentrated using a 10 kDa cut-off 
centrifugal filter for crystallization experiment. 
4.2.4.3 Crystallization, X-ray diffraction and data collection of HepIII 
 HepIII was concentrated to 15 mg/mL and the crystallization experiments were carried out 
using many commercially available screens at room temperature (~20oC). The initial hit conditions 
were optimized by the hanging drop vapor diffusion method. Both micro and macro seeding 
techniques were used to improve the crystal quality. The diffraction quality HepIII crystals were 
cryoprotected with mother liquor supplemented with 20% glycerol and flash frozen in liquid 
nitrogen. Diffraction data were collected at the 08ID beamline equipped with a CCD X-ray 
detector at the CLS (Grochulski et al., 2011). The diffraction images were processed using 
HKL2000 (Otwinowski and Minor, 1997). 
4.2.4.4 Structure determination 
 The structure of HepIII was solved using the Phaser-MR program in the PHENIX package 
(Adams et al., 2011). The phase information was obtained from the previously solved HepIII 
structure in Dr.Cygler’s lab. Manual inspection, model building and structure refinement were 
carried out using COOT and the PHENIX refinement program, respectively (Emsley and Cowtan, 
2004; Adams et al., 2011). The refined structure was validated using the MolProbity server (Chen 
et al., 2010). 
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4.2.4.5 Putative active site mutants and enzyme activity 
 The active site mutants of HepIII, namely; Y301F, H431A, Y457F, N247A were made as 
described in section 4.2.1.5. These mutants were purified in the same way as the native protein 
and were tested for enzyme activity. The assay solution was composed of 0.15 mg/mL heparan 
sulfate in 20 mM HEPES pH 7.5, 150 mM NaCl and 2 mM DTT. One µg of enzyme was added 
directly to the assay solution. A control reaction without enzyme was used to remove the 
background absorbance from substrate. The plate was immediately placed on a temperature 
controlled SpectraMax plate reader (Molecular Devices, Sunnyvale, CA) set at 25° C. Absorbance 
readings at 230 nm were taken every 20 s for 30 min.  
4.2.4.6 Crystallization of HepIII mutant with substrate and structure solution 
 One of the HepIII mutants, Y301F was purified in large scale following the protocol used 
for wildtype HepIII. The methylated monodisperse Y301F sample was used in various 
crystallization screens with substrate to obtain a complex structure. The tetrasaccharide substrates 
used were heparosan dp4 (ΔUA-GlcNAc-GlcA-GlcNAc) and heparosan dp4S (ΔUA-GlcNS-
GlcA-GlcNS). The substrates were received from the Dr. Lindhardt laboratory, United States. In 
one of the co-crystallization experiments, the Y301F mutant was mixed with tetrasaccharide 
substrates in various ratios, incubated overnight at 4° C and screened for new crystallization hits 
as described in section 4.2.3. Also, using the hanging drop vapor diffusion method, the protein 
substrate complex was screened around the condition where the wild type HepIII had crystallized. 
Microseeding using wild type crystals were also carried out in these screens. Crystals of Y301F 
alone were grown by the hanging drop vapour diffusion method in the condition giving rise to wild 
type HepIII crystals. For the soaking experiment, the aforementioned tetrasaccharides and a 
digested product of long heparin by native HepIII were used. On a cover slip, 3 µl of substrate was 
mixed with 3 µl of well solution and equilibrated against 500 µl of well solution. Y301F mutant 
crystals were soaked in the pre-equilibrated substrate solution for different time periods. For the 
diffraction experiment, substrate soaked crystals were cryo protected with mother liquor 
supplemented with 20% glycerol and flash cooled in liquid nitrogen. Diffraction data of substrate 
soaked Y301F crystal was collected at the CMCF-ID beamline at the CLS. The diffraction data 
were processed using HKL2000 (Otwinowski and Minor, 1997) and the structure was solved by 
MR using the MR-Phaser program available in PHENIX package (Adams et al., 2011). 
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4.2.4.7 Normal mode analysis (NMA) 
Biologically significant conformational changes in proteins occur over a long period of 
time, from nanoseconds to seconds. Calculating molecular dynamics simulation for such a long 
timescale is computationally taxing. In such situations, NMA is a useful technique to calculate the 
possible large conformational changes by treating the Cα atoms in proteins as spheres and the 
peptide bonds connecting them as strings (Yang and Bahar, 2005; Bahar et al., 2010). In simple 
terms, by applying Hooke’s and Newton’s law of motion to a simplified model (spheres connected 
by strings), movements with low frequency and high amplitude are calculated. NMA applies a 
diagonalized Hessian matrix, in which the elements are mass weighed secondary derivatives of 
protein potential energy. This minimizes the complexity that would otherwise accompany the 
computation of values for many atoms. The resulted eigenvectors are normal modes, which 
describe the directions of protein motions/conformational changes, whereas the eigenvalues are 
the frequencies of the corresponding normal modes. The collective movements of the protein are 
approximately described by the superposition of several low-frequency normal modes, whereas 
the other normal modes mostly represent local vibrations, which do not contribute to large scale 
conformational changes.                
In order to investigate the large-scale movements of HepIII, NMA was performed on the 
apo form of two proteins: One is the crystal structure of the open form of HepIII determined here 
and the other is the relatively closed crystal structure 4FNV homolog (Dong et al., 2012) . 
Calculations were done in elNemo online server, (Suhre and Sanejouand, 2004). The potential 
energy of the protein was described by an elastic network with a cutoff of 8 Å. Homology models 
of the closed state of HepIII and the open state of 4FNV were constructed and used to determine 
the contributions of each mode to the conformational changes. For NMA of each crystal structure, 
two lowest frequency modes were selected and analyzed based on their contributions. Perturbation 
was applied on the crystal structures to get deformed conformations along these normal modes by 
g_nmtraj tool in GROMACS package. The magnitude of the deformation was determined based 
on the distance between the deformed structure and the homology model.  
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4.2.5 Ulvan lyase 
 The ulvan lyase genes from marine cohabiting bacteria were identified in the laboratory 
of Dr.William Helbert (CNRS, France) and Dr. Ehud Banin (Bar-Ilan University, Israel). These 
genes were cloned without signal peptide in the pET28a expression vector. The expression 
plasmids containing ulvan lyase genes were obtained from them. The list of genes and the NCBI 
accession numbers are mentioned in table 4.2-4. In addition, a few truncated constructs of the 
ulvan lyase genes were made by following the LIC protocol as mentioned in section 4.2.1.1. Small 
scale protein expression and solubility analysis were attempted for all the received genes. 
Table 4.2-4. Newly identified ulvan lyase genes. 
 
4.2.5.1. Production and Purification of wildtype LOR107 and PLSV3936  
 LOR_107 and PLSV_3936 genes have several codons that are rare in Escherichia coli so 
BL21(DE3)-RIPL cells were used for protein production. The protein was expressed as described 
in section 4.2.2. Briefly, an overnight inoculum of the expression strain containing the plasmid 
was sub-cultured into one liter of TB medium supplemented with 50 µg kanamycin and 50 µg 
chloramphenicol. Cells were allowed to grow at 37° C until the absorbance at 600 nm reached 1.5, 
then the temperature was lowered (reduced to 18° C and 20° C for LOR107 and PLSV3936 
respectively) and protein expression was induced with 0.5 mM IPTG. After overnight growth the 
cells were harvested and lysed using a cell disruptor. LOR107 and PLSV3936 were cloned with 
an N- terminal 6X His tag and purified by metal affinity chromatography using cobalt talon resin 
Strains Short ulvan lyase Long ulvan lyase 
Alteromonas sp. LOR LOR_107 (59.6 KDa) 
WP_052010193.1 
LOR_61 (110.9 KDa) 
WP_032096165.1 
Alteromonas sp. LOR LOR_29 (53.7 KDa) 
WP_052010178.1 
 
Pseudoalteromonas sp.  PLSV PLSV_3875 (59.6 KDa) 
WP_033186987.1 
PLSV_3925 (111.4 KDa) 
WP_033186955.1 
Pseudoalteromonas sp.  PLSV PLSV_3936 (50 KDa)  
WP_033186995.1 
 
N. ulvanivorans  NLR NLR_48 (33.4 KDa) 
WP_036579443.1 
NLR_42 (59 KDa) 
WP_036579437.1 
N. ulvanivorans  NLR NLR_492 (50 KDa) 
WP_036580476.1 
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following the protocol delineated in section 4.2.2.1. Buffers used in the purification are listed in 
table 4.2-5. The LOR107 and PLSV3936 eluted with 40 mM imidazole were concentrated using a 
10 kDa cut-off centrifugal filter and injected onto a GE S200 size exclusion column. The protein 
fractions eluted in a single peak with the molecular weight corresponding to that of a monomer. 
These peak fractions were pooled together and concentrated. In the case of LOR107 the protein 
was concentrated to 17 mg/mL and PLSV3936 was concentrated to 29 mg/mL. This concentrated 
protein solution was then screened for crystallization. Problems were encountered in the 
expression of LOR107. The protein did not express when grown in large scale (1 litre TB). To 
overcome this difficulty, the LOR107 protein was expressed in five aliquots of 200 mL TB media. 
All the mutants of LOR107 were expressed in this way. 
Table 4.2-5 Buffers used in LOR107 andPLSV3936 purification 
LOR107 & PLSV3936 
Lysis buffer 20 mM Tris pH8.0, 200 mM NaCl, 5% glycerol and 5 mM 
imidazole 
Wash buffer Lysis buffer +20 mM imidazole 
Lysis buffer +40 mM imidazole 
SEC column and  buffer Bio-Rad SEC650 and GE S200, 20 mM HEPES pH 7.5, 150 mM 
NaCl  
 
4.2.5.2. Production and purification of SeMet incorporated LOR107 and PLSV3936 
 Selenomethionine was incorporated into LOR107 and PLSV3936 by inhibiting the 
methionine biosynthesis pathway (Walden, 2010). Briefly, an overnight inoculum in 100 mL LB 
media was grown at 37° C. The cells were then spun down and the pellet was resuspended in M9 
minimal media. The resuspended cells were used to subculture 1 L of M9 minimal media 
supplemented with 50 µg kanamycin and 50 µg chloramphenicol. Cells continued to grow at 37oC 
until the optical density at 600nm (OD600) reached ~1 (5-6 h). Then 100 mg of hydrophobic amino 
acids lysine, phenylalanine, threonine, 50 mg of isoleucine, leucine, valine and 60 mg of L-
selenomethionine were added. After a 15 min incubation, protein expression was induced by the 
addition of 0.5 mM IPTG and the cells continued to grow at 20oC for 16 hours. Next, cells were 
spun down and the SeMet incorporated protein was purified in the same way as native protein 
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(except 2 mM DTT was included in the lysis buffer and purification buffer in the SeMet 
incorporated protein purification). After passing through a GE S200 column, the LOR107 and 
PLSV3936 fractions corresponding to the monomeric form of protein were concentrated to 20 
mg/mL and 30 mg/mL, respectively. These concentrated samples were used for hanging drop 
crystallization experiments.  
4.2.5.3. Site directed mutagenesis and enzyme activity assay 
 Several putative active site mutants were made for LOR107 and PLSV3936 by following 
the protocol described in section 4.2.2.5. The first set of mutants made for LOR107 are as follows: 
H146A, H167A, R259A, T242A, Y243F, N263A, Y303A, R320A, Y330F, R259N and R259L. 
The second set of LOR107 mutants: H146N, H167N, R259N, R259L, R320N and R320L were 
made specifically to obtain a complex structure. 
 The putative active site mutants made in PLSV3936 are H123N, H143N, Y188F, R204N 
and H264N. The list of primers used in the site directed mutagenesis PCR to make the 
aforementioned mutants are listed in section 4.3.1.4. 
 The enzyme activity of wild-type and various mutants of LOR107 and PLSV3936 were 
measured by monitoring the absorption at 232 nm on a SpectraMax plate reader set at 25°C. The 
assay solution was composed of 0.5 mg/mL ulvan polysaccharide in 20 mM HEPES pH 7.5 and 
150 mM NaCl. One µg of the enzyme was added directly to the assay solution with constant 
stirring. The absorbance of the substrate alone was used as a control.  
4.2.5.4. Crystallization and diffraction of wild type and SeMet incorporated LOR107  
 Crystallization screening of wild type LOR107 was carried out at room temperature 
(~20oC) using various commercial screens as described in section 4.2.3. The initial hit condition 
was optimized by the hanging drop vapor diffusion method. For data collection, the LOR107 
crystals were cryoprotected by briefly immersing in the mother liquor and were flash cooled in 
liquid nitrogen. Diffraction data were collected at the 08ID beamline at the CLS equipped with 
Rayonix MX300 CCD detector (Grochulski et al., 2011). The crystal to detector distance was set 
to 250 mm. A total of 360 degrees with 0.7o oscillation was collected. This recorded 520 diffraction 
frames. The diffraction data was processed with the XDS program (Kabsch, 2010). The 
crystallization of SeMet-LOR107 was attempted by hanging drop vapor diffusion method through 
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systematic grid screening around the condition where wild type LOR107 had crystallized. The best 
crystals of SeMet-LOR107 were produced through several rounds of micro seeding. The initial 
round of seeding was done using crushed crystals of wildtype LOR107 and the following several 
rounds of seeding were done using microcrystals of SeMet-LOR107. For data collection, the 
SeMet-LOR107crystals were briefly transferred to mother liquor and flash cooled in liquid 
nitrogen. Diffraction data were collected at the 08ID beamline (Grochulski et al., 2011) at the CLS. 
The SeMet-LOR107 crystals were scanned for Se absorption peak and the diffraction data was 
collected at the Se absorption edge wavelength. The crystal to detector distance was set to 320 
mm. A total of 360 degrees with a 0.75o oscillation was collected. This recorded 480 diffraction 
frames. Diffraction data was processed using HKL 3000 (Minor et al., 2006) by treating the Friedel 
pairs as different reflections. 
4.2.5.5. Crystallization and diffraction of wild type and SeMet incorporated PLSV3936 
 Like LOR107, crystallization screening of wild type PLSV3936 was carried out at room 
temperature (~20oC) using various commercial screens. Initial crystallization hit conditions of wild 
type PLSV3936 were optimized by the hanging drop vapor diffusion method through systematic 
grid screening. The crystallization of SeMet-PLSV3936 was achieved by the hanging drop vapor 
diffusion method through systematic grid screening around the wild type crystallization condition. 
For data collection, both wild type and SeMet crystals were cryo protected with well solution 
supplemented with 30% ethylene glycol and flash cooled in liquid nitrogen. Diffraction data of 
wild type and SeMet crystals were collected at the 08B1 beamline at the CLS (Fodje et al., 2014) 
equipped with a Rayonix MX300HE detector. For the wildtype crystal, a total of 360 diffraction 
frames with 0.5o oscillation were collected. The crystal to detector distance was set to 190 mm. 
Diffraction data was processed with XDS (Kabsch, 2010). The SeMet crystals were scanned for 
Se absorption peak and the diffraction data was collected at the Se absorption edge wavelength. 
The crystal to detector distance was set to 250 mm. A total of 514 frames with 0.7o oscillation was 
collected. Diffraction data was processed using HKL 3000 (Minor et al., 2006) by treating the 
Friedel pairs as different reflections. 
4.2.5.6. Structure determination and refinement of LOR107 and PLSV3936 
 The structure of LOR107 was solved from the SeMet data using the automated structure 
solving pipeline CRANK2 (Skubák and Pannu, 2013). Structure of PLSV3936 was solved using 
4. Methods and Materials 
 
60 
 
autosol program (Terwilliger et al., 2009) in PHENIX using the data from the SeMet crystal. Both 
programs have done all the steps including Se substructure identification, density modification and 
hand correction. This led to the generation of an initial model. Both structures were refined with 
the PHENIX software (Adams et al., 2011) and manual rebuilding and solvent placement was 
conducted with the COOT program (Emsley and Cowtan, 2004). The stereochemistry of both 
models were validated with MolProbity (Chen et al., 2010). 
4.2.5.7. Purification and crystallization of protein-ligand complex 
The tetrasaccharide substrates used in the co-crystallization and soaking experiments were 
obtained from Dr. William Helbert (CNRS, France). They were prepared by enzymatic digestion 
of ulvan polysaccharide with LOR107 ulvan lyase (PL24) from Alteromonas LOR sp. (Kopel et 
al., 2016) and separated by HPLC chromatography. Tetrasaccharide I (DP4-1) shown in Figure 
4.2:1 contains a mixture of ΔUA-Rha3S-GlcA-Rha3S/ and ΔUA-Rha3S-IdoA-Rha3S/ with 
some traces of hexasaccharides. Tetrasaccharide II (DP4-2) is a pure sample of ΔUA-Rha3S-Xyl-
Rha3S/. 
To obtain the complex structure of LOR107 with substrate, the following active site 
mutants, H146N, H167N, Y243F, R259N, R259L and R320N were expressed and purified in the 
same way as native LOR107. The purified mutants were passed through the GE S200 column to 
separate aggregates and different oligomeric states. The monomeric fractions of LOR107 mutants 
(namely R259N, R259L, Y243F and R320N) were concentrated to 22 mg/mL and screened for 
crystallization. In the co-crystallization experiments, the R259N mutant and dp4-1 tetrasaccharide 
were mixed at various ratios and incubated for a few hours at 4oC. The protein-ligand mixture was 
screened for crystallization as described in section 4.2.2.2. For the soaking experiment, crystals of 
mutant (R259N, R320N and Y243F) were grown by a grid screen around the condition where the 
native protein crystallized. Several rounds of microseeding were also carried out to obtain mutant 
crystals of LOR107. 
In the PLSV3936 project, the mutants H123N, Y188F and H264N were purified in the 
same way as the native protein. The monomeric fractions of H123N and H264N mutants from the 
SEC experiment were concentrated to approximately 29 mg/mL and Y188F mutant to 17 mg/mL. 
All the three mutants were screened for crystallization by the hanging drop vapor diffusion method 
around the conditions where native crystals grew.  
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4.2.5.8. Soaking experiment and data collection 
 For soaking experiments, 3 µl of tetrasaccharide substrate was mixed with 3 µl of well 
solution in a cover slip and equilibrated against 1 mL of well solution. This soaking experiment 
was done with both dp4-1 and dp4-2 substrates. Also, soaking experiments were carried out at 
various incubation times, ranging from 5 minutes to 8 hours in length. 
 Crystals of LOR107 single mutants, R259N, Y243F and R320N, were soaked for ~5 hours 
in the two different tetrasaccharide substrates. After soaking, the crystals were flash cooled in 
liquid nitrogen. Diffraction data of the R259N crystals were collected at the 08B1 beamline (Fodje 
et al., 2014), at the CLS. The crystal to detector distance was set to 300 mm. A total of 360 frames 
Figure 4.2:1 Schema of ulvan tetrasaccharide 
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were collected with 1o oscillation. Data was processed with the XDS software (Kabsch, 2010). For 
R320N substrate soaked crystals, the diffraction data of the crystals were collected at the 08ID 
beamline (Grochulski et al., 2011), at the CLS. 
 In PLSV3936, the H123N mutant crystals were soaked in the substrate solution at various 
time points. After soaking, the crystals were cryo protected with mother liquor containing 30% 
ethylene glycol and flash cooled in liquid nitrogen. Diffraction data were collected at the 08B1 
beamline at the CLS (Fodje et al., 2014) and processed with XDS (Kabsch, 2010). The crystal to 
detector distance was set to 210 mm. A total of 514 frames were collected with 0.7o oscillation. 
4.2.5.9. Complex structure solution and ligand modelling 
 The mutant crystals were isomorphous to the native crystal, and one round of rigid body 
refinement was done on the complex dataset with the PHENIX refinement program. The 
coordinates and the restraint file for the tetrasaccharide were created using Jligand program 
(Lebedev et al., 2012) available in the CCP4 package and elbow (Moriarty et al., 2009) from the 
PHENIX package. The complex structure of both LOR107 and PLSV3936 mutants were refined 
using the PHENIX refinement program. Modelling of ligand into the electron density, structural 
inspection and other aspects of model building were carried out using COOT (Emsley and Cowtan, 
2004). The stereochemistry of these structures was validated using MolProbity (Chen et al., 2010). 
4.2.6 NLR48  
 The construct NLR48(26-302) lacking the signal peptide was cloned into expression vectors 
with different tags to improve solubility and to aid in purification. The NLR48(26-302) fusion 
constructs were made by following the LIC protocol. GST-NLR48(26-302) fusion was made by 
cloning into the pRL652 vector; His-MBP-NLR48(26-302) fusion was made by cloning into the 
pMCSG9 vector. Based on secondary structure predictions, a shorter construct lacking a few 
residues at the N-terminal unstructured region of NLR48(53-302) was cloned into the pMCSG7 
vector.  
4.2.6.1. Expression and purification of wild type NLR48 
 His-NLR48(26-302), His-MBP-NLR48 (26-302)) GST-NLR48(26-302) and His-NLR48(53-302)were 
expressed as described in section 4.2.2. The 6X His and His-MBP tag constructs were purified 
using Ni-NTA metal affinity chromatography as described in section 4.2.2.1. Although various 
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NLR48 constructs were made, only GST-NLR48(26-302) was used for structural studies and active 
site mutant construction. Briefly, GST-NLR48(26-302) was expressed and purified as follows: The 
GST-NLR48(26-302) plasmid was transformed into BL21(DE3) expression cells. The protein was 
expressed with 0.5mM IPTG at 18oC. The GST-NLR48(26-302) fusion protein was sensitive to 
higher temperature, so all the purification steps were carried out at 4oC. After overnight growth, 
the cells were harvested and resuspended in 40 ml of lysis buffer containing 20 mM Tris pH8.0, 
400 mM NaCl, and 5% glycerol. The cells were then disrupted by sonication (7 seconds on, 7 
seconds off for 4 minutes, output level 5) and the protein was purified using glutathione resin (as 
described in section 4.2.2.1). The GST tag was cleaved at 4° C by TEV protease added at the mass 
ratio of 1:50 over the course of ~14 hours. The TEV protease was removed as described in section 
4.2.2.1. Purified NLR48(26-302) was then injected onto a Bio-Rad SEC650 column to check its 
oligomeric state. The peak fractions corresponding to the monomeric molecular weight of the 
protein were concentrated to 16 mg/ml using a 30 kDa cut-off centrifugal filter. This concentrated 
protein was then used for crystallization experiments. 
Table 4.2-6. Buffers used in NLR48 purification. 
NLR48 (all purification steps were carried out at 4oC) 
Lysis buffer 20 mM Tris pH8.0, 400 mM NaCl, and 5% glycerol 
Wash buffer 200 mM NaCl+lysis buffer 
TEV cleavage buffer and condition  20 mM Tris pH8.0, 400 mM NaCl, and 5% glycerol, 
~12 hours at 4oC 
SEC column and  buffer Bio-Rad SEC650, 20 mM Tris pH8.0, 150 mM NaCl 
 
4.2.6.2. Selenomethionine incorporation of NLR48 
 Expression plasmid carrying the GST-NLR48(26-302)  fusion construct was transformed into 
methionine auxotroph cells B834 (DE3). An overnight inoculum grown in 50 mL M9 medium 
supplemented with methionine was subcultured into 1 L M9 medium containing methionine. For 
selenomethionine incorporation, cells were grown at 37˚C until OD600 value reaches 1 and cells 
were spun down in sterile centrifuge bottles at 3000 x g using beckman JLA9.1 rotor for 20 
minutes. Cell pellets were resuspended in 1 L of M9 medium and the culture was incubated at 
37˚C for another 4 hours to deplete the remaining methionine. After depletion, 50 mg/L of 
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selenomethionine was added to the cell culture 30 minutes prior to the addition of IPTG. The cells 
were further grown at 18° C. After ~16 hours of growth, the cells were spun down and 
selenomethionine incorporated protein was purified following the same protocol used for native 
enzyme purification.  
4.2.6.3. Crystallization and diffraction experiment of wild type and SeMet-NLR48(26-302) 
 The GST tag cleaved NLR48(26-302)  was concentrated to 16 mg/mL and screened for 
crystallization by following the protocol described in 4.1.3. The crystallization plates were 
maintained at 15° C and 9° C. Both wildtype and SeMet-NLR48(26-302) crystals were improved by 
the hanging drop vapor diffusion method through grid screening. Microseeding using wild type 
NLR48(26-302) crystals was carried out to improve the quality of SeMet-NLR48(26-302) crystals. For 
diffraction data collection, the SeMet crystals were cryoprotected with 30% ethylene glycol and 
flash frozen in liquid nitrogen. Diffraction data was collected at the 08BM beamline at the CLS. 
The crystal to detector distance was set to 250 mm and a total of 370 frames were collected with 
1o oscillation. Data was processed with XDS package (Kabsch, 2010). 
4.2.6.4. Active site mutants- enzyme activity and crystallization 
 Putative active site single mutants Q137A, K139M, Y258F, R94N and R193N were made 
using the GST-NLR48(26-302) fusion plasmid as a template. All clones were confirmed by 
sequencing. The active site mutants were expressed and purified in the same way as the wildtype 
enzyme. Enzyme activity of wild type and single mutants were measured using the protocol 
described for other ulvan lyase (section 4.2.5.3). 
 The active site mutants K139M and Y258F were concentrated to 17 mg/mL and screened 
for crystallization. Crystals were grown by the handing drop vapor diffusion method at both 15° C 
and 9° C. Crystal growth was promoted by microseeding using wildtype crystals. The substrate 
soaking solution was made as described in section 4.2.5.8. The mutant crystals were soaked in the 
dp4-1substrate solution for ~2 hours and cryo-protected with well solution containing 30% 
ethylene glycol followed by flash cooling in liquid N2. Diffraction data were collected at the 08ID 
beamline (Grochulski et al., 2011) equipped with Pilatus3 S 6M detector at the CLS. The crystal 
to detector distance was set to 300 mm and 1350 frames were collected with 0.2o oscillation. The 
mutant crystal was isomorphous to the wild type NLR48 crystals. One round of rigid body 
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refinement was done on the complex dataset. The refinement was performed with the PHENIX 
refinement program. Manual building of the substrate into the positive density, structure inspection 
and rebuilding were done using COOT (Emsley and Cowtan, 2004). Further refinement was done 
using the PHENIX refinement program (Adams et al., 2011). The complex structure was evaluated 
for stereochemistry using MolProbity (Chen et al., 2010).   
4.3 . List of Materials 
4.3.1 List of Primers used in various projects 
4.3.1.1. HEPIII mutants 
N247A 5’ CTCTGATCAGGGTGCTCACTTGTTGTTC 3’ 
5’ GAACAACAAGTGAGCACCCTGATCAGAG 3’ 
Y457F 5’ GTTCGTATGTGTTTGCCGGTGAAGG 3’ 
5’ CCTTCACCGGCAAACACATACGAAC 3’ 
H431A 5’ CCGAAAGGTTTCTGGGCCTGTCAGCCGGATAAC 3’ 
5’ GTTATCCGGCTGACAGGCCCAGAAACCTTTCGG 3’ 
Y303F 5' CTTGACCCGCATTTTCATCTTGCTGC 3' 
5' GCAGCAAGATGAAAATGCGGGTCAAG 3' 
 
4.3.1.2. LOR107 
H146A 5’ GTAGGTGAATCGGCCAACACCATTG 3’ 
5’ CAATGGTGTTGGCCGATTCACCTAC 3’ 
H167A 5’ GTTTACGACATGGCCGCCTATGTTG 3’ 
5’ CAACATAGGCGGCCATGTCGTAAAC 3’ 
H167N 5’ GTTTACGACATGAACGCCTATGTTG 3’ 
5’ CAACATAGGCGTTCATGTCGTAAAC 3’ 
H167F 5’ GTTTACGACATGTTCGCCTATGTTG 3’ 
5’ CAACATAGGCGAACATGTCGTAAAC 3’ 
T242A 5’ TTTTCTGCGCTAGCCTATCCTAAAT 3’ 
5’ ATTTAGGATAGGCTAGCGCAGAAAA 3’ 
Y243F 5’ CTGCGCTAACCTTTCCTAAATTTTAC 3’ 
5’ GTAAAATTTAGGAAAGGTTAGCGCAG 3’ 
R259A 5’ GCTTCACTATATGGCCTGGGGTGGCAA 3’ 
5’ TTGCCACCCCAGGCCATATAGTGAAGC 3’ 
R259N 5’ GCTTCACTATATGAACTGGGGTGGCAA 3’ 
5’ TTGCCACCCCAGTTCATATAGTGAAGC 3’ 
R259L 5’ GCTTCACTATATGCTCTGGGGTGGCAA 3’ 
5’ TTGCCACCCCAGAGCATATAGTGAAGC 3’ 
N263A 5’ ATGCGCTGGGGTGGCGCTAACAACGGCGCTTATTACTT 3’ 
5’ AAGTAATAAGCGCCGTTGTTAGCGCCACCCCAGCGCAT 3’ 
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Y303F 5’ CAATTGGGGACTGTTTGGCCAAATGAAG 3’ 
5’ CTTCATTTGGCCAAACAGTCCCCAATTG 3’ 
R320A 5’ GTAGGGTTTCAACAGGCTAGCGCAAATAATG 3’ 
5’ CATTATTTGCGCTAGCCTGTTGAAACCCTAC 3’ 
R320N 5’ CGTAGGGTTTCAACAGAATAGCGCAAATAATG 3’ 
5’ CATTATTTGCGCTATTCTGTTGAAACCCTACG 3’ 
Y330F 5’ GCAAATAATGATGACCGTTTTAAATTTCAAAATGGTGTTTATTATGCC 3’ 
5’ GGCATAATAAACACCATTTTGAAATTTAAAACGGTCATCATTATTTGC 3’ 
4.3.1.3. PLSV3936 
H123F 5’ GAAATTCGATAATTTTGGTAAGCCAACC 3’ 
5’ GGTTGGCTTACCAAAATTATCGAATTTC 3’ 
H123N 5’ GAAATTCGATAATAATGGTAAGCCAACC 3’ 
5’ GGTTGGCTTACCATTATTATCGAATTTC 3’ 
H143F 5’ TTTTTACGGCGGATTTGGCGGTCAGGCA 3’ 
5’ TGCCTGACCGCCAAATCCGCCGTAAAAA 3’ 
H143N 5’ TTTTTACGGCGGAAATGGCGGTCAGG 3’ 
5’ CCTGACCGCCATTTCCGCCGTAAAAA 3’ 
R204L 5’ ATTTATTTTTCCTCCACGGTGCTCA 3’ 
5’ TGAGCACCGTGGAGGAAAAATAAAT 3’ 
R204N 5’ ATTTATTTTTCAACCACGGTGCTCA 3’ 
5’ TGAGCACCGTGGTTGAAAAATAAAT 3’ 
H264F 5’ CCTACGACTATTTCGTTTGCTGGGA 3’ 
5’ TCCCAGCAAACGAAATAGTCGTAGG 3’ 
H264N 5’ CCTACGACTATAACGTTTGCTGGGA 3’ 
5’ TCCCAGCAAACGTTATAGTCGTAGG 3’ 
Y188F 5’ CCATTTGGTACCTTTAACCAAGCAATC 3’ 
5’ GATTGCTTGGTTAAAGGTACCAAATGG 3’ 
4.3.1.4. NLR48 
Q137A 5’ GCTACTTTATGGCGGCTAAAGGCAAA 3’ 
5’ TTTGCCTTTAGCCGCCATAAAGTAGC 3’ 
K139H 5’ CTTTATGCAGGCTCACGGCAAACACACAG 3’ 
5’ CTGTGTGTTTGCCGTGAGCCTGCATAAAG 3’ 
K139M 5’ CTTTATGCAGGCTATGGGCAAACACAC 3’ 
5’ GTGTGTTTGCCCATAGCCTGCATAAAG 3’ 
K139A 5’ TTTATGCAGGCTGCAGGCAAACACA 3’ 
5’ TGTGTTTGCCTGCAGCCTGCATAAA 3’ 
Y258F 5’ AGATATGGTGCCTTCCGTGTTAAAG 3’ 
5’ CTTTAACACGGAAGGCACCATATCT 3’ 
R94N 5’ CATTACAGCCTAACATAGAACGTTCC 3’ 
5’ GGAACGTTCTATGTTAGGCTGTAATG 3’ 
R94A 5’ CATTACAGCCTGCGATAGAACGTTC 3’ 
5’ GAACGTTCTATCGCAGGCTGTAATG 3’ 
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R193N 5’ CAGGTTCTGCTGGAAATACTGAAGTTTTTC 3’ 
5’ GAAAAACTTCAGTATTTCCAGCAGAACCTG 3’ 
R193A 5’ GGTTCTGCTGGAGCAACTGAAGTTTTTC 3’ 
5’ GAAAAACTTCAGTTGCTCCAGCAGAACC 3’ 
  
4.3.2 List of Chemicals 
100 mM dCTP and 100 mM dGTP NEB, N0446S  
100×BSA  NEB  
30% Acrylamide/Bisarcylamide(29:1)  Bioshop, ACR009.500   
Ammonium persulfate (APS)  BioShop, AMP001.25   
Bis-Tris  BioShop, BST602.250   
Borane dimethylamine complex  Sigma-Aldrich, 180238-5G   
Bromophenol Blue  Sigma-Aldrich, 114413-5G   
Coomassie Brilliant Blue R-250  AMRESCO, (0427-25G)   
Dithiothreitol (DTT)  Thermo Fisher Scientific, BP17225  
DNA loading buffer  Norgen, 28129   
DpnI  NEB, R0176L  
Enrich SEC650 Bio-Rad, 780-1650 
Formaldehyde  Polysciences, Inc, 04018   
Gelgreen nucleic acid gel stain  Biotium, 41005   
Glutathione superflow resin, 635608  Clontech  
Glycerol  Thermo Fisher Scientific, G31-4   
Glycine  Thermo Fisher Scientific, BP381-5   
HEPES (4-(2-hydroxyethyl)-1- 
piperazineethanesulfonic acid) 
BioShop, HEP001.1   
Hitrap chelating column  GE Healthcare Life Science,  
17-0409-03   
Imidazole  BioShop, IMD508.1   
Isopropyl β-D-1-thiogalactopyranoside (IPTG)  Thermo Fisher Scientific,  
BP1755100  
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KOD hot start DNA polymerase kit  Novagen, 71086   
L-Glutathione (GSH)  BioShop, GTH003.25   
MPD (Methyl-pentane-diol)    Hampton Research, Aliso Viejo, CA  
Nickel (II) sulfate hexahydrate  Sigma-Aldrich, 227676-500G    
Ni-NTA agarose  Qiagen, 142338540   
Poly-ethylene glycol (PEG) Molecular weight  400, 
3500,6000, 8000  
  Hampton Research, Aliso Viejo, CA  
Polyethylene glycol 3350 (PEG3350)  Sigma-Aldrich, P4338-1KG   
Potassium phosphate dibasic (K2HPO4)  BioShop, PPD303.1   
Potassium phosphate monobasic (KH2PO4)  Thermo Fisher Scientific, P285-500   
Protein marker  Bio-Rad, 161-0377   
QIAprep Spin Miniprep Kit (250)  Qiagen, 27106    
QIAquick Gel Extraction Kit (250)  Qiagen, 28706   
Sodium chloride (NaCl)  BioShop, SOD002.10   
Sodium dodecyl sulfate (SDS)  BioShop, SDS001.1   
Superdex 200 10/300  GE Healthcare Life Science, 28990944   
T4 DNA ligase and corresponding buffer  NEB, M0202S  
T4 DNA polymerase and corresponding buffer  NEB, M0203L  
TEMED (N,N,N′,N′-Tetramethylethane)  BioShop , TEM001.25 
Tryptone  Thermo Fisher Scientific, BP1421-2   
Yeast Extract  BioShop, YEX401.205   
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5. Structure and Substrate Specificity of HepIII from Bacteroides Thetaiotaomicron (Bt4657) 
 
The objective of this section is to describe the substrate specificity and catalytic mechanism 
of HepIII (PL12 family) from Bacteroides Thetaiotaomicron. To accomplish this, we first solved 
the crystal structure of wildtype HepIII. Second, we identified the putative active site residues 
through a structural comparison with a homolog and confirmed these residues to be catalytic by 
enzyme activity assays. At the same time, in a collaboration with Dr. Robert Linhardt (Rensselaer 
Polytechnique institute, USA) we studied the substrate specificity of HepIII using natural and 
chemically modified heparin/heparan sulfate polysaccharides. Third, we attempted to obtain the 
structure of the HepIII-substrate complex. Despite extensive efforts, we did not succeed in 
obtaining crystals of the HepIII-substrate complex or HepIII-product complex with either wildtype 
or active site mutants. However, structural comparison with HepIII homologs revealed structural 
flexibility in the domain arrangement, indicating an open-closed states of the substrate-binding site 
of HepIII. Finally, in a collaboration with Dr. D. Peter Tieleman’s group at the University of 
Calgary, we performed Normal Mode Analysis (NMA), and modelled a possible large-scale 
motion of the HepIII structure during its catalytic cycle.  
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5.1 Expression, purification and methylation of HepIII 
 Expression of HepIII21-666 was carried out in the E. coli BL21 cell line. The protein was 
purified as described in section 4.2.4.1. To increase the crystallization propensity, HepIII was 
methylated and the methylating reagents were removed by SEC. The purified fractions and the 
SEC fractions of HepIII were analyzed in a 10% SDS-PAGE (Figure 5.1A,C) The SEC fractions 
of HepIII corresponding to the monomeric size of the protein were concentrated and used for 
crystallization experiments.  
5.2 Crystallization, X-Ray diffraction and data collection of HepIII 
 Methylated HepIII was concentrated to 15 mg/ml in a buffer containing 20 mM HEPES 
pH 7.5, 150 mM NaCl and 3 mM DTT. Screening for crystallization and optimization was carried 
out as described in section 4.2.4.3. Diffraction quality crystals were produced in 25% (W/V) PEG 
3350, 100 mM Tris pH 8.5, 200 mM MgCl2 and 500 mM NDSB-201. These crystals were 
morphologically different from the previously obtained crystals, which were used to solve the 
structure of HepIII. The new crystals described here are referred to as form 2. For data collection 
the crystals were transferred to a cryo solution containing 20% glycerol in mother liquor and were 
flash cooled with liquid nitrogen. Diffraction data were collected at the 08ID beamline (Grochulski 
et al., 2011) at the CLS and processed with HKL2000 (Otwinowski and Minor, 1997). These 
crystals belong to space group P21 with unit cell parameters a=66.4, b=80.4, c=83.5 Å, α=γ=90, 
β=104.1ο and diffracted to 2.4 Å resolution. Data collection statistics are summarized in Table 5.1.  
5.3 Structure determination and refinement 
 The structure was solved by molecular replacement with the program Phaser (McCoy et 
al., 2007) using the previously solved HepIII from our lab as a search model. Subsequent model 
building and refinement were performed using ARP/wARP (Langer et al., 2008), COOT (Emsley 
and Cowtan, 2004) and PHENIX (Adams et al., 2011). One molecule of HepIII is present in the 
asymmetric unit. The final model contains residues 22-666, one Mg2+ ion and 121 water molecules. 
The refinement of the model converged to Rwork/Rfree of 0.215/0.256.  
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Figure 5:1Purification and crystallization of wildtype HepIII(22-666). 
A) Affinity purification of the GST-HepIII using Glutathione agarose resin, cleavage of the GST 
tag using His-TEV protease and the follow up purification using Ni-NTA resin. Protein used for 
methylation after the GST cleavage and TEV removal is highlighted in box. B) SEC on the S200 
column showing monomeric protein and the SDS-PAGE showing the purity of the peal fractions. 
C) Crystals of methylated HepIII(22-666) obtained from 25% (W/V) PEG 3350, 100 mM Tris pH 
8.5, 200 mM MgCl2 and 500 mM NDSB-201. 
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5.4 Crystal Structure of HepIII 
 The overall structure of HepIII consists of two domains: an N-terminal α-helical and a 
C-terminal β-sheet domain (Figure 5.2A). The N-terminal domain is comprised of residues 21-
387 and is folded into 16 α-helices. The majority of the domain is formed by ten α-helices forming 
five hairpin pairs arranged into an incomplete toroid fold, designated (α/α)5. The α-helices forming 
five hairpins are HP1 (α6-α7), HP2 (α9-α10), HP3 (α11-α12), HP4 (α13-α14) and HP5 (α15-α16). 
The helices α6, α9, α11, α13 and α15 form the inner surface of this partial toroid and helices, α7, 
α10, α12, α14 and α16 form an outer wall of the toroid. The loops within the hairpins are rather 
short while the loops connecting the hairpins are significantly longer. The N-terminal segment of 
~110 residues form three α-helices (α1, α2, α3) along the side of the hairpin HP1 and on the top 
of HP2 and HP3; this is followed by a long linker of 18 residues connecting to an α-helix (α4), β-
hairpin and α-helix (α5) (Figure 5.2B).  
 The C-terminal domain is comprised of residues 397- 666 and is folded into three twisted, 
antiparallel β-sheets. The top β-sheet is close to the N-terminal domain and contains 8 β-strands 
(β1-4, β5, β10, β14 and β15). A helix (H1) is inserted between β4 and β5. The middle layer also 
contains 8 β-strands (β6-9, β11-13 and β16). The bottom layer contains only 3 β-strands (β17-19) 
(Figure 5.2D). A nine-residues linker connects the N terminal α-helical and C terminal β-sheet 
domains.  
 A metal ion was identified beneath the N-terminal domain and at the top β-sheet of the C-
terminal domain. Based on the coordination geometry and the liganding residue distance, the metal 
ion was identified as Mg2+. This Mg2+ ion is coordinated in an octahedral fashion by Gln433, Asp451, 
His476 and three water molecules. The ion-liganding atom distances vary between 2.16 and 2.29 
Å. The identity of this Mg2+ ion was further supported during refinement, which produced no 
negative density at this site and gave a similar B-factor for Mg2+ to those of the liganding atoms 
(Zheng et al, 2008).  
The methylation of surface-exposed lysine residues was essential for the crystallization of 
full length HepIII (22-666). Inspection of the HepIII electron density indicated that many lysine 
sidechains are partially disordered and the identification of methylated lysines from the electron 
density map is inconclusive. The coordinates were deposited in the PDB and the accession number 
is 5JMD.  
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A) Cartoon representation of HepIII showing α helices (red) in the N-terminal domain and β- 
sandwich (yellow) in the C-terminal domain; B) the N-terminal α-helical domain forming an 
incomplete (α/α)5 toroid fold. Helices that are not part of the toroid are colored white, the hairpins 
(HP) are marked in different colors, the inner helix is a darker shade and the outer helix is a lighter 
shade. The metal ion (Mg2+) is shown as green sphere; C) the Mg2+ ion and the liganding residues 
from the C-terminal domain are shown; D) the C-terminal β-sheet domain showing stacks of three 
β-sheets colored yellow, orange and wheat, respectively; the β-strands forming the three β-sheets 
are marked. 
5.5 Active Site 
 Although HepIII and HepII share very little sequence identity and are classified into 
different families in the CAZy database, they both have the (α/α)n toroid+ β-sandwich fold. HepIII 
Figure 5:2 Structure description of HepIII. 
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was structurally similar to HepII (PDB code: 3E7J, 2FUT) from Pedobacter heparinus. HepII is 
capable of cleaving the C4-O1 bond next to either GlcA or IdoA epimers. The complex structure 
of HepII with tetrasaccharide substrate delineated the potential active site residues and the catalytic 
mechanism; the identified catalytic residues are His202, Tyr257, His406 and Glu205 (Shaya et al, 
2006).  
 In HepII, the first step in the β-elimination mechanism (i.e. neutralization of the charge on 
the C6 carboxylic group) is done by Glu205 with the help of His406 and Arg261. For the cleavage 
of the GlcA epimer, Tyr257 plays both catalytic base and acid roles. For the cleavage of the IdoA 
epimer, His202 and Tyr257 play the catalytic base and acid roles, respectively. A structural 
comparison of the whole protein of HepIII and HepII does not align well. Structural superposition 
based on individual domains however, allowed us to draw some conclusions. The catalytically 
important residues Glu205, Tyr247, His406 of HepII have structural equivalents in HepIII namely 
Asn247, Tyr303 and His431, respectively. Aside from these similarities between HepII and HepIII 
active sites, there are also two notable differences. Namely, the absence of a His202 equivalent 
residue in HepIII and the presence of a second tyrosine sidechain, Tyr457 in HepIII facing the 
putative active site and opposite to Tyr301. Therefore, these residues N247, Y301, H431 and Y457 
were selected as putative active site residues in HepIII (Figure 5.3A). 
5.6 Site-directed mutagenesis of active site and putative binding site residues 
 Four single mutants Y301F, H431A, Y457F and N247A, were made as described in section 
4.2.1.5. The mutant proteins were purified in the same way as wildtype HepIII. The activity assay 
of the wildtype HepIII, methylated wildtype HepIII and the mutants on the heparan sulfate 
substrate was carried out as mentioned in section 4.2.4.5. This assay detected the activity of HepIII 
and showed that methylated HepIII is still able to depolymerize heparan sulfate albeit with reduced 
efficiency. Meanwhile, the Y457F mutation only moderately decreased the activity, suggesting 
that this residue is involved in substrate binding but not in catalysis. The other putative active site 
mutants (N247A, Y301 and H431) inactivated the enzyme, supporting their key role in catalysis. 
(Figure 5.3B). 
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Figure 5:3 Putative active site residues and enzyme activity. 
(A) Superposition of the HepIII (colored magenta) and HepII (yellow, PDB code: 2FUQ) 
structures based on the C-terminal domains. The insert shows the close-up of the active site 
Tyr301, His431 and Asn247 in stick representation. (B) Measurement of activity of the enzyme 
with heparan sulfate substrate. The absorbance at 232 nm was measured as a function of time.  
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5.7 Crystallization of HepIII mutant (Y301F) 
 The active site mutant (Y301F) of HepIII was purified in large scale for crystallization 
experiments. To obtain a protein ligand complex, efforts were made to co-crystallize the Y301F 
mutant with tetrasaccharide substrates (Section 4.2.4.6). Even after extensive screening for a 
crystallization condition, we were unable to obtain crystals of the protein–ligand complex. The 
methylated Y301F mutant on its own however, crystallized in multiple conditions, which 
happened to be slight variations on the condition where native HepIII crystallized: (1) 
20%peg3350, 50 mM MgCl2, 0.1M Tris pH 8.5, 1 mM DTT with SB201 additive and in, (2) 25% 
peg3350, 0.2 M MgCl2, 0.1M Tris pH 8.5, 5% glycerol, 1 mM DTT with SB195 additive. 
Tetrasaccharides substrates and long heparin digested by native HepIII were also soaked into the 
Y301F mutant crystals. For data collection, soaked crystals were transferred into a cryo solution 
containing 20% glycerol in mother liquor and flash cooled in liquid nitrogen. Diffraction data of 
the Y301F crystal was collected at the CLS, CMCF-ID beam line and the crystals diffracted to 
3.6Å resolution. These crystals belong to space group P21 and contained one molecule in the 
asymmetric unit. However, the electron density map showed no density representing the 
tetrasaccharide substrates. In addition, soaking these crystals in the solution containing the 
substrate lowered the resolution of the diffraction pattern. Extensive attempts to obtain the 
structure of the HepIII (Y301F)-tetrasaccharide complex through either co-crystallization or 
soaking were not successful.  
5.8 Structural comparison with homologs 
 While the author was working on crystallizing the HepIII-substrate complex, the structures 
of two other PL12 family enzymes were published; namely heparinase III (gene product of Bt4662, 
PDB code: 4FNV) from Bacteroides thetaiotaomicron  (Dong et al., 2012) and heparin sulfate 
lyase/heparinase III (HepC, PDB code: 4MMH) from Pedobacter heparinus (Hashimoto et al., 
2014). Despite extensive trials, both groups were unable to capture the enzyme 
substrate/product/analog complex. Both structures were crystallized in the apo form and the 
putative active site residues were deduced by structural comparison with the HepII-substrate 
complex (PDB code: 3E7J). Comparison of the three HepIII structures from the PL12 family, as 
well as a comparison with HepII, allows us to rationalize the inability to capture the 
HepIII/substrate complex structure. 
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 The homologs 4FNV and 4MMH share 35% and 40% sequence identity with HepIII, 
respectively. The structural comparison of 5JMD (our HepIII structure), 4FNV and 4MMH 
showed that the N- and C-terminal domains have similar arrangements, but the relative orientation 
of the domains differ between the three structures (Figure 5.4A). The difference in the domain 
orientation is even observed in the structural comparison of two crystal forms of HepIII (5JMD 
and 5JMF-previously obtained crystal form in our lab) (Figure 5.4B). The structural superposition 
of the N-terminal, α-helical domains of HepIII (residue 21-387) with 4FNV (residue 44-408) and 
4MMH (residue 29-378) showed a root-mean-square deviation (RMSD) of 4.2 and 2.3 Å for 336 
Cα atoms. In this structural superposition, the N-terminal helical cap and the first three α-hairpins 
superimpose well and the structures start to deviate for the fourth and fifth α-hairpins. This 
structural deviation in the last two α-hairpins defines the toroid fold as open (in the case of 4MMH) 
or closed (in the case of 4FNV). 
 Similarly, the structural superposition based on C-terminal, β-sheet domains of HepIII 
(390-666) with 4FNV (residue 424-702) and 4MMH (residue 392-659) showed an RMSD of 1.8 
Å and 1.6 Å for 264 Cα atoms. Thus, the structural comparison of individual domains shows that 
the C-terminal domains are structurally better conserved than the N-terminal domains.  
 The superposition of entire proteins based only on their C-terminal β-sheet domains 
showed that the end of the second helix in the third α-hairpin, the following two antiparallel β- 
strands and the fourth (with the exception of the intra-hairpin loop) and fifth α-hairpins are rigidly 
attached to the C-terminal β-sheet domain (Figure 5.4A). This connection between the N-terminal 
domain and the C-terminal domain may be solidified by the Mg2+ion.  Importantly, the active site 
residues are within this rigid region; Tyr301 is located at the beginning of the first helix in the 
fourth α-hairpin, and His431 is in the loop between third and fourth β-strands of the first β-sheet. 
(Figure 5.5A). These structural comparisons give clues about the hinge region, which is located 
near Asn281 in HepIII, at the bottom of the second helix of the third α-hairpins (within the N-
terminal domain).  
 The structural superposition of HepII (3E7J) and HepIII (5JMD), based on the C-terminal 
β-sheet domains, showed an RMSD of 1.58 Å for 171 Ca atoms (out of 247). The structural 
superposition based on the N-terminal α-helical domains showed good overlap of the first two α-
helical hairpins (RMSD of 1.49 Å for 76 Ca), with the remaining three hairpins showing larger 
divergence. However, the fourth and fifth hairpins superimpose well with divergence of the first  
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Superposition of the structures of heparinase III enzymes based on their C-terminal domains. The 
N-terminal domains were found in different orientations in these enzymes. (A) Comparison of 
5JMD (green), 4FNV (red) and 4MMH (blue). In each case the chain preceding the first helical 
hairpin was removed for clarity. The spheres indicate the position of the hinge regions. The main 
hinge is located within the loop between the hairpins h3 and h4 (green sphere). Additionally, the 
inner loop within hairpin h4 with the tips of the helices (between the wheat-colored spheres) 
follows the movement of the N-terminal part of the protein; (B) Two crystal forms of HepIII 
(5JMD, 5JMF) superimposed based on their C-terminal domains. A small difference in the 
orientation of the N-terminal domains is easily visible. The hinge points are the same as when 
comparing different hepIII shown in A. 
 
 
Figure 5:4 Superposition of various HepIII structures showing domain orientation. 
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(A)Location of the active site residues (shown in stick mode, green) relative to the hinge points in 
HepIII (5JMD). The hinge points are marked as spheres. The N-terminal segment 23-291 (colored 
wheat) and residues 308-331 (orange) move together, while the end of -helix and the following 
loop (aa 292-307, red) containing Tyr301 move together with the -sheet C-terminal domain 
(magenta). The loop between hp4 and hp5 (aa 347-361, red) is tied in to the -sheet domain by the 
metal ion (Mg); (B) Putative location of the tetrasaccharide substrate relative to the active site of 
HepIII (5JMD). The tetrasaccharide was extracted from HepII-tetrasaccharide (PDB code: 3E7J) 
complex structure upon superposition of the C-terminal domains. 
three hairpins. This further supports the idea that differences in the arrangement of the five hairpins 
at the N-terminal domains is related to conformational changes around the third hairpin.  
 Also, in the structural superposition based on the C-terminal domains of HepII (3E7J) and 
HepIII (5JMD) the Tyr-His catalytic dyads, superimpose well. The location of the tetrasaccharide 
Figure 5:5 Location of putative active site residues and hinge point. 
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in this superposition gives a good approximation of the expected location of the substrate in the 
active site of HepIII (Figure 5.5B). However, it is evident from this superposition that the contacts 
of the substrate with the observed ‘open’ conformer of HepIII (5JMD) are rather limited, and there 
are no contacts with the other end of the open toroid. The same lack of contact of the substrate 
with the upper end of the N-terminal domain occurs for 4MMH that was also crystallized in an 
open conformation (Hashimoto et al., 2014). The 4FNV has been captured in a closed 
conformation and here the modeled tetrasaccharide would make contacts with the inner α-helix of 
the first α-hairpin (Dong et al., 2012). However, the lack of success in the crystallization of 4FNV 
with a substrate suggests that this conformation is also not compatible with substrate binding and 
catalysis. 
5.8.1 Normal mode analysis 
 The three-dimensional structures of proteins from the PL12 family captured in the crystals 
display different conformations of their N-terminal α-helical domains and, based on our analysis 
described above, none of them represent the active conformation. This is different from enzymes 
belonging to several other PL families with the same fold, namely hyaluronan lyase, 
chondroitinase AC and heparinase II, which were crystallized in active conformations. To better 
understand the conformational dynamics of PL12 family enzymes, we employed molecular 
dynamics simulations. Since we were interested in large-scale movements rather than local 
dynamics, we opted for the NMA (Bahar et al, 2010). Starting from the crystal structures, we 
performed NMA for all three proteins. In each case, we found that the first two orthogonal normal 
modes describe the large-scale motions (Figure 5.6 A-C). The first mode represented a bending 
motion that brought the N- and C-terminal domains closer to each other, whereas the second mode 
represented a rotational motion that adjusted the orientation of the two domains. These motions 
occur within the N-terminal α-helical domain and the hinge region is located within the third α-
hairpin. The hinge points in trajectories of all three HepIII enzymes are very closely mirroring the 
hinge points deduced from comparing the three crystal structures. We were further interested to 
see if the movement along the first two normal modes brings all three proteins to pass through a 
common conformation. This was indeed the case and the common conformation is shown in 
(Figure 5.6D). This might be the active conformation. The position of the tetrasaccharide substrate 
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Figure 5:6 NMA and possible active conformation of HepIII. 
Trajectory along the two normal modes of the NMA. All molecules are aligned using the C-
terminal β-sheet domain only and shown in the same orientation. (A) Initial, open (blue, from the 
crystal structure) and the last, closed conformation (red) along the calculated trajectory for HepIII 
(5JMD); (B) the same for 4MMH, first - blue, last – red; (C) 4FNV, first - blue, last - red. Here the 
initial conformation is of the closed state and the final one is of the open state; (D) Stereo view of 
the conformations along the 51-frame trajectories of HepIII (5JMD) (blue), 4FNV (red) and 
4MMH (green) that are closest to each other. They correspond to frame 25 for HepIII (5JMD), 
frame 20 for 4FNV and frame 51 for 4MMH and they approximate the active conformation of this 
family of heparinases; (E) The tetrasaccharide fitted into the observed conformation of HepIII 
(5JMD) (surface representation, top) and in the conformation common to all trajectories (bottom). 
The surface corresponding to the catalytically essential residues, Tyr301, His431 and Asn247, is 
colored green. 
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as transferred from HepII (3E7J), in the observed conformation of HepIII (5JMD) is shown in 
(Figure. 5.6E, top) and in the conformation common to all trajectories in (Figure. 5.6E, bottom). 
 The fact that the all structures captured in the crystal are in an inactive conformation 
suggests that the lowest energy state of these lyases does not represent the conformation required 
for activity and that the shift to active conformation is driven by the energy derived from substrate 
binding. It might be that this conformational change is stimulated more easily by a longer heparan 
sulfate chain rather than by a tetra- or hexasaccharide that was used in the co-crystallization 
attempts. 
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Table 5-1 Data collection and refinement statistics of HepIII 
Crystal form Form 2 
Space group P21 
a, b, c (Å), β(o) 66.5, 80.5, 83.3, 103.9 
Wavelength (Å) 0.9796 
Resolution (Å) 40.5-2.4 
Observed hkl 155894 
Unique hkl 33448 
Completeness (%) 99.5 (98.5) 
Redundancy  4.7 
Rsym 0.130 (1.27) 
I/(σI) 9.3 (1.6) 
Rwork 0.219 
Rfree  0.258 
Wilson B (Å2) 58.1 
B-factor (Å2, atoms)  
   Protein 67.8 (5146) 
   Solvent 57.5 (122) 
Ramachandran plot  
   Favored (%) 94.3 
   Allowed (%) 5.1 
   Disallowed (%) 0.6 
R.m.s. deviation  
   Bonds (Å) 0.003 
   Angles (°) 0.6 
PDB code 5JMD 
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6. Structure and catalytic mechanism of ulvan lyase enzymes 
 
This section describes the structure and functional characterisation of the recently 
discovered and characterized ulvan lyases. The first identified and biochemically characterized 
ulvan lyases were NLR42 and NLR48 from Nonlabens ulvanivorans. They are currently classified 
within the PL28 family in the CAZy database. This was followed by identification and biochemical 
characterization of LOR107 (short ulvan lyase) & LOR61 (long ulvan lyase) from Alteromonas 
strain LOR. A blast search against the non-redundant protein database leads to the identification 
of LOR107 & LOR61 homologs in Alteromonas strain LTR [LTR_2195 (long ulvan lyase), 
LTR_2241 (short ulvan lyase)] and Pseudoalteromonas strain PLSV (PLSV_3925, PLSV_3875). 
These ulvan lyases are classified within the PL24 family in the CAZy database. Further 
bioinformatics analysis of the genome of Pseudoalteromonas, Alteromonas and Nonlabens 
ulvanivorans identified three novel ulvan lyases that share no sequence homology to the previously 
identified ulvan lyases. They are PLSV3936, LOR29 & NLR492. We have received all the 
aforementioned genes from our collaborators Drs. Ehud Banin (Bar-Ilan University, Israel) and 
William Helbert (CNRS, France). All these genes were cloned without signal peptides into an 
expression vector (pET28a) with a C terminal 6xHis tag. Since the structural fold and catalytic 
mechanism of these new families are unknown, we became interested in studying their structure, 
catalytic mechanism and evolutionary relationship to other lyases. This section is divided into three 
subsections as follows: 
Subsection 6.1 titled “The structure and catalytic mechanism of LOR107 an ulvan lyase 
(PL24 family) from Alteromonas strain LOR”. Subsection 6.2 titled “The structure and catalytic 
mechanism of an ulvan lyase-PLSV3936 (PL25) from Pseudoalteromonas strain PLSV”. 
Subsection 6.3 titled “Structural characterization of NLR48 (Non-Classified PL category) from 
Nonlabens ulvanivorans”.  
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6.1 The Structure and catalytic mechanism of ulvan lyase-LOR107 (PL24) from Alteromonas 
strain LOR 
6.1.1 Expression and purification of LOR107  
 LOR107 was over expressed in BL21 (DE3)-RIPL cells and purified using TALON metal 
affinity resin as described in 2.2.5.1. The recombinant protein eluted with 40 mM imidazole was 
concentrated and loaded onto a S200 size exclusion column. The protein eluted as a single peak 
with an apparent molecular weight corresponding to a monomer (Figure 6.1.1C) was concentrated 
to 17 mg/ml and screened for crystallization. The results of affinity purification and SEC were 
evaluated by SDS-PAGE. (Figure 6.1.1A, C).  
6.1.2 Crystallization, Diffraction, Data Collection and Data Processing of LOR107 
 The wildtype LOR107 was screened for crystallization at room temperature as described 
in section 4.2.5.4. Initial crystals appeared in drops containing 25.5% PEG8K, 0.17 M ammonium 
sulfate, 0.085 M sodium cacodylate pH 6.5, and 15% glycerol as well solution. Optimization of 
this initial condition was carried out in hanging drops using 24-well grid screens. Crystals most 
suitable for diffraction were obtained after two weeks at room temperature in condition 23% 
PEG8K, 0.17M ammonium sulfate, 0.085M 4-Morpholineethanesulfonic acid (MES) pH 6.5 and 
15% glycerol at a protein concentration of 20 mg/ml (Figure 6.1.1B).  
 For data collection the crystals were cryoprotected by briefly immersing in the mother 
liquor and flash cooled in liquid nitrogen. Diffraction data were collected at the 08ID beamline 
(Grochulski et al., 2011) at the CLS and processed with the XDS program (Kabsch, 2010). These 
crystals diffracted to 1.9 Å resolution and belonged to space group P212121 with unit cell 
parameters a=83.6, b=121.3, c=123.9 Å. Since there were no structures of homologs sharing high 
sequence identity with LOR107, we decided to use the single anamolous dispersion method to 
solve the structure. In preparation for this approach, selenomethionine (SeMet) incorporated 
LOR107 was purified and crystallized.  
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(A) The coomassie stained SDS-PAGE analysis of LOR107 purified on cobalt affinity resin. Wash 
I and Wash II fractions corresponds to 20 mM Imidazole and 40 mM Imidazole in lysis buffer, 
respectively. Elution I, II are 250 mM and III, IV are 500 mM imidazole in lysis buffer, 
respectively. (B) Crystals of the LOR107 obtained from 23% PEG8K, 0.17 M ammonium sulfate, 
0.085 M 4-Morpholineethanesulfonic acid (MES) pH 6.5 and 15% glycerol at room temperature. 
(C) SEC profile of LOR107 on GE S200 column. Peak2 elutes around ~15 ml represents the 
monomer behavior of LOR107. SDS-PAGE showing the purity of peak2 and the fractions used in 
the crystallization experiments (highlighted in pink box). 
Figure 6.1:1 Purification and Crystallization of Wildtype LOR107. 
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(A) SDS-PAGE analysis on cobalt affinity purified SeMet-LOR107. Lysis buffer and the various 
fractions in the purification were all similar to wildtype purification. (B) Crystals of SeMet-
LOR107 obtained from 25.5% PEG 8K, 0.17 M ammonium sulfate, 0.1 M MES pH 6.5 and 17% 
glycerol at room temperature. (C) SEC profile of SeMet-LOR107 on GE S200 column. Peak2 
elutes around ~15 ml represents the monomeric behavior and SDS-PAGE showing the purity of 
peak2 fractions (fractions used in the crystallization experiments are highlighted in the pink box). 
 
6.1.3 SeMet incorporation into LOR107, purification and crystallization 
 SeMet incorporated LOR107 (SeMet-LOR107) was produced by inhibiting the methionine 
biosynthesis pathway and purified as described in section 4.2.5.2 and 4.2.5.4. The purification and 
SEC profile of SeMet-LOR107 are shown in (Figure 6.1.2A & C). Crystallization was carried in 
a 24-well grid screens using variations on the condition under which the native protein crystallized. 
Figure 6.1:2 Purification and Crystallization of SeMet-LOR107. 
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After optimization through microseeding the best crystals of SeMet-LOR107 were grown in 25.5% 
PEG 8K, 0.17 M ammonium sulfate, 0.1M MES pH 6.5 and 17% glycerol.  
6.1.4 Diffraction, Data Collection and Data Processing of SeMet-LOR107 
 The SeMet-LOR107 crystals were briefly immersed in mother liquor for cryoprotection, 
followed by flash cooling in liquid nitrogen. Diffraction data were collected at the 08ID beamline 
at the CLS (Grochulski et al., 2011). Data was processed using HKL 3000 (Minor et al., 2006). 
The SeMet-LOR107 crystals diffracted to 2.5 Å resolution. These crystals belong to space group 
P212121 with unit cell parameters a=84.2, b=121.9, c=124.3 Å. Data collection statistics are shown 
in Table 6-1.1. 
6.1.5 Structure determination and refinement 
 The structure of LOR107 was solved with the automated structure solving pipeline 
CRANK2 (Skubák and Pannu, 2013) using data from the SeMet crystal. A total of 20 selenium 
sites were identified and the initial model contained 839 out of 1000 residues. This model was 
refined with the 1.9 Å resolution native crystal data. The structure was refined with the PHENIX 
refinement program (Adams et al., 2011) and manual rebuilding and solvent placement was 
conducted with the COOT program (Emsley and Cowtan, 2004). Two large peaks in a difference 
electron density map were observed in identical positions within each molecule. Based on the 
coordination and distances to the liganding atoms, these peaks were assigned as Ca2+ ions. The 
final model contains residues 40 to 520 in both chains, four Ca2+ ions, fourteen SO4 ions, five 
glycerol molecules, one PEG (Polyethylene glycol) molecule and 753 water molecules. The 
refinement converged at Rwork=0.175 and Rfree=0.200. The stereochemistry of the model was 
validated with MolProbity (Chen et al., 2010). The coordinates were deposited in the PDB and the 
PDB code of wild type LOR107 is 6BYP. 
6.1.6 Crystal structure of LOR107 
 The protein crystallized with two molecules in the asymmetric unit. Both molecules appear 
to be identical and superimpose with a RMSD of 0.29 Å for all Cα atoms. The molecule adopts a 
seven-bladed β-propeller fold (Figure 6.1.3A). Each propeller consists of four antiparallel β-
strands.  
6.1 Structure and catalytic mechanism of LOR107 
 89 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The structure of LOR107. (A) Topology diagram of LOR107; (B) Cartoon representation of 
LOR107 painted in rainbow colors, from blue at the N-terminus to red at the C-terminus. Two Ca2 
ions are shown as cyan spheres. (C) The surface representation showing a long canyon along its 
top surface with lower rims of the propeller at the ends of the canyon. The view is rotated by 70 
degrees along horizontal axis relative to panel B. Color scheme as in panel B; (D) The Ca2+ ions 
in sites 1 (left) and 2 (right).  
 
Figure 6.1:3 Structure description of LOR107. 
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 Blades 1, 2, 3, 4, 5 and 6 are formed by residue 90 - 133, 148 - 208, 240 - 286, 299 - 369, 
382 - 434 and 444 - 478. The 7th blade is formed from three C-terminal β- strands, 483 - 518 and 
the 4th β-strand is provided by the N-terminal residues 43 - 56. The participation of both N- and 
C- terminal residues in the formation of a single blade in the β-propeller fold is a stabilizing 
phenomenon termed “molecular Velcro” (Munoz-Munoz et al., 2017). The fourth strand in blade 
2 is distorted, forming fewer inter-chain hydrogen bonds. This strand is followed by a long loop 
that is stabilized by a metal ion. The loops joining β-strands extend on either side of the propeller. 
The loops on one side of the propeller are rather short (bottom of the propeller) while the loops on 
the opposite end are of varied length, with some extending high above the ends of the β-sheets (top 
of the propeller). Loops within blades 1, 2, 4, 5 and 7 are especially long, while those within blades 
3 and 6 are much shorter. These long loops delineate a deep canyon on the top surface of the 
propeller, with high walls on two sides and a lower ‘neck’ located between blades 2 and 4 and over 
the short loops within blade 3 (Figure 6.1.3C). The opposite end of the canyon also has a lower 
wall formed by blade 6. This canyon is lined with a cluster of highly conserved surface exposed 
residues, indicating that this surface defines the substrate binding site of LOR107. 
 The presence of metal ions in the structure was indicated by four very strong peaks in the 
difference electron density map. Two metal ions are present in each independent molecule at 
identical positions. Based on their coordination geometry these ions were identified as Ca2+. The 
Ca2+ ions are located on the periphery of the propeller. Ca2+ in site 1 stabilizes the long loop leading 
from blade 2 to blade 3 and abutting the long loop between the distorted strand β4 of blade 2 and 
β1 of blade 3. This Ca2+ ion is surrounded by seven ligands in a pentagonal bipyramidal 
coordination. The equatorial ligands are provided by OD1 and OD2 of Asp222, a carbonyl oxygen 
of Lys224 and two water molecules, while the axial ligands are OD2 of Asp212 and another water 
molecule (Figure 6.1.3D, left). The Ca2+ in site 2 is located in blade 4 and stabilizes a long loop 
between strands β2 and β3. The loop connecting blades 4 and 5 is leaning onto this loop. The 
coordination of this Ca2+ is also pentagonal bipyramidal, with equatorial ligands being OD2 of 
Asp326 and four water molecules, while the axial ligands are carbonyls of Asn323 and Phe328 
(Figure 6.1.3D, left).  
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6.1.7 Evolutionary analysis and active site architecture of LOR107 
 The evolutionarily conserved residues of LOR107 were identified using the program 
ConSurf (Landau et al., 2005). Two clusters of highly conserved residues were identified on the 
top of the propeller along the sides of the canyon, and contain polar, charged residues that could 
constitute the active site (Figure 6.1.4A). Residues His146, His167, Thr242, Tyr243 and Arg259 
belong to cluster I and are located on one side of the canyon at the inner edges of blades 2 and 3. 
Asn263, Tyr303, Arg320 and Tyr330 belong to cluster II and are on the opposite side of the canyon 
on the edge of blade 4 (Figure 6.1.4B). These residues are highly conserved among PL24 
sequences. The two clusters are separated by ~8-10 Å, defining the width of the canyon, which is 
sufficient to accommodate a linear ulvan polysaccharide. We have investigated the contribution of 
these amino acids to the enzyme activity of LOR107 by site-directed mutagenesis.  
6.1.8 Active site mutants and Enzyme activity  
 The identified conserved residues were subjected to mutation studies. Single mutants 
H146A, H167A, T242A, Y243F, R259A, N263A, Y303F, R320A, and Y330F were made as 
described in section 4.2.5.3. The mutants were expressed and purified in the same way as the 
wildtype protein. The enzyme activity of the wildtype LOR107 and mutants on the ulvan substrate 
was measured as described in section 4.2.5.3. Mutation of H146A, H167A, R259A and R320A led 
to a complete loss of activity against the substrate. The Y243F mutant showed very low activity 
while the N263A and Y330F mutants showed reduced activity. Mutating Thr242 to an alanine led 
to a very small decrease in activity, while the Y303F mutant unexpectedly showed a small increase 
in activity relative to the wildtype LOR107. Together, these data suggested that His146, His167, 
Arg259 and Arg320 play essential roles during catalysis. Tyr243 is also important in catalysis, 
since the Y243F mutants showed only residual enzyme activity. The remaining investigated side 
chains most likely affect the organization of the active site or binding of the ulvan substrate (Figure 
6.1.4C)
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Figure 6.1:4 Sequence conservation and enzyme activity analysis of LOR107. 
(A) The surface representation of the enzyme looking at the top of the propeller. The surface is 
colored by the level of sequence conservation among homologs. The burgundy color marks highly 
conserved and surface exposed residues. A cluster of highly conserved residues is visible near one 
end of the canyon; (B) The enlarged view of the conserved surface cluster. The surface is shown 
as semi-transparent and the conserved residues are shown in stick representation; (C) Activity of 
wildtype LOR107 and its mutants. Reaction conditions are 0.5mg/ml ulvan substrate and 1 µg of 
enzymes in 20 mM HEPES pH 7.5, 150 mM NaCl. Appearance of unsaturated sugars resulted 
from the lytic cleavage was measured at 232nm for 45 minutes.  
  
.  
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6.1.9 Purification and crystallization of LOR107 mutants 
 To capture the substrate within the enzyme, several single mutants were made in which 
His146, His167, Tyr243, Arg259 and Arg320 were changed for other amino acids. His146 and 
H167 mutated to Asn or Leu did not express well and most of the protein was trapped in inclusion 
bodies. The successfully expressed mutants were Y243F, R259N and R320N. These mutants were 
purified in the same way as the native protein and concentrated to ~ 23 mg/ml. Crystallization of 
these proteins required optimization with the final condition being close to that of the native protein 
(25.5% PEG8000, 170 mM ammonium sulfate, 15 % glycerol, 0.1 M MES, pH 6.5).  
6.1.10  Soaking experiments, diffraction and data collection of LOR107 mutant crystals 
 Crystals of LOR107 single mutants (R259N, Y243F and R320N) were soaked for ~5 hours 
in a solution containing two different tetrasaccharide substrates (section 4.2.5.7). Tetrasaccharide 
I (DP4-1) contained a mixture of ΔUA-Rha3S-GlcA-Rha3Sα/β and ΔUA-Rha3S-IdoA-Rha3Sα/β 
with some traces of hexasaccharide (Figure 4.2). Tetrasaccharide II (DP4-2) was ΔUA-Rha3S-
Xyl-Rha3Sα/β. After soaking in tetrasaccharide solution, the crystals were flash frozen in liquid 
nitrogen. Diffraction data of R259N, Y243F were collected at the 08B1 beamline (Fodje et al., 
2014) and R320N were collected at the 08ID beamline (Grochulski et al., 2011) at the CLS. Data 
were processed with the XDS program (Kabsch, 2010). These crystals diffracted to 2.2 Å 
resolution and belong to space group P212121 (were isomorphous to the native crystals). A strong 
positive difference electron density corresponding to the bound substrate was observed in R259N 
and R320N mutant crystals but not in the Y243F mutant soaked in DP4-1. No binding was detected 
for the crystal soaked in DP4-2. Data collection and refinement statistics are in Table 6.1.1. The 
coordinates of R259N and R320N complexes with the tetrasaccharide substrate were deposited in 
the PDB and the PDB codes are 6BYX and 6BYT, respectively. 
6.1.11 Complex structure of LOR107 mutants with substrate 
6.1.11.1 Structure of R259N mutant with tetrasaccharide substrate 
 The difference electron density map calculated for the R259N mutant showed an elongated 
blob of positive density located within the canyon on the top of LOR107 in proximity to the two 
clusters of conserved residues. We could fit the entire DP4-1 tetrasaccharide into this electron 
density (Figure 6.1.5A, left panel). The GlcA could be fitted in the +1 position in a chair 
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conformation, while IdoA fitted only in a high energy boat conformation. In addition, since 
LOR107 shows specificity for cleavage next to GlcA, we have modelled and identified the uronic 
acid as GlcA in the +1 position. The substrate is located close to, and makes contacts with Arg320, 
Tyr303 and Asn263 (cluster II). Arg320 is in the center of this cluster and its sidechain makes 
hydrogen bonds to the +1 position O3GlcA and to -1 position O5Rha3S. Arg320 is sandwiched 
between the two tyrosine sidechains conserved among PL24 sequences, Tyr303 and Tyr330, with 
the C6Rha3S methyl group abutting the face of the Tyr330 aromatic ring. Asn263, located next to 
the Arg320, forms H-bonds to NH1Arg320 and contacts the +1 position C2GlcA proton through the 
aliphatic part of its side chain. In addition, Tyr303 is hydrogen-bonded to the +1 position O6BGlcA 
of the acidic group and the O6AGlcA is ~5 Å from Tyr243. Finally, His384 hydrogen-bonds to the 
-2 position O6AΔUA and Val386 faces the hydrophobic side of the -1 position Rha3S. Residues 
His146 and Tyr243 of cluster I lie nearest (~4-5Å) to the +1 position O6AGlcA of the tetrasaccharide 
substrate. Additionally, Arg177 H-bonds to the +2 position O2Rha3S (Figure 6.1.5A, right panel). 
The mutated sidechain, Asn259 is far from the tetrasaccharide, but when this structure is 
superimposed on the native LOR107, the sidechain of    
Arg259 extends toward the carboxylic group of GlcA at the +1 position and could form a salt 
bridge with it. The tetrasaccharide in the complex described above is somewhat distant from 
His146, His167 and Tyr243, which are important for catalysis, suggesting that this binding site is 
not catalytically competent. We therefore investigated the R320N mutant where the key cluster II 
contact residue has been changed.  
6.1.11.2 Structure of the R320N mutant with tetrasaccharide substrate 
 In the R320N substrate complex, the substrate is positioned close to cluster I residues 
(Figure 6.1.5B, left panel). Unexpectedly, the Arg259 sidechain assumes two conformations in 
chain A. The minor conformer (occupancy 0.4) corresponds to that of the wild-type enzyme and 
forms a salt bridge with the acidic group of GlcA at the +1 position, while the major conformer 
(occupancy 0.6) points away from GlcA and is directed toward the backbone of Gly262-Asn263. 
His146 points toward the +1 position H5GlcA and the NE2His146 is only ~2 Å away from this proton 
(~3Å from C5GlcA). In addition, this NE2 nitrogen forms an H-bond with the bridging O4 between 
+1 and -1 sugars. Tyr243 also points toward C5 of GlcA and the bridging O4 but the distances are 
~4 Å, too long for a direct participation in proton transfer. The SO3 of Rha3S at the -1 position  
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Figure 6.1:5 Structures of R259N and R320N mutants with tetrasaccharide substrate. 
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(A) Location of the tetrasaccharide within the canyon on the top of the propeller in R259N (left 
panel). The omit electron density map of the tetrasaccharide in R259N mutant contoured at 2.8σ 
with the model of the tetrasaccharide. The contacts with the protein are marked with dashed lines. 
Right panel-a close-up of the tetrasaccharide with the surrounding residues shown in stick 
representation; (B) Location of the tetrasaccharide within the canyon on the top of the propeller in 
R320N (left panel). The omit electron density map of the tetrasaccharide in the R259N mutant 
contoured at 2.8σ. The contacts with the protein are marked with dashed lines: Asn263 changes 
the conformation clamping the substrate. Right panel-a close-up of the tetrasaccharide with the 
surrounding residues shown in stick representation: (C) Superposition of the tetrasaccharides from 
R259N and R320N complexes and their location in the substrate binding canyon. Tetrasaccharide 
from R259N complex is colored green and R320N complex is colored gray.  
 
 
fills a hydrophilic pocket made by Ser145, Tyr243 and His146 side chains. Similarly, the SO3 of 
+2 position Rha3S fits into a depression formed by Arg137, Arg177, His167 and the Phe137 side 
chains. Moreover, Asn263 clamps the tetrasaccharide from the opposite side by H-bonding to the 
oxygen atom that bridges +1 and +2 sugars. The unsaturated sugar in the -2 position is located near 
the main chain of Phe80 and Gly81 and makes only van der Waals interactions with the protein 
(Figure 6.1.5B, right panel). 
 The R259N and R320N mutations had minimal effect on the overall structure of the 
protein. However, there is a significant difference in the way the tetrasaccharide substrate binds to 
these mutants (Figure 6.1.5C). In the R259N complex, the tetrasaccharide substrate binds cluster 
II sidechains, interacting largely with Arg320, and is located at the upper part of the canyon, distant 
from the residues affecting catalysis. Nearby Asn263 is H-bonded to Arg320 and directed toward 
the top of the canyon. In the R320N complex the tetrasaccharide binds deeper in the canyon and 
approaches the cluster I sidechains. The Asn263 changes conformation and extends toward the 
other wall of the canyon making it narrower and pinning the substrate to the active site. 
6.1.12 Putative Catalytic Mechanism 
 The importance of Arg320 in cluster II for bond cleavage, combined with the structure of 
the LOR107 (R259N)-tetrasaccharide complex, suggests that the initial binding of the substrate in 
the canyon is coordinated by Arg320. This binding site is near the top of the canyon and is distant 
from the residues essential for catalysis. We postulate that, upon initial binding the Arg259 side 
chain extends toward the acidic group of the +1 position GlcA and this promotes movement of the 
substrate deeper into the canyon toward the cluster I residues. The associated movement of the 
Asn263 sidechain narrows the canyon and locks the substrate in the active site. Indeed, the Asn263 
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side chain plays a role in the catalytic mechanism since its mutation to an alanine has a detrimental 
effect on activity (Figure 6.1.3C).  
 In the R259N mutant, the Arg259 side chain is absent and the substrate remains in the 
initial binding site. However, when the Arg320 side chain is missing but Arg259 is present (i.e. 
the R320N mutant), the substrate goes directly to the final destination site near the bottom of the 
canyon. This binding site is largely preformed when compared with the native LOR107 structure. 
In the absence of Arg320 the tetrasaccharide substrate binds in what appears to be a catalytically 
competent or nearly competent conformation. We postulate that in the wild type LOR107, the 
movement of substrate deeper into the canyon pulls on Arg320 and causes a change in the 
conformation of Asn263, narrowing of the canyon and forcing the substrate into the catalytically 
competent conformation.  
 The catalytic mechanism of polysaccharide lyase family enzymes follow three steps: 1) 
neutralization of the negative charge on carboxylic acid of the uronic acid sugar. This reduces the 
pKa of the C5 proton; 2) abstraction of the C5 proton by a base; 3) donation of proton to the leaving 
group by an acid. A comparison of the wild type and R320N structures indicates that the role of 
the neutralizer is performed by Arg259 with the help of His167 (Figure 6.1.6A). We suggest that 
the presence of His167 is essential for correctly orienting the acidic group on GlcA for the 
interaction with Arg259. The role of proton abstraction is likely performed by His146, which is 
properly oriented by stacking with His167 and interaction with Tyr243. The ND2His146 atom 
becomes close to both H5GlcA of +1 GlcA and to the bridging O4 (to Rha3S), suggesting that 
His146 might shuttle the proton directly to the bridging O4 (Figure 6.1.6B). The fact that the 
Y243F mutant displays residual activity indicates that Tyr243 plays a supporting role but is not 
directly involved in proton transfer. Therefore, LOR107 possesses an active site consistent with 
the His/Tyr mechanism, one of the two mechanisms identified so far in polysaccharide lyases, but 
applies a modification to this mechanism, in which the tyrosine plays a supporting rather than a 
direct role in proton shuffling (Figure 6.1.6B). 
 The R320N mutant is inactive and this reflects the fact that either the substrate position 
observed in the R320N mutant or the arrangement of catalytic site residues are not fully compatible 
with catalysis. In this mutant, the Arg259 side chain is predominantly directed away from the 
substrate and toward the backbone of Gly262-Asn263, likely due to a small rearrangement of a  
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Figure 6.1:6 Proposed catalytic mechanism of LOR107. 
Proposed catalytic mechanism. (A) A stereo view of the close-up of the central disaccharide 
showing the surrounding sidechains. The hydrogen bonds are shown as green dashed lines. The 
magenta dashed line indicates the 2.0 Å distance from NE2His146 to H5 proton of GlcA. The 
yellow dashed line indicates a short distance of ~3 Å between His146 and Tyr243. Tyr243 could 
form a H-bond to ND2 when His146 flips the sidechain by 180o; (B) The proposed mechanism. 
Arg259 acts as a neutralizer of the charge of GlcA acidic group. His146 is the most likely candidate 
to play the role of acid and base by abstracting the proton from C5 of GlcA and donating it to the 
bridging O4. Tyr243 plays a supporting role in properly orienting the imidazole ring of His146. 
His167 contributes by stacking with His146 and also H-bonding to the acidic group of GlcA for 
its proper alignment in the active site. 
 
neighboring segment near Asn263. Therefore, Arg259 cannot neutralize the acidic group of +1 
GlcA, which in turn, prevents the C5 proton abstraction.  
To summarize, we solved the crystal structure of LOR107, the first atomic structure of the 
PL24 family. LOR107 adopts the seven bladed β-propeller fold. The complex structures of two 
different active site mutants (R259N, R320N) with the tetrasaccharide allowed us to postulate the 
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possible catalytic mechanism. The catalytic cycle starts with a two-step binding event, first 
substrate interacts near the top of the canyon coordinated by Arg320, followed by sliding of the 
substrate into the canyon toward the active site residues. This is followed by the neutralization of 
negative charge on the acidic group of GlcA by Arg259 with the help of His167. Meanwhile, 
His146 plays the role of general base and/or general acid. 
 
Table 6.1-1. Data collection and refinement statistics of LOR107 
Crystal form Native 
LOR_107 
SeMet 
LOR_107 
Complex 
(R259) 
Complex 
(R320) 
Space group P 21 21 21 P 21 21 21 P 21 21 21 P 21 21 21 
a, b, c (Å) 83.6, 121.3, 
123.8 
84.2, 121.9, 
124.3 
83.05, 121.0, 
127.2 
84.2, 120.7, 
127.1   
Wavelength (Å) 0.9795 0.9794 0.9787 0.9796 
Resolution (Å) 49.07-1.90 
(1.95-1.90) 
46.26-2.5  
(2.57-2.50) 
48.89-2.21 
(2.26-2.21) 
49.05-2.20 
(2.26-2.20) 
Observed hkl 1497238  661588  954175  344075   
# Unique hkl 99600   85354  64618  66028  
Completeness 
(%) 
99.9 (99.2)       99.8 (98.1) 99.0 (87.3) 99.9 (99.8) 
Redundancy  15 (14.9) 7.8  14.8 (13.5) 5.2 (5.2) 
Rsym 0.107 (1.94) 0.135 (1.35) 0.105 (1.32) 0.101 (1.25) 
CC1/2 99.9 (65.2) 99.8 (64.7) 100.0 (91.0) 99.9 (53.6) 
I/(σI) 16.56 (1.72) 13.27 (2.12) 23.8 (2.63) 12.93 (1.58) 
Rwork 0.175  0.20 0.20 
Rfree  0.20  0.25 0.25 
Wilson B (Å2) 33.7  36.05 39.3 
Ramachandran 
plot 
  
   Favored (%) 96.66  94.87 95.41 
   Allowed (%) 3.34    4.81 4.49 
Clash score 4.25  8.84 7.82 
R.m.s. 
deviation 
  
   Bonds (Å) 0.006  0.007 0.008 
   Angles (°) 0.802  0.981 1.02 
PDB code 6BYP  6BYX 6BYT 
 
 
6.2 Structure and catalytic mechanism of PLSV3936  
100 
 
6.2 The Structure and Catalytic Mechanism of PLSV3936 from Pseudoalteromonas 
 Genome mining of ulvanolytic bacteria revealed the organization of co-regulated PULs. 
Functional characterization of the enzymes encoded by PULs lead to the identification of another 
ulvan lyase family unrelated to the PL24 enzymes (Foran et al., 2017). These new ulvan lyases 
were found in Alteromonas LOR (LOR29), Nonlabens ulvanivorans (NLR492) and 
Pseudoalteromonas PLSV (PLSV3936). They have been added to the PL25 family in the CAZY 
database. These three enzymes share ~ 70% sequence similarity with one another, but less than 
14% with LOR107. We attempted to crystallize these proteins to gain insight into the folds and 
catalytic mechanisms of ulvan lyases with unrelated sequences. 
6.2.1 Purification of PL25 family (PLSV3936, LOR29, NLR492)  
 Constructs of PLSV3936, LOR29 and NLR492 lacking the signal peptide were 
overexpressed in BL21(DE3)-RIPL cell lines. The proteins were purified as described in section 
4.2.5.1. The fractions were eluted with 40mM Imidazole in lysis buffer, concentrated and analyzed 
by SEC. The results of affinity purification of PLSV3936 are shown in (Figure 6.2.1A). 
PLSV3936, LOR29 and NLR492 behave as monomers on SEC and the fractions corresponding to 
this monomeric peak (Figure 6.2.1C) were concentrated to ~30mg/ml and used for crystallization 
screening. 
6.2.2 Crystallization trials of PLSV3936, LOR29 and NLR492 
 All the three enzymes were screened for crystallization by the sitting drop method as 
described in section 4.2.5.4. The protein NLR492 did not crystallize and LOR29 formed thin plate 
or rod-shaped crystals in several conditions but these crystals could not be improved. However, 
PLSV3936 also crystallized in several conditions with Peg 3350 as a precipitant and in the 
presence of various salts (0.2 M ammonium acetate, 0.2 M potassium iodide, 0.2 M sodium 
formate, and 0.2 M ammonium formate). Optimization of PLSV3936 crystals by the hanging drop 
vapor diffusion method improved the quality of these crystals (Figure 6.2.1B). For data collection, 
crystals grown in 20% PEG3500, 0.2 M ammonium acetate, 0.1 M Bis-Tris pH 5.5 were briefly 
soaked in cryo protectant (70% Mother liquor and 30% Ethylene glycol) and flash cooled in liquid 
nitrogen. Diffraction data was collected at the 08B1 beamline at the CLS (Grochulski et al, 2011) 
and processed with XDS (Kabsch, 2010). 
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(A) The coomassie stained SDS-PAGE analysis of PLSV3936 purified on cobalt affinity resin. 
Lysis buffer used in the purification is 20 mM Tris pH8, 200 mM NaCl, 5% glycerol and 5 mM 
Imidazole. Wash I and Wash II fractions corresponds to 20 mM Imidazole and 40 mM Imidazole 
in lysis buffer respectively. Elution I, II are 250 mM and 500 mM imidazole in lysis buffer 
respectively. (B) Crystals of His-PLSV3936 obtained from 20% PEG3500, 0.2 M Ammonium 
acetate, 0.1 M Bis-Tris pH 5.5 at room temperature. (C) Size exclusion chromatogram of 
PLSV3936 on S200 column. Peak2 elutes around ~15.8 ml represents the monomeric behavior. 
SDS-PAGE showing the purity of peak2 and the fractions used in the crystallization experiments 
(highlighted in the yellow box). 
 
 These crystals diffracted to 1.45 Å resolution and belonged to space group C2 with unit 
cell parameters a=174.3, b=72.1, c=109.5 Å and β=122.5o. There are two molecules in the 
asymmetric unit. Since PLSV3936 shares ~ 14% sequence identity with LOR107, the structure 
could not be solved by molecular replacement. SeMet incorporated PLSV3936 (SeMet-
Figure 6.2:1 Purification and Crystallization of Wildtype PLSV3936. 
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PLSV3936) was therefore prepared to facilitate the structure determination by anomalous phasing 
methods. 
6.2.3 Purification and crystallization of SeMet- PLSV3936 
 SeMet- PLSV3936 was produced by inhibiting the methionine biosynthesis pathway 
(Walden, 2010) as described in section 4.2.5.5. Purification and SEC analysis of SeMet-PLSV3936 
are shown in (Figure 6.2.2A, C). The SeMet-PLSV3936 was concentrated to 30 mg/ml and used 
for crystallization. After optimization around the wildtype protein crystallization condition, the 
best crystals of SeMet-PLSV3936 were grown in 20% PEG3500, 0.2M ammonium acetate, 0.1M 
MES pH 6.5 (Figure 6.2.2B). These crystals were briefly transferred to mother liquor containing 
30% Ethylene glycol and flash cooled in liquid nitrogen. Diffraction data was collected at the CLS 
(08B1 beamline) (Fodje et al., 2014). The crystals diffracted to 2.05 Å resolution and the data was 
processed using XDS (Kabsch, 2010). The crystals belong to space group C2 with unit cell 
parameters a=174.2, b=71.7, c=109.4 Å and β=122.6o. Data collection statistics are summarized 
in Table 6-2.1. 
6.2.4 Structure determination and refinement 
 The structure of PLSV3936 was solved with the AUTOSOL program (Terwilliger et al., 
2009)(available in the PHENIX software) using data from the SeMet incorporated crystal. There 
are two molecules in the asymmetric unit and each contains 10 methionine residues. A total of 23 
anomalous scatterers were found and the initial model contained 787 out of 978 residues. This 
model was refined against the native dataset (1.45 Å resolution) using PHENIX software (Adams 
et al., 2011) with manual inspection and rebuilding using COOT (Emsley et al., 2010). A strong 
peak was observed in the mFo-DFc difference electron density map at identical positions, in each 
molecule. Based on the coordination and distances to the liganding atoms these peaks were 
identified to be Zn2+ ions. The fluorescence scan at the beamline confirmed the presence of Zn2+ 
ion in the crystal and these ions were also identified as anomalous scatterers in the single-
wavelength anomalous diffraction (SAD) experiment. The final model contains residues 47 to 486 
in chain A, 48 to 487 in chain B, two Zn2+ ions, two SO4 ions, one PO4 ion, one glycerol, nine 
ethylene glycol molecules and 1129 water molecules. The final refined structure has Rwork=0.134 
and Rfree=0.143. The stereochemistry of the model was checked with PHENIX software and the 
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Figure 6.2:2 Purification and Crystallization of SeMet-PLSV3936. 
(A) SDS-PAGE analysis on cobalt affinity purified SeMet-PLSV3936. Lysis buffer and the 
various fractions in the purification were all similar to wildtype purification. (B) Crystals of 
SeMet-PLSV3936 obtained from 20% PEG3500, 0.2 M Ammonium acetate, 0.1 M MES pH 6.5 
at room temperature. (C) SEC profile of SeMet-PLSV3936 on S200 column. Peak2 elutes around 
~15.8 ml represents the monomeric behavior and SDS-PAGE showing the purity of peak2 
(fractions used in the crystallization experiments are highlighted in the yellow box). 
refinement statistics are shown in Table 6-2.1. The coordinates and structure factors have been 
deposited in the Protein Data Bank with accession number 5UAM (for the native structure). 
6.2.5 Crystal structure of PLSV3936 
 The protein crystallized with two molecules in the asymmetric unit and they superimpose 
with a RMSD of 0.21 Å for all Cα atoms. The molecule adopts the fold of a seven-bladed β-
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propeller (Figure 6.2.3A). Each propeller consists of four antiparallel β-strands. Blades 1, 2, 3, 4, 
5 and 6 are formed by residues 69 - 106, 125 - 180, 185 - 233, 240 - 321, 327 -378 and 385 - 434. 
The 7th blade is formed from three C-terminal β-strands, 435 - 474, with the 4th β-strand provided 
by the N-terminal residues 51 - 59. The loops joining the β-strands are short on one side of the 
cylinder (bottom), while the connecting loops on the opposite side (top) are of varied length and 
significantly longer. In particular, the 4th and 5th blades have long extensions on top of the propeller 
and the connection between the 1st and 2nd blade is also long. As a consequence, one end of the 
cylinder is flat, with only a small depression in the center while the other end has a deep and 
elongated crevice. The walls of the crevice on two sides are made of long extensions and are high. 
Conversely, the wall of the crevice over the 3rd blade is lower, forming a shallow neck as an 
entrance to the crevice (Figure 6.2.3B). A sulfate molecule and several metal ions are bound within 
this crevice, making it the ‘business end’ of the lyase where the substrate binds. A Zn2+ ion is 
bound between the 2nd and 3rd blade in both molecules in the same place, liganded by the sidechains 
of His208, His 264, His278 and Cys266 in a tetrahedral coordination. The distances to the histidine 
NE2 or ND1 atoms 2.05 Å and to SG of cysteine 2.27 Å (soft restraints were used in the PHENIX 
refinement) (Figure 6.2.3C). 
6.2.6 Identification of Catalytic site and site directed mutagenesis: 
 Although LOR107 and PLSV3936 share only ~14% sequence identity, they adopt the same 
seven bladed β-propeller fold, with each blade having four antiparallel β strands. The putative 
catalytic site of PLSV3936 was identified based on a structural comparison with LOR107 and the 
nature of the residues in the binding pocket (Figure 6.2.4A). We were interested in obtaining 
inactive mutants that we could use to capture the enzyme-substrate complex. To that end, the 
following mutants were made: H143N, H123N, R204N, H264N and Y188F. All these mutants 
were purified in the same way as the native enzyme. The activity was measured for the native 
enzyme and each mutant. All mutants except H143N, showed no measurable activity against the 
ulvan substrate (Figure 6.2.4B). This indicates the involvement of these residues in either catalysis 
or substrate binding.
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Figure 6.2:3 Structure features of PLSV3936. 
 (A) Overall structure of PLSV3936 in cartoon representation and colored in rainbow pattern from 
blue at N terminus to red at C terminus. The seven blades of β-propeller are named from 1-7. (B) 
Surface representation in same orientation as Figure A, pointing out the neck and crevice. (C) Zn 
2+ and phosphate ions environment and the residues making contact with are shown in stick 
representation. (ThirumalaiSelvi Ulaganathan et al., 2017) 
 
6.2.7 Purification and crystallization of PLSV mutants (H123N, H264N, Y188F) 
 The three mutants H123N, Y188F, H264N were purified in the same way as the native 
protein. Purified H123N, H264N and Y188F mutant proteins were concentrated to 29, 29 and 17   
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(A) Active site residues of LOR107 (colored white) and their corresponding structure equivalent 
in PLSV3936 (colored pink), numbering of amino acid is LOR107/PLSV3936. (B) Enzyme 
activity plot of PLSV3936 and active site mutants against ulvan polysaccharide. Absorbance at 
232nm was observed for reactions containing 1 µg of enzyme in 20 mM HEPES pH 7.5, 150 mM 
NaCl and ulvan substrate at 0.5 mg/ml concentration. 
 
mg/ml, respectively. We attempted to crystallize these proteins in the same condition under which 
the native protein had been crystallized (i.e. 20% PEG 3500 as precipitant and in different salts 0.2 
M ammonium acetate, 0.2 M Sodium formate, 0.2 M potassium iodide, 0.2M ammonium 
formate).The H264N (the presence of Zn2+ ion coordinated by the H264 residue were not identified 
at this time) and Y188F mutants precipitated, whereas H123N crystallized in PEG 3500 (15%- 
23%) , 0.2 M ammonium acetate and pH values between 5 and 6.5. 
6.2.8 Soaking experiments of H123N mutant crystals with tetrasaccharide ulvan substrates 
 Mutant crystals of H123N grown in 15% PEG 3500, 0.2 M ammonium acetate, 0.1M Bis-
Tris pH 5 were soaked for ~ 5 hours in a solution containing two different tetrasaccharide 
substrates (details as described in the LOR107 section). After soaking, the crystals were briefly 
washed in the cryoprotectant solution (30% ethylene glycol in mother liquor) and flash frozen in 
liquid nitrogen. Diffraction data was collected at the 08B1 beamline at the CLS (Grochulski et al, 
2011) and processed with XDS (Kabsch, 2010). These crystals diffracted to 1.6 Å resolution and 
belonged to space group C2 with unit cell parameters a=173.6, b=71.8, c=109.3 Å and β=122.5o. 
There are two molecules in the asymmetric unit. The strong positive difference electron density 
peak in the vicinity of the active site was observed in a crystal that had been soaked in DP4-1 
Figure 6.2:4 Identification of putative active site in PLSV3936. 
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substrate. No such density was found in crystals soaked with DP4-2 substrate. Data collection and 
refinement statistics are shown in Table 6.2.1. The coordinates and structure factors have been 
deposited in the PDB with accession number 5UAS for the enzyme-tetrasaccharide complex.  
6.2.9 Structure of the PLSV3936 (H123N) complexed with ulvan tetrasaccharide: 
 The H123N mutant crystal soaked in DP4-1 tetrasaccharide diffracts to 1.6 Å resolution 
and the difference electron density map showed density for all four sugar residues. The uronic acid 
epimer in the complex structure is identified as GlcA. This suggests preferred binding of the 
tetrasaccharide containing GlcA over the one containing IdoA. The sulfate groups of the Rha3S 
residues serve as markers for placing the tetrasaccharide in the positive density and determining 
the directionality of the oligosaccharide. The naming of the tetrasaccharide follows the same 
convention described for LOR107. The reducing end of the tetrasaccharide (i.e. the Rha3S (+2 
site)) sits at the entrance of the crevice, whereas the GlcA acid and a second Rha3S (+1 and -1 
site) are positioned deep in the crevice. The last residue at the non-reducing end of the 
tetrasaccharide (-2 site), ΔUA, extends toward the surface of the crevice, making a sharp turn 
relative to the direction of the first three sugars (Figure 6.2.5). 
 Three residues that were shown by mutagenesis to be essential for activity, His123, Tyr188 
and Arg204, make contacts with the GlcA at the +1 site within the tetrasaccharide. The most 
contacts with the protein are made by the two middle sugars, GlcA (+1 site) and Rha3S (-1 site), 
and these two sites are determinants of substrate recognition (Figure 6.2.6A). The GlcA (+1 site) 
contacts the protein on both sides of the sugar ring. The acidic group of GlcA forms a salt bridge 
with Arg204 and a hydrogen bond with NE2His143 on one side and OHTyr246 on the other side 
(Figure 6.2.6B). This is exactly the location of the phosphate ion observed in the native structure. 
The arginine fulfills the role of a charge neutralizer, with the aid of His143 and Tyr246. The 
retaining activity of the H143N mutant indicates that the contribution of His143 on its own is less 
crucial. When His123 was modeled onto the asparagine sidechain in the complex structure, 
NE2His123 is ~2.3 Å away from the oxygen bridging GlcA (reducing end) and Rha3S (non-reducing 
end) and these atoms also lie in the same plane. The modeled His123 is too close to the C5 
hydrogen (NE2–HC5 hydrogen distance of 1.6 Å), indicating that the substrate is slightly shifted 
when bound to the active enzyme. Moreover, the H-C5 bond is nearly perpendicular to the histidine 
ring, an inappropriate geometry for proton abstraction. However, Tyr188 is well positioned to 
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Figure 6.2:5 Location of the tetrasaccharide in the crevice. 
Surface representation of PLSV3936 showing substrate in the active site crevice. The zoomed view 
showing the substrate and catalytic residues. Difference electron density map contoured at 3σ level 
around the substrate.  
 
abstract the C5 hydrogen, with its hydroxyl group extending toward this hydrogen and with a 2.4 
Å distance between OHTyr188 and H-C5. There is one more hydrogen bond formed, between O3GlcA 
at the +1 site and ND2His208. 
 The sulfate group of -1 site Rha3S is specifically recognized through hydrogen bonds to 
Asn60, Asn123, Lys125 and to Gln66 through a bridging water molecule. The O2 hydroxyl of 
Rha3S forms an additional hydrogen bond to Arg282 through a bridging water molecule (Figure 
6.2.6A). The C6 methyl group of Rha3S makes van der Waals contacts with methyl groups of 
Thr280, Thr355 and with the Phe329 ring. This might contribute to the binding selectivity for this 
sugar. The +2 site Rha3S predominantly makes van der Waals contacts with the protein, namely 
with the faces of His143, His158, His208 and with Ala207, while the sulfate makes hydrogen 
bonds with His278 and Lys354 (weak). Finally, O2∆UA at the -2 site hydrogen bonds to Asn60 and 
extends toward the surface. 
Y188
R204
H123
+2
+1
-1
-2
6.2 Structure and catalytic mechanism of PLSV3936   
 109 
6.2.10 Proposed catalytic mechanism 
 The structure of the enzyme-substrate complex, together with the enzymatic data from the 
mutants, allowed us to deduce the catalytic cycle and firmly identify the residues participating in 
catalysis. The elimination mechanism, as observed in all polysaccharide lyases, requires 
neutralization of the C5 acidic group on the uronic acid residue in the +1 position. In other 
polysaccharide lyases, this is accomplished either by a bound metal ion or an asparagine, aspartate 
or histidine sidechains. The neutralization of the C5 acidic group of the uronic acid in the +1 
subsite is a prerequisite for making the C5 proton susceptible to attack by a base. The product 
analysis indicates that PLSV3936 can break the bond next to either GlcA or IdoA. Our structural 
data provide direct information about the binding of a substrate containing GlcA at the +1 position 
and delineate residues involved in its degradation. Therefore, we will discuss further the specific 
breakdown of this substrate.  
 The acidic group of the substrate is neutralized by Arg204 with some help from His143 
and Tyr246. The sidechains in close proximity to the C5 proton are Tyr188 and His123. Our model 
suggests that a slight repositioning of the substrate in the active site of the wildtype enzyme, would 
give a distance of ~2-2.5 Å between the C5 proton and OHTyr188 or NE2His123. This distance is 
compatible with either of these residues acting as a base (Figure 6.2.6B). However, the H-C5 bond 
would be nearly perpendicular to the histidine ring, making proton transfer to His123 less likely. 
Tyr188, on the other hand, is pointing directly toward H-C5 and is well poised for proton 
abstraction. The His123 and Tyr188 are in close proximity, with the NE2His123 and OHTyr188 of 
these residues are within 3.3 Å in the wildtype structure. When H123 is modelled into the H123N 
mutant, this distance is even shorter, allowing for a proton transfer from Tyr188 to His123. This 
would result in His143+ and Tyr188-O-, preparing Tyr188 for C5 proton abstraction. This must be 
followed by donation of a proton onto the bridging oxygen. His123 appears to be best positioned 
for this action, with the ring being ~2.5 Å away from the bridging oxygen, already in the plane of 
the histidine ring. Although OHTyr188 is only ~3.4 Å away from this oxygen, the hydroxyl group is 
nearly perpendicular to the (Rha3S) C1-O-C4 (GlcA) plane and in less favorable geometry for 
proton transfer. Importantly, since the position of the substrate in the wildtype enzyme might be 
slightly different due to the fact that H123N replacement creates a small additional space for the  
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(A) Stereo view of the residues in close proximity to the tetrasaccharide. Green dashed lines 
indicate hydrogen bonds, red dashed lines indicate very close contacts; (B) close-up of the central 
sugars GlcA and Rha3S and their contacts with neighboring sidechains; (C) The proposed reaction 
mechanism of PLSV3936 with indicated roles of active site residues. 
 
Figure 6.2:6 proposed catalytic mechanism of PLSV3936. 
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substrate to move into, we cannot be absolutely certain about the precise roles of His123 and 
Tyr188 from the structure alone. However, since the Y188F mutation inactivates the enzyme, we 
postulate that this sidechain plays a major role in catalysis and is the most likely candidate for a 
base. Meanwhile, His123 would then transfer one of its two protons to the bridging oxygen, with 
a concomitant breaking of the C4-O bond and the formation of a C4-C5 double bond. It is unclear 
if Tyr188 and His123 act in concert as a proton relay, or if there is a deprotonation at C5 followed 
by elimination. These could be either E2 or E1CB mechanisms, but we favor the latter since it is 
a syn elimination. The proposed mechanism is summarized in (Figure 6.2.6C). 
 The H264N mutation also inactivated the enzyme, although this sidechain is not in contact 
with the substrate. The structure suggests a role for this residue, His264 together with His208, 
His278 and Cys266 are ligands of the Zn2+ ion. Replacement of His264 by an asparagine likely 
results in a loss of Zn2+ binding. This metal plays a structural role and its removal would destabilize 
the region near the active and substrate binding sites, which would inactivate the enzyme. This 
mutant precipitates readily during purification under the conditions where the wildtype and other 
mutants are soluble, supporting the notion that some structural changes have taken place.  
To summarize, we solved the crystal structure of PLSV3936, a member of PL25 family in 
the apo state and in complex with the tetrasaccharide. This enzyme shares 14% sequence identity 
with PL24 family Lor107. PLSV3936 adopts the seven bladed β-propeller fold with an extended 
crevice on one side of the propeller. Identification of the sugar binding region, site directed 
mutagenesis coupled with enzyme activity measurements and the complex structure of PLSV with 
the dp4-1 tetrasaccharide have allowed us to delineate a possible catalytic mechanism. For this 
enzyme, the negative charge of the acidic group on the GlcA is neutralized by Arg204 with the 
help of His143 and Tyr246. Tyr188 is most likely the catalytic base while His123 likely plays the 
role of general acid. 
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Table 6.2-1 Data collection and statistics table of PLSV3936 
Crystal form Native 
PLSV_3936 
SeMet 
PLSV_3936 
Complex 
PLSV_3936 
Space group C2 C2 C2 
a, b, c (Å) 
ß (o) 
174.3, 72.1, 109.5 
122.5 
173.6, 71.8, 109.1 
122.4 
173.6, 71.8, 109.3 
122.4 
Wavelength (Å) 0.9791 0.9788 0.9871 
Resolution (Å) 49.01-1.45 47.8-2.0 46.3-1.6 
Observed hkl 763554 574743 1094771 
# Unique hkl 194580 145561* 143664 
Completeness (%) 96.2 (83.2) 98 (95.2) 96.0 (90.0) 
Redundancy  3.7 3.9 7.6 
Rsym 0.044 (0.71) 11.1 (0.76) 0.097 (1.35) 
CC1/2 99.9 (82.2) 99.7 (69.0) 99.9 (65.5) 
I/(σI) 19.15 (2.74) 11.23 (2.11) 13.75(1.5) 
Rwork 0.134  0.182 
Rfree  0.143  0.212 
Wilson B (Å2) 16.5  18.0 
   Protein 21.2 (7012)  24.0 (6956) 
   Ligand 36.3 (58)  28.2 (130) 
   Solvent 34.5 (1128)  36.4 (1128) 
   Favored (%) 96.8  96.2 
   Allowed (%) 3.1  3.8 
Clash score 2.1  5.7 
   Bonds (Å) 0.007  0.009 
   Angles (°) 1.00  0.96 
PDB code 5UAM  5UAS 
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6.3 Structural characterization of NLR48 (PL28) from Nonlabens ulvanivorans 
 NLR42 and NLR48 from Nonlabens ulvanivorans were the first discovered ulvan lyases. 
Both enzymes had poor solubility and the purified protein formed soluble aggregates. To improve 
solubility, the gene encoding NLR48 lacking the signal peptide (NLR48(26-302)) was cloned into 
expression vectors with different tags. A shorter construct lacking a few residues at the N-terminal 
unstructured region (named as NLR48(53-302)) was also made. Efforts were made to overcome the 
solubility issues with NLR42. Based on secondary structure predictions, one construct (NLR42-
82D) lacking residues at N-terminus was made, but this truncated construct did not express well. 
This led us to focus only on NLR48 (From here on, the construct NLR48(26-302) which lacks the 
signal peptide is called as NLR48). 
6.3.1 Expression and purification of wildtype NLR48 
His tagged NLR48 and the shorter construct NLR48(53-302) had good expression but the 
purified enzyme tends to form soluble aggregates, as evidenced by SEC. His-MBP-NLR48 did not 
express, but the GST-NLR48 construct expressed as properly folded protein and resulted in a 
sample suitable for crystallization experiments. After subjecting to SEC, the monomeric peak 
fractions were used for crystallization trials. All the purification and SEC profiles of NLR48 are 
shown in (Figure 6.3.1). After GST cleavage, the approximate yield of NLR48 from 6 liters of 
cell culture was 3 mg which was used for further experiments.  
6.3.2 Crystallization of wildtype NLR48 
 NLR48 at a concentration of 16 mg/ml was screened for crystallization at 15oC and 9oC. 
Crystals were obtained at both 15oC and 9oC in 0.056M sodium phosphate monobasic, 1.344M 
potassium phosphate dibasic, pH 8.2 and only at 15 degrees in condition 0.49 M sodium phosphate 
monobasic monohydrate, 0.91 M potassium phosphate dibasic, pH 6.9. Crystals grown at 9oC are 
larger than crystals grown at 15oC. For data collection, crystals from both 9oC and 15oC were 
briefly transferred to mother liquor containing 30% ethylene glycol and flash cooled in liquid 
nitrogen. These native crystals diffracted to ~2.5Å resolution. Due to low sequence homology 
between the unknown structure and the best starting model, this structure could not be solved by 
molecular replacement. This led to pursue anomalous phasing using a SeMet derivative (SeMet-
NLR48). 
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(A) Affinity purification of the GST-NLR48 using Glutathione agarose resin. (B) Cleavage of the 
GST tag using His-TEV protease and the follow up purification using cobalt metal affinity resin. 
The NLR48 used for SEC after GST cleavage and TEV removed is highlighted in yellow box. (C) 
SEC profile of NLR48 showing the monomer behavior and the SDS-PAGE showing the purity of 
the peak fractions. D) Crystals of NLR48 obtained from 0.056 M Sodium phosphate monobasic, 
1.344 M Potassium phosphate dibasic, pH 8.2 at 15o C. 
Figure 6.3:1 Purification and Crystallization of Wildtype NLR48. 
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6.3.3 Production, purification and crystallization of SeMet-NLR48 
 Selenomethionine incorporation of NLR48 was done using a methionine auxotroph 
mutant. SeMet-NLR48 was by purified following the same protocol used for native enzyme 
purification. SeMet-NLR48 was concentrated to 16 mg/ml for crystallization experiments.  
(A) Affinity purification of GST-NLR48 using Glutathione agarose resin. (B) Cleavage of GST 
tag using His-TEV protease and the follow up purification using cobalt metal affinity resin. Protein 
after GST cleavage and TEV removal used for SEC is highlighted in yellow box. (C) SEC on 
SEC650 column showing monomeric behavior of the protein and the SDS-PAGE showing the 
purity of the peak fractions. D) Crystals of SeMet- NLR48 obtained from 0.49 M Sodium 
phosphate monobasic monohydrate, 0.91 M Potassium phosphate dibasic, pH 6.9 at 9o C. 
Figure 6.3:2 Purification and Crystallization of SeMet incorporated wildtype NLR48. 
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 The crystals grown at 9o C in 0.49 M sodium phosphate monobasic monohydrate, 0.91 M 
potassium phosphate dibasic, pH 6.9 were cryoprotected with 30% ethylene glycol and shot at the 
BM beamline (Fodje et al., 2014) at the CLS. Data was processed with XDS (Kabsch, 2010) and 
the data collection statistics are shown in Table 6.31. All the purification and SEC profiles are 
shown in (Figure 6.3.2). 
6.3.4 Structure solution and refinement of wildtype NLR48 
 The structure of wildtype NLR48 was solved using the autosol program (Terwilliger et al., 
2009) by single anomalous dispersion method on a SeMet derivative dataset. A total of 6 Se sites 
were identified and the model contained residues 21-280. SeMet-NL48 crystals diffracted better 
than the wildtype NLR48. One of the SeMet crystals diffracted to 1.9Å. The crystal belongs to 
space group P212121 with unit cell dimensions a=82.49, b=102.12, c=103.71. The initial model was 
refined against this high-resolution dataset. Refinement was done using the PHENIX refinement 
program (Adams et al., 2011). Manual inspection of the structure was done using COOT (Emsley 
et al., 2010). The final structure was validated by Molprobity (Chen et al., 2010).  
6.3.5 Crystal structure of NLR48 
 The three-dimensional crystal structure of NLR48 was solved at 1.9Å resolution. The 
asymmetric unit contains two molecules related by a non-crystallographic 2-fold rotation 
(Fig.6.3.3B). The two molecules are nearly identical and display a RMSD of 0.1Å over all Cα 
atoms. Each molecule covers a residue range of 21-280. Since the two molecules are identical, the 
following observations were made from chain A. The overall structure of NLR48 is a β-sandwich 
jelly roll fold with two concave beta sheets stacked together. This fold has been seen in both 
polysaccharide lyase (PL7, PL8, PL13, PL14, and PL20) and glycoside hydrolase (PL16) family 
enzymes. Each sheet has 7 antiparallel β strands (Strand A1- A7 at the inner concave and B1-B7 
at the outer concave) (Figure 6.3.3C). The residues Cys32 at the N terminal loop and Cys59 at the 
loop connecting A1 & B1 strands form a disulfide bridge. The inner β sheet (A1-A7) forms a deep 
cleft and electrostatic surface potential analysis (done using APBS plugin PyMol) (Baker et al., 
2001) on the structure showed that this cleft is formed by positively  
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 (A) Topology diagram of NLR48 generated using PDBsum (Laskowski et al., 1997). (B) Two 
molecules in the asymmetric unit related by non- crystallographic 2-fold rotation. The loops shown 
in green, magenta and orange corresponds to the equivalent loop in each molecule. (C) Schematic 
representation of NLR48 shown in cartoon representation and colored from N to C terminus. 
Calcium ion is shown as green sphere and phosphate are shown in stick representation. Strands in 
inner and outer concave are numbered from A1-A7 and B1-B7 respectively. Loops lining the walls 
of the cleft are indicated. (D) Electrostatic surface potential representation showing the positively 
charged cleft and the phosphate occupied the cleft is shown in stick representation.  
 
charged amino acids (Figure 6.3.3D). The loops connecting strands A4 & A5, B2 & A2, A6 & 
A7, and B4 & A4 make up the cleft wall. Both molecules have two positive difference density 
peaks (Fo-Fc) at the same site in the cleft, for which the scattering is higher than expected for 
water. Two phosphate molecules (from the crystallization solution) were modelled in the positive 
density and fit well in the cleft (Figure 6.3.3D). This indicates that this region may be the putative 
substrate binding site of NLR48. Additional positive peaks were identified on both molecules at 
the loop region connecting strands A1 & B1. Based on the environment and the coordination 
geometry, these peaks are assigned as Ca2+ ions. This site is located away from the positively 
Figure 6.3:3 Structure description of NLR48. 
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charged cleft (Figure 6.3.3C) which indicates that Ca2+ plays a structural role in NLR48 and not 
in catalysis.  
6.3.6 Putative substrate binding site 
The Ca2+ ion is coordinated by pentagonal bipyramid arrangements. The equatorial ligands 
are backbone carbonyl oxygens of Gly36 (2.47Å) and Ser58 (2.25 Å), OD1 (2.49 Å) & OD2 (2.46 
Å) of Asp56 and OD1 (2.46 Å) of Asn62. The axial ligands are OD1 (2.31 Å) of Asn38 and the 
backbone carbonyl oxygen (2.28 Å) of Ala61 (Figure 6.3.4B). The phosphate (PO4
3-) in the 
positively charged cleft made many interactions with surrounding residues. PO4
3- at site1 H-bonds 
with N2 (2.85Å) of Lys139, NE2 (2.58Å) and OE1 (3.17Å) of Gln137, NH1 (2.84Å) of Arg94, OH 
(2.63Å) of Tyr258. PO4
3- at site2 makes H-bond with NH2 (2.72Å) of Arg193, OG (2.72Å) of Ser148 
and the backbone nitrogen (2.96 Å) of Ala152 (Figure 6.3.4A). Based on these observations, the 
cleft region was considered a putative substrate binding site and all residues interacting with the 
PO4
3- ions (Arg94, Gln137, Lys139, Arg193, and Tyr258) were subjected to mutation studies.  
6.3.7 Site directed mutagenesis and enzyme activity of NLR48 mutants  
To obtain a structure of the enzyme substrate complex, the following mutants were made: 
R94N, Q137A, K139M, R193N and Y258F. All the active site mutants were expressed and 
purified in the same way as the native protein. The enzymatic activity of wildtype NLR48 and the 
various mutants on ulvan substrate was measured by monitoring the absorption at 232 nm, 
indicative of the formation of an unsaturated double bond in the non-reducing end. All the mutants 
had abolished the enzyme activity against the ulvan substrate (Fig.6.3.4C).  
6.3.8 Expression, purification, crystallization and structure solution of NLR48 mutants 
 Putative active site mutants K139M, Y258F, R94N derived from enzyme activity analysis 
were purified in large scale (3 liter TB for each mutant). The GST fusion constructs of the mutants 
were expressed and purified using the same protocol followed for wildtype NLR48. The mutant 
R94N was poorly expressed. This led to follow up only with K139M and Y258F mutants for 
crystallization trials. Purified K139M and Y258F mutants were concentrated to 17 mg/ml and set 
up for crystallization in 0.056 M Sodium phosphate monobasic, 1.344 M Potassium phosphate 
dibasic pH 8.2 and 0.49 M Sodium phosphate monobasic  
6.3 Structure and catalytic mechanism of NLR48 
 119 
 
Figure 6.3:4 Putative substrate binding site. 
 (A) Phosphate molecules (Site I & II) in the putative active site and the surrounding residues 
making contact with them, all shown in stick representation. (B) Pentagonal bipyramidal 
coordination of Ca ion in wildtype NLR48. (C) Enzyme activity plot of wildtype and NLR48 
mutants on the ulvan substrate. 
 
monohydrate, 0.91 M Potassium phosphate dibasic, pH 6.9 at both 9oC and 15oC. Only the K139M 
mutant was crystallized and these crystals grew at both 15oC and 9oC in 0.49 M sodium phosphate 
monobasic monohydrate, 0.91 M potassium phosphate dibasic, pH 6.9. The crystals grown in the 
lower pH condition were soaked in tetrasaccharide substrates (DP4-1) for 2 hours and diffracted 
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to as low as 2.2 Å resolution. Diffraction data was collected at the ID beamline in the CLS and 
processed using XDS (Kabsch, 2010). The crystals belonged to space group P212121 and the cell 
dimensions were a=82.5, b=102.7, c=103. One round of rigid body refinement was carried out on 
the data using the PHENIX refinement program. Positive difference density for the substrate was 
visible at the entrance to the active site. Manual substrate placement and further refinement were 
done using COOT (Emsley et al., 2010) and PHENIX, respectively (Adams et al., 2011) . Data 
collection and statistics are shown in Table 6.3. 
6.3.9 The structure of NLR48 mutant with bound substrate 
 Just as in the native structure, two molecules were observed in the asymmetric unit related 
by a 2-fold non-crystallographic rotation. The electron density map calculated for the complex 
structure showed a blob of positive density in both molecules at the entrance to the cleft. The entire 
tetrasaccharide could be built into this density. The substrate occupies -1 to -4 subsite positions. -
1, -2 and-3 subsites make many interactions with residues in the cleft and the loop region which 
makes up walls of cleft. Rha3S at -1 subsite interacts with Tyr258, Arg193, Arg259 and Tyr134. GlcA 
at -2 subsite interacts with Ser188 and Lys261. Rha3S at -3 subsite interacts with Ser190 (Figure 
6.3.5A & B). No aromatic stacking interaction is observed in the -1 to -4 subsites. 
 A structure comparison of the native NLR48 and the K139M mutant complex showed no 
significant difference in the overall fold and the substrate binding site; active site residues adopted 
the same conformation in both structures. The second phosphate site present in the native structure 
is not seen in the complex. Instead Rha3S at -1 occupies this site with a slight shift in the position. 
Similarly, the phosphate 1 position is also shifted slightly inside the cleft. A new positive 
difference density blob (not seen in wildtype NLR48 structure) is seen in the substrate binding 
cleft and a phosphate molecule fits well in this new site (Figure 6.3.5C & D). The distance 
between this new site and the sugar at the -1 subsite is ~12.5Å (Figure 6.3.5B). This distance can 
accommodate three sugar moieties, possibly +1, +2 and +3 subsites of substrate binding. 
Therefore, this new phosphate site might correspond to the +3 subsite vicinity of substrate. The 
new phosphate molecule interacts with NH2 (2.92Å) & NE (3.18Å) of Arg101, NH1 (2.83Å) of 
Arg254 and OG (3.15Å) of Ser98 (Figure 6.3.5B &D). The two molecules in the asymmetric unit 
appear to prevent the substrate from passing through the cleft (molecule B blocks substrate in 
molecule A and vice versa). Co-crystallization of the K139M mutant with the substrate did not 
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Figure 6.3:5 Complex structure of NLR48-K139M mutant. 
(A) Complex structure of NLR48-K139M mutant. (B) The electron density (2fo-fc) map for the 
sugar contoured at 1.5σ. Sugars numbered from -1 to -4, the distance between the new phosphate 
site and the -1 substrate site is shown as green dashed lines (~12.5Å). Residues at H bonding 
distance to the substrate and the new phosphate site are shown in stick representation. (C) 
Structural comparison of wildtype (colored rainbow) and K139M mutants (colored white). (D) 
The electron density (2fo-fc) map for the sugar contoured at 1.5σ. -1 subsite occupies the vicinity 
of phosphate site 2 of wildtype with small shift. Phosphate at site I in K139M complex has a slight 
shift moved inner because of the substrate binding. This may correspond to +1 subsite of sugar. 
The space between the new site and the -1 subsite is which can fit 3 sugar moieties.  
 
yield any crystals in this condition. This outcome could be rationalized by suggesting that the 
presence of substrate disrupts the crystal contacts at the dimer interface. This may also explain 
why the substrate docked at the active site entrance spanned the -1 to -4 subsites. Also, the high 
concentration of phosphate in the crystallization condition might effectively block the center of 
the cleft from the incoming tetrasaccharide and prevent it from occupying the +1 subsite. 
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6.3.10 Comparison with other β-jelly roll fold enzymes 
 The glove-like β-jelly roll scaffold has been reported in many polysaccharide lyase (PL7, 
PL14, PL18, PL13 and PL20) families (M. L. Garron and Cygler, 2014). Among these PL7, 14 
and 18 have enzymes which degrade alginate. PL13 has heparin lyase I which degrades the GAG 
heparin. PL20 has an enzyme which cleaves Poly-GlcA substrates. Interestingly, all these enzymes 
share very little sequence identity (~<14%) with NLR48. The number of β-strands in the inner and 
outer β-sheet varies but the core structures of the enzymes superpose well with the core of NLR48. 
The putative catalytic site residues of NLR48 are structurally conserved among those lyases. 
Differences appear in the loop region (Figure 6.3.6). In PL7 alginate lyase the lid loop mechanism 
or loop motion is important in substrate recognition and binding (Ogura et al., 2008). Also in HepI 
from PL13 family the mobility of lid loop and the presence of a thump domain is important for 
substrate binding (Han et al., 2009). In NLR48 there is no indication of loop mobility because the 
electron density of these loops are clearly defined. This fold is also seen in glycoside hydrolase 
GH16 family. GH16-Kappa carrageenases, enzymes degrading marine sulfated polysaccharide 
carrageenans have a β-sandwich domain with a tunnel shaped active site (Matard-Mann et al., 
2017).  
6.3.11 Possible catalytic mechanism 
 A complex structure with substrate has been reported for the PL7 family alginate lyase A1-
II’ (Ogura et al., 2008) and PL13 family heparin lyase (HepI) (Han et al., 2009). In both enzymes, 
a His/Tyr mediated reaction mechanism is observed. Therefore, to understand the role of the 
residues in the cleft, these structures (NLR48, HepI/substrate complex and A1-II'/substrate 
complex) were superimposed based on the backbone atoms of their conserved residues. This 
superposition represents the local environment of the active site. In this superposition the +1 
uronate is the only sugar that has similar position and orientation among the structures. The +2 and 
-1 sugars are oriented differently. Nevertheless, the O1 of Rha3S in the NLR48 complex is in 
nearly the same place as the corresponding anomeric O atoms in -1 sugars of the other two 
complexes. It is therefore very likely that the +1 GlcA/IdoA sugar is placed in the same way as in 
the other two lyases. In such a case, Gln137 can neutralize the acidic group on the +1 sugar and 
forces the C5 deprotonation. Tyr258 is in the vicinity and its hydroxyl group is pointing toward 
the bridging oxygen. With GlcA in the +1 site the hydroxyl group of Tyr258 is in close proximity 
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Figure 6.3:6 Structural comparison of NLR48 with other β jelly roll fold enzymes 
(A) Cross eyed stereo view of NLR48 (colored cyan), PL7 family alginate lyase PDB code: 2CWS 
(colored green) and PL13 family HepI PDB code: 3IKW (colored grey). The inner and outer 
concave β strands are numbered based on NLR48 structure from A1-A7 and B1-B7, respectively. 
(B) Sequence alignment based on structure superposition, conserved residues used to align the 
active site (R94, E96, Q137, K139, R254 and Y258) are marked with triangle.  
6.3 Structure and catalytic mechanism of NLR48 
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Figure 6.3:7 Putative catalytic mechanism of NLR48. 
(A) Superposition of enzyme-oligosaccharide complexes based on the backbone of conserved 
residues in the cleft (Arg94, Glu96, Gln137, Arg254 and Tyr258 and their equivalences in other 
lyases. NLR48, PL7 (2ZAA) and PL13 (2INA) are colored green, cyan and yellow respectively. 
Only the +1 sugar in PL7 and PL13 and -1 subsite (Rha3S) of NLR48 is shown for clarity. The 
hydrogen bond network between the acidic group of +1 sugar, Gln, Arg and Glu is shown with 
dashed lines (B) (Top panel) Tyr258 act as a base and acid for the cleavage near GlcA, while for 
IdoA the base is Lys139 and the acid is Tyr258 (bottom panel). 
6.3 Structure and catalytic mechanism of NLR48 
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to the C5 proton. Therefore Tyr258 could perform the role of both proton abstraction and donation. 
In the case of a IdoA, the proton is on the opposite side of the sugar ring to Tyr258. The only 
sidechain close to this proton is Lys139. There is a histidine in an equivalent position in PL13 
lyases that cleave next to IdoA and in PL7 lyases that cleave next to guluronate, the same epimer 
as IdoA. However, in PL20 lyases, which cleave next to GlcA, the C5 proton is on the opposite 
side facing the tyrosine and the Lys139 position is taken by an isoleucine. Since NRL48 can likely 
cleave the bond next to either epimer of uronic acid like its homolog NRL42, Lys139 can act as 
an acid for proton abstraction. The role of a lysine residue as a proton acceptor is not unusual and 
seen in other PL families with different folds, namely PL3, PL9, PL6 and PL11. Overall, both the 
fold and the catalytic machinery are conserved between families PL28, PL7, PL13, PL18 and 
PL20. 
To summarize, we solved the crystal structure of NLR48, a member of PL28 family in apo 
state and complex with the tetrasaccharide. NLR48 adopts the β-jelly roll fold with an extended 
substrate binding site. A complex structure of NLR48 with substrate and comparison with 
structural homologs help us to delineate the possible catalytic mechanism. The negative charge of 
the acidic group on the GlcA/IdoA is neutralized by Gln137 with help from Arg94 and Glu96. For 
the cleavage near GlcA Tyr281 act as a base and acid, while for IdoA the base is Lys139 and the 
acid is Tyr258. 
  
6.3 Structure and catalytic mechanism of NLR48 
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Table 6.3-1 Data collection and statistics table of NLR48 
Crystal form NLR48(SeMet) NLR48(K139M)-
tetrasaccharide 
Space group P 21 21 21 P 21 21 21 
a, b, c (Å), ß (o) 82.5, 102.1, 103.7   82.5, 102.7, 103.0 
Wavelength (Å) 0.98013 0.97949 
Resolution (Å) 50-1.9 50-2.2 
Observed hkl 1,001,093 432,911 
# Unique hkl 131,854 44,398 
Completeness (%) 99.8 (97.7) 99.8 (97) 
Redundancy  7.6 9.8 
Rsym 0.143 (1.25) 0.10 (1.16) 
I/(σI) 10.01 (1.82) 14.86 (2.0) 
Refinement statistics 
Rwork 0.169 0.189 
Rfree  0.201 0.220 
Wilson B (Å2) 26.28 49.57 
Ramachandran plot (%)   
   Favored 96.57 95.35 
   Allowed 2.67 3.88 
Outliers 0.76 0.78 
R.m.s. deviation   
   Bonds (Å) 0.015 0.008 
   Angles (°) 1.214 1.091 
PDB code 6D2C 6D3U 
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Chapter 7 
 
7. Discussion 
The main goal of the research described in this thesis is to expand our structural and 
mechanistic understanding of the enzymes catalysing the breakdown of naturally occurring 
polysaccharides via the β-elimination mechanism. Polysaccharides that can be degraded by this 
mechanism contain a sugar with a carboxylic group at the C5 position. General steps involved in 
the β-elimination mechanism are: (1) neutralization of the acidic group, (2) abstraction of the C5 
proton and (3) transfer of a proton to the leaving group (Gacesa, 1987). The main classes of 
polysaccharides that are substrates for polysaccharide lyases (PLs) include pectin/pectate, 
rhamnogalacturonan, heparin, heparan sulfate, heparosan, chondroitin sulfate, dermatan sulfate, 
alginate xanthan, glucuronan and ulvan. The PLs are classified based on their sequence similarities 
into 27 families (CAZy database). Five of these families were added to the database only recently 
(PL24-PL28). At the onset of this work there were no structural data for the PL12 family. 
Therefore, HepIII of the PL12 family from Bacteroides thetaiotaomicron became the subject of 
my research. Subsequently, three new PL families with specificity for ulvan were identified (PL24, 
PL25 and PL28) and the representative lyases from each of these families became additional 
subjects of my studies. Polysaccharides are commercially important and are utilized in food, 
pharmaceutical, cosmetic, biomaterial and other industries. Polysaccharide lyases are useful tools 
to process polysaccharides and tailor them to specific applications.  
 Four polysaccharide lyases have been structurally and mechanistically characterized in this 
research, namely HepIII, LOR107, PLSV3936 and NLR48. These enzymes provide the structural 
templates for lyases in four PL families. 
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Structural comparison of HepIII with other GAG lyases  
HepIII has an (α/α)5 toroid + β-sandwich fold. This fold had been observed in other GAG 
lyase families, namely PL8 (Hyl, ChonAC, ChonABC) and PL21 (HepII). Crystallographic 
investigation to understand the molecular basis of HepIII-substrate recognition was unsuccessful. 
However, the active site residues (Tyr301, Asn247, and His431) were deduced from structural 
comparison with the closest structural homolog, HepII. The participation of these residues in 
catalysis/substrate binding was further confirmed by mutation and the lack of enzymatic activity 
of the mutants on its natural substrate, heparan sulfate (HS).  
HepII can degrade HP and HS by cleaving next to both GlcA and IdoA epimers. The 
catalytic residues involved in GlcA degradation are Glu205 (neutralizer) and Tyr257 (base/acid) 
whereas for IdoA degradation, the anti elimination, involves Glu205 (neutralizer), His202 (base) 
and Tyr257 (acid). Based on structural comparison with HepII and the known specificity of HepIII 
for the GlcA epimer, it is most likely that Tyr301 performs the roles of both catalytic base and acid 
during syn elimination. Neutralization of the carboxylic group in the +1 site to force the C5 
deprotonation is most likely performed by Asn247. The role of Asn247 as a neutralizer is further 
supported by the structural comparison of HepIII with chon AC and Hyl. In these proteins, charge 
neutralization is accomplished by the asparagine sidechain (Li et al, 2000; Lunin et al, 2004). 
 The structures of the three lyases from PL12 are currently known and none of them were 
crystallized with the substrate. A comparison of their structures showed that the individual 
domains of the proteins overlap well, whereas their relative orientations differ in each enzyme. 
Our molecular dynamics simulation via NMA calculated large-scale movements with the hinge 
point at the bottom of second helix in the third α-helical hairpin; near Asn281 at the N-terminal 
domain. The movement trajectories of these proteins intersected in one conformation that 
represents a semi-closed state. We postulated that this is the most likely active conformation of 
these lyases and the conformations observed in the crystal are more stable but not catalytically 
compatible. The shift to an active conformation is likely driven by the energy derived from 
substrate binding and may require a longer polysaccharide. It might be that this conformational 
change is stimulated more easily by a longer HS rather than by a tetra- or hexasaccharide that was 
used for co-crystallization attempts.  
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Heparinase enzymes in Gut microbiome 
 The microbes residing in the gut depend on the dietary and host-derived glycans for their 
nutrient source. Bacteroides thetaiotaomicron, one of the major members of the gut-residing 
microbes, depend on HS and HP as their major nutrient source. The heterogeneity of HS and HP 
in terms of the degree of polymerization (DP), sulfation pattern and the uronate epimerization 
increases the complexity of these polymers and makes their degradation more challenging. Hence, 
the B. thetaiotaomicron genome contains multiple genes related to HS digestion. They are 
organized as HS utilization loci that encode a repertoire of enzymes to degrade the host HP and 
HS. Recent research on the HS PULs in Bacteroides thetaiotaomicron proposed a model for HS 
degradation. The key findings are: 1) HepIII, the product of bt4662 (PDB code: 4FNV), is 
identified as a surface lyase, with a highest degree of degradation on HS and desulfated HP. Bt4662 
was also identified as an endo-lyase and is active on oligosaccharides containing a minimum of 10 
monomer units. This is in accordance with our finding that the catalytically competent active state 
of HepIII is driven by the binding of longer substrates. 2) In addition, HepIII (product of bt4657, 
PDB code: 5JMD) was identified as an endo-acting periplasmic lyase with some degree of 
processivity. Consistent with our substrate specificity assay, 5JMD shows highest activity against 
HS (less sulfated). 3) PL13 family HepI, the gene product of bt4675, showed higher activity against 
HP and was inactive against desulfated Hep, which suggest that the sulfate group is required for 
its activity. Overall our findings on the substrate recognition and specificity of heparinase enzymes 
through crystallography help in understanding the big picture of the HS degradation system 
(Cartmell et al., 2017).   
Ulvan lyase 
 Ulvan degrading lyases have been identified and characterized only recently. This 
discovery led to the addition of new families in the CAZy database namely, PL24, PL25 and PL28. 
We have determined the first crystal structure of a member of each family; LOR107 (PL24), 
PLSV3936 (PL25) and NLR48 (PL28). LOR107 and PLSV3936 adopt a seven bladed β- propeller 
fold, whereas NLR48 has a β-jelly roll fold. All three enzymes utilize the His/Tyr catalytic 
mechanism with slight modifications.  
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Comparison of LOR107 and PLSV3936  
 LOR107 and PLSV3936 adopt the same fold, despite sharing only ~14% sequence identity. 
The two structures can be superimposed with a RMSD of 1.73 Å for 188 Cα atoms (out of ~440 
common).  The parts of the structures that are similar include β-strands of the propeller, while the 
loops differ in their conformations (Figure 7.1A). Despite adopting the same fold, the two 
structures display several features that differentiate them: (1) in the structural superposition, the β-
strands of the blades align well but the loops diverge; they have different lengths and 
conformations, particularly the long loops at the top of the propeller. (Figure 7.1A). (2) While 
both enzymes contain structural metal ions, LOR107 has two Ca2+ ions that are distant from the 
active site while PLSV3936 contains a Zn2+ ion that is located closer to the active site and likely 
rigidifies it. 3) The residues crucial for LOR107 activity are divided into two clusters, whereas the 
activity of PLSV3936 depends on residues forming one cluster. The LOR107 residues from cluster 
I, His146, His167, Thr242, Tyr243 and Arg259 have structural equivalents His123, His143, 
Thr187, Tyr188, and Arg204 in PLSV3936, respectively. In the structural superposition, the blades 
1-3 and 7 of the propeller in both proteins align well while blades 4-5 in LOR107 are shifted more 
outside, resulting in widening of the substrate binding canyon (Figure 7.1 B). (4) As a result, 
cluster II residues in LOR107 (Asn263, Tyr303, Arg320 and Tyr330) are shifted slightly outside. 
Moreover, in cluster II of LOR107, only Tyr303 has a conserved counterpart (Tyr246 in 
PLSV3936). The residue that corresponds spatially to Arg320 in LOR107 is His264 in PLSV3936 
(Figure 7.1 C). His264 in PLSV3936 mediates the Zn2+ ion and mutating this residue leads to 
aggregation of the protein. Whereas Arg320 in LOR107 is not involved in metal coordination but 
plays a key role in substrate binding. (5) Another notable difference is the essential role of His167 
(cluster I) in the catalysis of LOR107, while mutation of the structurally equivalent residue His143 
in PLSV3936 does not affect the enzyme activity.  
Substrate binding in LOR107 and PLSV3936 
 The substrate binding in LOR107 is captured as a two stage binding event in the crystal 
structures. A comparison of the substrate binding in PLSV3936 with LOR107 (R320N mutant 
complex structure) shows that the tetrasaccharide binds in a similar region relative to the catalytic 
residues. The -2 and -1 sugars take on the same conformations. However, the +1 and +2 sugars 
show different orientations. The +1 GlcA are in slightly different orientations relative to the active 
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site residues in these two lyases but the orientation of the +2 Rha3S differ significantly; the rings 
are flipped by ~180o and the sulfate groups point in opposite directions in these two binding sites 
(Figure 7.1 D), indicating that the ‘+’ sugars follow different paths along the enzyme surfaces. 
The small difference in the orientation of the +1 GlcA indicates some plasticity in the His/Tyr 
active site that can accommodate changes in substrate orientation and maintain efficient bond 
cleavage. 
 Biochemical studies showed that LOR107 cleaves specifically after GlcA (+1 site) and 
PLSV3936 can cleave after GlcA/IdoA (+1 site) within the ulvan polysaccharide. The crystal 
structures of PLSV3936 was captured with GlcA at the +1 site. However, the mutations of Arg204 
(neutralizer), Tyr188 (base) and His123 (acid) in PLSV3936 completely inactivate the enzyme. 
This suggests that these sidechains could be involved in degrading both uronic acid epimers. 
However, in IdoA, the C5 proton is on the opposite side of the sugar ring to Tyr188. There are two 
residues, Tyr246 and His208, facing the C5 proton of IdoA (Figure 7.1 F). In that, His208 is the 
Zn2+ coordination ligand. At this point, the mechanism of cleavage next to IdoA by PLSV3936 is 
less clear. A detailed understanding of the IdoA-containing ulvan degradation mechanism requires 
structure determination of PLSV3936 in complex with the ΔUA-Rha3S-IduA-Rha3S substrate. 
However, positioning IdoA at the +1 site in LOR107 shows that Tyr303 would point toward the 
C5 proton (Figure 7.1 E) and mutation of Tyr303 to Phe does not affect the enzyme activity. This 
structural data, along with mutation studies and enzyme activity assays, support the substrate 
specificity of LOR107 for GlcA epimer. 
Comparison with NLR48 
Despite its different fold, NLR48 shares similarities with the PL24 and PL25 lyases in their 
catalytic mechanisms. The biochemical characterization of NLR48 finds that NLR48 can cleave 
next to both uronic acid epimers (Colle et al., 2011). In accordance with that result, mutation of 
Lys139 (potential base for IdoA cleavage) and Tyr258 (potential acid for IdoA as well potential 
acid/base for GlcA) inactivates the enzyme. Therefore, the catalytic site of NLR48 might be similar 
to PLSV3936, provided that Tyr256 is involved in catalysis. Nevertheless, all three lyase enzymes 
utilize the His/Tyr mechanism. However, neutralization of the C5 acidic group is achieved by 
different means. NLR48 uses a glutamine that faces the carboxyl and forms two hydrogen bonds 
with it. A neighboring Glu96 and Arg94 residue assists in neutralization. In PL24 and 25 enzymes,  
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Figure 7:1 Structure comparison of LOR107 and PLSV3936. 
(A) Cartoon representation of LOR107 (colored as rainbow) and PLSV3936 (colored magenta) 
superposition, the divergence of loops on the top of propeller. (B) The same superposition as A 
but rotated 90o along Y axis, showing the widening of barrel in LOR107 by the strand deviation 
in blade 4 and 5 (the loops are smoothened for better view). (C) Zoomed view of active site vicinity 
showing the equivalent residues in both structures. (D) Substrate binding and catalytic residue in 
LOR107 (colored white) and PLSV3936 (colored magenta). (E, F) IdoA at +1 site in LOR107 and 
PLSV3936 respectively, the green dashed line showing the interaction of C5 proton and the 
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potential catalytic residues, the yellow dashed line showing the catalytic residues of GlcA 
cleavage. 
 
the neutralization of the +1 sugar acidic group is accomplished by the formation of a salt bridge 
with an arginine residue. 
Comparison with other PL family enzymes 
 The β-propeller fold has been observed in two other PL families: a seven-bladed 
β-propeller in PL22, oligogalacturonan lyases (OGL) from Yersinia enterocolitica (PDB code: 
3PE7) (Abbott et al., 2010) and an eight-bladed β-propeller in PL11, rhamnogalacturonan lyases 
(RGL) (Ochiai et al., 2009). The structural comparison of PL22 OGL and PLSV3936 shows that 
the two enzymes have roughly the same barrel diameter and that PLSV3936 has extended loops 
that form the substrate binding site (Figure 7.2B). The structure based alignment of PLSV3936 
with 3PE7 shows only ~5% sequence identity and blade n of 3PE7 superimposes with blade n+1 
of PLSV3936.  
 The structure of LOR107 and OGL superimpose with a RMSD of 1.7 Å for 95 Cα atoms. 
This superposition covers only four blades. In addition, the orientation of β-strands relative to the 
central axis of the propeller differs between the two structures. This leads to differences in the 
diameter of the propellers, with those of LOR107 being wider than OGL (Figure 7.2A).  
 There is currently no structure of OGL in complex with a substrate. Consequently, only a 
putative catalytic mechanism has been proposed for this enzyme. The OGL mechanism differs 
from that of ulvan lyase, in that it likely uses a metal ion (Mn2+) mediated β elimination reaction 
mechanism. His242 was proposed to act as a base and two other residues (Arg217 and His211) 
were also identified to play a role in catalysis. These putative residues are located on the 4th and 
5th blade, whereas the catalytically important residues in LOR107 and PLSV3936 are in the 2nd 
and 3rd blades (Figure 7.2C). Despite having the same fold, the putative active site residues in 
OGL are in a different structural context than LOR107 and PLSV3936. The presumed catalytic 
residues cannot be superimposed and the participation of Mn2+ in OGL catalysis suggests a distant 
evolutionary relationship (if one exists at all).  
 
  134 
 
Figure 7:2 Structure comparison of LOR107, PLSV3936 and PL22 OGL 
(A) Cartoon representation of LOR107 (colored as rainbow) and OGL (colored cyan) 
superposition showing the widening of propeller in LOR107 along blade 4 and 5 (naming of blade 
based on LOR107). (B) Cartoon representation of PLSV3936 (colored magenta) and OGL (colored 
cyan) (naming of blade based on PLSV3936) superposition showing the propeller. In both A & B, 
numbering of blade is based on ulvan lyase. (C) Zoomed view of active site vicinity of PLSV3936 
and OGL showing the catalytic residues are in different blades. 
Convergence of the catalytic site 
 The β-elimination mechanism employing His/Tyr catalytic apparatus is one of the two 
catalytic mechanisms observed among PL enzymes. This favours the syn and/or anti β-elimination 
reaction mechanism. All three ulvan lyases adopt the His/Tyr reaction mechanism with slight 
modifications. Specifically, LOR107 and PLSV3936 appears to use an Arg residue as neutralizer. 
Most PL family enzymes that utilize this mechanism were reported to use Asn, Asp, Glu or Gln as 
a neutralizer of the C5-acidic group, to force its deprotonation. Only in the PL15 family (an exo-
type alginate lyase from Agrobacterium fabrum), an arginine is reported to act as a neutralizer of 
the acidic group (Ochiai et al., 2010). However, the PL15 enzyme, adopts the two-domain (α/α)5,6 
toroid antiparallel β-sandwich fold. The completely different fold of ulvan lyases (LOR107 and 
PLSV3936 - seven bladed β-propeller) and that of the PL15 enzymes and yet similarity in the 
active site arrangement, indicates a convergent evolution of these enzymes toward the same active 
site. As mentioned above, other PL families (PL11 and PL22) with β-propeller folds are evolved 
to utilize the metal assisted mechanism, with a Ca2+ (PL11) and Mn2+ (PL22) ion being the 
neutralizer. Thus PL24 (LOR107) and PL25 (PLSV3936) family ulvan lyases expand the range of 
PL folds that adopt the histidine-tyrosine mechanism of catalysis. 
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Comparison with other seven bladed β propeller enzymes 
 A large number of proteins with a similar seven-bladed β-propeller fold have been 
identified using DALI (Holm and Rosenström, 2010) and deconSTRUCT (Zhang et al., 2010) 
servers. This fold was observed frequently in enzymes as well as in protein domains that bind other 
proteins. However, a good structural fit is limited to a subset of blades for most of them. 
BACOVA_03493 from the gut bacteria Bacteroides ovatus (PDB code: 4IRT, Joint Center for 
Structural Genomics) shows the best structural fit that encompasses all blades. These two 
structures, PLSV3936 and 4IRT, can be superimposed with an RMSD of 1.64 Å for 267 Cα atoms 
with all the blades showing good overlap (Figure 7.3A). The structure-based alignment shows 
only 15% sequence identity, indicating a distant evolutionary relationship.  
 The structural comparison of PLSV3936 and BACOVA_03493 revealed that the highly 
conserved amino acids forming the active site of PLSV3936 are also present in BACOVA_03493. 
The key residues of PLSV3936 are indeed conserved, namely His90 (His123 in PLSV3936), 
His110 (His143), Tyr143 (Tyr188), Arg159 (Arg204), Tyr197 (Tyr246) (Figure 7.3 F). Several 
other residues conserved in PL25 enzymes (PLSV3936), in addition to the active site, were also 
present in BACOVA_03493. Therefore, despite a low sequence identity between these two 
proteins, we rationalized that their catalytic mechanisms might be the same. This hypothesis is 
further supported by the analysis of the surrounding genes. The gene encoding BACOVA_03493, 
is located in the polysaccharide utilization loci and flanked by the glycoside hydrolase (GH) family 
enzymes namely; BACOVA_03492, a GH43 and BACOVA_03494, a GH105 family glycoside 
hydrolases. The GH105 members are known to hydrolyze the disaccharide end products of lyases. 
The purified BACOVA_03493 protein sample was obtained from The Scripps Research Institute 
(TSRI) and was tested for enzyme activity against the ulvan polysaccharide. However, no activity 
was detected, indicating that this enzyme is not an ulvan lyase. Enzyme activity of 
BACOVA_03493 was tested against heparin, chondroitin, hyaluronan and xanthan at the 
CERMAV (Centre de recherches sur les macromolécules végétales) and no activity was detected 
against these substrates. Unexpectedly, a glycoside hydrolase activity was detected for this enzyme 
and the active site was found on the opposite end (posterior side) of the β-propeller (Figure 7.4C) 
(Munoz-Munoz et al., 2017).  
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Figure 7:3 Structure comparison of PLSV3936 and hydrolase 
(A) Cartoon representation of PLSV3936 (colored magenta), 4IRT (colored green) and 5MUL 
(colored green) superposition showing the propeller. (B) The active site of PLSV3936 containing 
the substrate at anterior side of propeller, indicating by arrow. The catalytic residue and the 
substrate are shown as sticks and colored white. (C) The active site of 4IRT and the conserved 
residues at anterior and posterior side of propeller, indicating by arrow. (D) The active site of 
5MUL at posterior side of propeller. (E) Posterior side of 5MUL propeller and the catalytic site. 
The GlcA is colored yellow and the interacting residues are colored white. (F) Active site 
comparison showing the residue conservation of PLSV 3936 active site and anterior side of 4IRT. 
(G) Active site comparison showing the residue conservation of 5MUL active site and posterior 
side of 4IRT.  
 Interestingly, the hydrolase active site does not contain the canonical hydrolase catalytic 
apparatus (with two carboxylic groups in the active site) similar to BT3686 (PDB code: 5MUL), 
a member of GH145 family (Figure 7.3D). This is quite unusual and suggests an evolutionary 
switch of the active site and catalytic mechanism in a fold that was performing a different function. 
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8. Summary and future perspectives 
 
The work presented in this thesis involves the structural studies on four PL family enzymes. 
The PL enzymes degrade the uronic acid containing polysaccharide through a β-elimination 
mechanism. The general steps involved in this lytic degradation are: (1) neutralization of the acidic 
group (2) abstraction of a C5 proton and (3) transfer of a proton to the leaving group 
In the first part of this work, the crystal structure of HepIII (a GAG degrading PL12 family 
enzyme) has been determined. HepIII adopts the two domain (α/α)n toroid+β-sandwich fold. A 
structural comparison with homologs showed that the His-Tyr catalytic dyad is conserved in 
HepIII. The unsuccessful attempts to obtain the HepIII-substrate complex structure was explained 
by the conformational flexibility seen in this enzyme. The results of our NMA calculation on the 
three HepIII structures identified a large-scale domain movement; with the hinge region near 
Asn281. In addition, the NMA predicts the possible active conformation of these lyases and this 
conformational change could be induced by the binding of longer GAG substrates. 
In the second part of this work, the first crystal structure of three ulvan lyase enzymes: 
LOR107, PLSV3936 and NLR48 from marine bacteria have been determined. All three enzymes 
share low sequence identity and degrade the marine polysaccharide, ulvan. Our structure data show 
that LOR107 and PLSV3936 adopt the β-propeller fold and NLR48 adopts the β-jelly roll fold. 
However, the His-Tyr catalytic dyad is conserved in all these enzymes. 
The complex structures of LOR107 with substrate suggest that Arg259 plays the role of 
neutralizer and His146 can play the dual base/acid role in the lytic degradation of the ulvan 
substrate. His167, Tyr243 are the other important residues facilitating the catalytic mechanism. A 
complex structure of PLSV3936 with substrate suggests that Arg 204 is the neutralizer of the 
carboxylic group, Tyr188 and His123 plays the catalytic base/acid role, respectively. However, 
the structural data in NLR48 suggests that the possible neutralizer of the carboxylic group is a 
Gln137. Tyr258 act as a base and acid for the cleavage near GlcA, while for IdoA the base is 
Lys139 and the acid is Tyr258. 
Overall the structural data suggests that the His/Tyr catalytic machinery is conserved 
among ulvan lyase enzymes. Differences seen in the active site reflect the plasticity adopted by 
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these enzymes to accommodate the heterogeneity of ulvan. Our structural data will serve as a 
template and aid researchers in engineering ulvan lyases to make them more suitable for industrial 
applications.  
Table 8-1 Summary of research contribution 
PL Family Substrate Fold Mechanism PDB Neutralizer Base Acid 
12 
Heparin 
lyase III 
Heparan 
sulfate 
(α/α)6 toroid + 
anti-parallel β-
sheet 
His/Tyr 5JMD Asn247 Tyr303 
24 
Ulvan 
lyase 
Ulvan 
β-propeller  
(7 blades) 
His/Tyr 
6BYP 
6BYX 
6BYT 
Arg259 His146 
25 
Ulvan 
lyase 
Ulvan 
β-propeller 
 (7 blades) 
His/Tyr 
5UAM 
5UAS 
Arg204 Tyr188 His123 
28 
Ulvan 
lyase 
Ulvan β-jelly roll His/Tyr 
6D2C 
6D3U 
Gln137 
Lys139 Tyr258 
Tyr258 
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